Cooperative Oligonucleotide-Directed Triple Helix Formation at Adjacent DNA Sites by Colocci, Natalia
Cooperative Oligonucleotide-Directed Triple Helix Formation 
at Adjacent DNA Sites 
Thesis by 
Natalia Colocci 
In Partial Fulfillment of the Requirements 
for the Degree of 
Doctor of Philosophy 
California Institute of Technology 
Pasadena, California 
1996 
(Submitted August 11, 1995) 
ii 
© 1996 
Natalia Colocci 
All Rights Reserved 
iii 
To my family 
iv 
ACKNOWLEDGMENTS 
I would like to express my gratitude to all the people who have helped 
make my time enjoyable during the past four years at Caltech. First, I would 
like to thank my advisor, Professor Peter B. Dervan. His constructive 
guidance, ever-present enthusiasm, scientific vision, and tremendous 
support have made it a pleasure for me to work with him. I have learned a 
lot at Caltech, about science and about being a researcher, and this I owe 
greatly to Peter. I am also grateful to present and past members of the Dervan 
group, who provided me with a stimulating environment in which to work. 
In particular, Michelle Parks and Jim Kelly have been fantastic people, both as 
friends and colleagues. Going through graduate school with them has been 
an experience I cherish and will never forget. Jim and Michelle have been an 
integral part of my graduate career, and I hope that there will be plenty of 
occasions in the future to have as much fun together as we have in the past. 
George Best has been an incredible friend, and I could not have asked for a 
better buddy. Conversing with him about politics, history, music (alas, 
country music too), and medicine, among many other things, was simply 
delightful. Milan Mrksich, Jason Szewczyk, David Liberles and Jurg Hunziker 
were great people to have around, and talking to them never ceased to be 
entertaining. Skiing with Scott Carter and Helmut Brunar was lots of fun. In 
addition, I would like to thank Eldon Baird for his tremendous help with 
technical ordeals. 
Mark Distefano was a great person to start working with as a neophyte. He 
is an excellent teacher, in technical as well as intellectual matters, and a lot of 
v 
what I learned in the lab I owe to him. Patrick Kearney from the Dougherty 
group helped me use the program Spartan for some of my studies. 
I would also like to thank all my friends from orchestra, USC, and UCLA. 
Life at Caltech without them would have been very different, and very much 
less appreciated. Weekend parties and skiing trips were always a welcomed 
break from lab work. In particular, I am grateful to Rita and Cecco for their 
friendship (and pasta), and to Jennifer and Greg. 
Finally, I would like to thank Ken. I had a great time with him during my 
last months at Caltech, and with him I shared many pleasant moments. I am 
also grateful to my family for their support in all my decisions. 
vi 
ABSTRACT 
Cooperative interactions between DNA-binding ligands are essential for 
their sequence specificity, binding affinity, and biological activity. Oligo-
nucleotides can bind cooperatively to adjacent sites on double-helical DNA by 
triple helix formation. The study of the cooperative binding of oligo-
nucleotides to DNA by triple helix formation is important as it provides 
useful information for the development of new methods leading to the 
sequence-specific recognition of DNA. As a first step towards this goal, the 
thermodynamics of the cooperative binding of oligodeoxyribonucleotides to 
adjacent DNA sites by triple helix formation have been determined by 
quantitative affinity cleavage titrations (Chapter Two). A 20-fold enhance-
ment in equilibrium association constant is realized for an llmer pyrimidine 
oligonucleotide binding in the presence of a neighboring bound site at 24 oc 
and pH 7.0 (25 mM TrisOAc, 10 mM NaCl, 1 mM spermine). This 
corresponds to an increase in binding free energy of 1.8 kcal•mol-1. This 
cooperativity is not observed when the two binding sites are separated by one 
base pair. The observed cooperative energy likely arises from favorable 
polarization and charge-charge interactions between the terminal bases at the 
triple-helical junction. 
In addition, the energetics of cooperative binding by oligodeoxyribonucleo-
tides to adjacent sites by triple helix formation have been determined as a 
function of sequence composition at the junction (Chapter Three). The 
binding affinity of an 11mer in the presence of a neighboring bound oligo-
nucleotide is enhanced by a factor of 12, 17, 61, and 127 when a 5'-TT-3', 
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5'-mcmC-3', 5'-TmC-3', and 5'-mCT-3' stack, respectively, is formed at the 
junction (10 mM Bis-Tris•HCl at pH 7.0, 10 mM NaCl, 250 J.!M spermine, 24 
°C) (me designates 5-methyl-2'-deoxycytidine). These binding enhancements 
correspond to an interaction energy between the two oligonucleotides of 1.5, 
1.7, 2.5, and 2.9 kcal•mol-1, respectively. The energetic penalties for a single-
base mismatch differ depending on sequence and the location of the mis-
match with respect to the 5'- or 3'-side of the junction. In the case of a 5'-TT-3' 
stack, a T•GC mismatch on the 5'- side of the junction decreases the inter-
action energy from 1.5 kcal•mol-1 to 0.6 kcal•mol-1, whereas a T•GC mis-
match on the 3'- side destroys cooperativity. For a 5'-mCT-3' stack, a mc•AT 
mismatch on the 5' -side of the junction decreases the cooperative interaction 
energy from 2.9 kcal•mol-1 to 1.7 kcal•mol-1, whereas a T•GC mismatch on 
the 3' -side of the junction destroys cooperativity. Most importantly, two 
llmer oligonucleotides interacting through a 5'-TT -3' stack binding to 
adjacent sites on DNA are significantly more sensitive to single-base 
mismatches than the corresponding 22mer binding to the same two abutting 
sites. 
The use of modified bases, such as 5-(1-propynyl)-2'-deoxyuridine, 
increases cooperativity between oligonucleotides bound to adjacent sites on 
DNA, presumably due to an increased stacking energy between the modified 
bases at the triplex junction (Chapter Four). Oligodeoxyribonucleotides 
containing 5-(1-propynyl)-2' -deoxyuridine and 5-methyl-2' -deoxycytidine as 
short as 8 nucleotides in length bind at micromolar concentrations to adjacent 
8-bp sites on double-helical DNA at 24 oc and pH 7.0 (10 mM Bis-Tris•HCl, 10 
mM NaCl, 1 mM spermine). Quantitative affinity cleavage titrations reveal 
that the binding affinity of an 8mer in the presence of a neighboring bound 
8mer is enhanced by a factor of at least 40. This corresponds to a remarkable 
Vlll 
cooperative interaction energy of> 4.5 kcal•mol-1. In addition, these coopera-
tive interactions allow oligonucleotides as short as 6mers to bind to three 
adjacent sites on double-helical DNA at near micromolar concentrations (10 
mM Bis-Tris•HCl at pH 7.0, 10 mM NaCl, 1 mM spermine, 24 °C). 
Cooperativity is also observed between purine-rich oligonucleotides 
(Chapter Five). Quantitative DNase footprinting titration experiments show 
that the binding affinity of an 11mer purine-rich oligonucleotide in the 
presence of a neighboring bound oligonucleotide is enhanced by a factor of 81 
when a 5' -GG-3' stack is formed at the junction (50 mM TrisOAc at pH 7.0, 10 
mM NaCl, 10 mM MgCh, 24 °C). This binding enhancement corresponds to 
an interaction energy between the two oligonucleotides of 2.7 kcal•moi-1, and 
is abolished when the two binding sites are separated by one base pair. 
The synthesis of pyrimidine oligonucleotide analogs containing 5-(1-
propynyl)- and 2'-0-allyl-modified nucleosides (Chapter Six), and the progress 
towards the synthesis of a novel base, N 7-2'-deoxyisoinosine, designed for the 
recognition of AT base pairs within a parallel isomorphous purine motif 
(Chapter Seven), are described. 
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CHAPTER ONE: 
Introduction 
Deoxyribonucleic acid (DNA) is a molecule of unsurpassed importance as 
it provides the genetic information necessary for the functioning and regu-
lation of cellular processes. Complex and diverse processes such as the bio-
synthesis of proteins, the immune response, and the hormonal action are 
only some of the fundamental ones responsible for the proper functioning of 
a living organism, and all depend on the specific interactions between native 
proteins and DNA. DNA plays a crucial role not only in biology, but also in 
medicine. The discovery that many diseases have a genetic component, and 
that nongenetic diseases are caused by improper gene expression, is revolu-
tionizing the field of medicine. The regulation of such gene expression, 
essential to both biological and physiological processes, relies on the ability of 
structurally different molecules such as proteins, carbohydrates, and low 
molecular weight natural products, to recognize and bind to a specific 
sequence on double-helical DNA through the formation of individually 
weak, noncovalent interactions. An understanding of these interactions is of 
fundamental importance as it would allow us on a microscopic level to 
control gene expression and, as a result, on a macroscopic level to direct the 
functioning of a living organism. 
DNA Structure. An analysis of the structure of DNA reveals the type of 
interactions involved in DNA-ligand complexes. The right-handed, double-
stranded helix comprises two antiparallel polymeric deoxyribonucleotide 
units held together by Watson-Crick hydrogen bonds between the bases on 
2 
opposite strands, and stabilized by vertical 7t-7t stacking interactions between 
bases on the same strand. 1 The major and minor groove present in DNA 
display different functionalities depending on the nature of the base pair 
(Figure 1.1). For example, the two hydrogen bond acceptors in the major 
groove of a GC base pair are the guanine-N7 and 06, and the hydrogen bond 
donor is the cytosine-NH2 group. In the major groove of an AT base pair, the 
two hydrogen bond acceptors are the adenine-N7 and thymine-04, while the 
hydrogen bond donor is the adenine-NH2 group. It is through the differential 
hydrogen bonding interactions between these functional groups displayed in 
the grooves of DNA and a DNA-binding ligand, as well as through 
electrostatic and van der Waal forces, that molecules bind to DNA, often with 
remarkably high specificity. 
Oasses of DNA-Binding Molecules. DNA binding molecules can be 
classified depending on the type of interactions involved with the double 
helix of DNA. One category includes intercalators such as the dyes ethidium 
and acridine orange and the drug daunomycin, which contain an extended, 
flat, often positively charged aromatic chromophore capable of inserting itself 
between DNA base pairs via the formation of 7t-stacking interactions (London 
dispersion and hydrophobic forces) with concomitant helix unwinding, 
lengthening, and stiffening.1 A second category comprises minor groove 
binders such as netropsin, distamycin, and Hoeschst 33258, which bind A, T-
rich sequences, and echinomycin and actinomycin D, which bind G,C-rich 
sequences of DNA. 1.2 These molecules recognize DNA through the 
formation of specific hydrogen bonds with the functional groups present in 
the minor groove, and/ or a combination of electrostatic interactions with the 
negatively charged phosphodiester backbone, favorable stacking interactions 
with the bases, and favorable hydrophobic contacts with the deoxyribose rings 
3 
Major Groove Major Groove 
. ' 
~Tr-w yN .. 
N~ H 
I o• 
dR ' Minor Groove Minor Groove 
Major Groove Major Groove 
Minor Groove Minor Groove 
Figure 1.1. Structure of the four Watson-Crick base pairs. Lone pa1rs are 
represented by the black shaded areas. The hydrogens available for hydrogen 
bonding to DNA-ligands are shaded. 
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present on the sides of the minor groove. Recently, a great deal of research 
has focused on the design and synthesis of distamycin and netropsin 
derivatives with the aim of learning more about the factors responsible for 
the sequence-specific recognition of DNA, and ultimately being able to 
modulate the specificity of these derivatives.2k·r Knowledge acquired from 
experiments of this nature has allowed Mrksich and Dervan to create 
oligomeric distamycin derivatives capable of GC (as opposed to AT) 
recognition.2j-o,2q.2r A third category of DNA-binding ligands includes natural 
proteins characterized by different structural motifs, such as leucine zippers, 
zinc fingers, helix-tum-helix, and helix-loop-helix, which are responsible for 
the different specificities observed.3 Specificity is derived from hydrogen 
bonds to the DNA bases in the major, or both major and minor groove, as 
well as from shape complementarity between the proteins and the DNA 
grooves. Salt bridges to the negatively charged DNA backbone may also be 
involved. Due to the present difficulty in predicting the tertiary and 
quaternary structure of proteins and the lack of simple rules governing the 
specificity of amino acids, it is currently very difficult to design proteins with 
a predetermined DNA specificity. A fourth class of DNA-binding molecules 
comprises oligonucleotides capable of sequence-specific recognition of DNA 
via the formation of a local triple helix stabilized by specific hydrogen bonds 
between the bases of the Watson-Crick duplex and those of the third strand. 
Of the classes of DNA-binding molecules mentioned above, oligonucleotides 
are the most specific ones. 
Triple-Helical Complexes. The first triple-helical complex was reported in 
1957 by Felsenfeld, Davies, and Rich, when they observed that in the presence 
of MgC12 three RNA strands form a polyribonucleotide complex in the 
stoichiometry of 2 poly(rU) to 1 poly(rA) strand.4 Rich et al. postulated the 
5 
formation of specific Hoogsteen hydrogen bonds between the adenine of an 
AU base pair and uridine in the third strand, which was subsequently 
confirmed by physical methods (Figure 1.2). Later experiments showed that 
poly(rC) was capable of forming a 2:1 complex with poly(rG) at low pH,5 
presumably due to the required protonation of C, and that poly(dT-dC) or 
poly(rU-rC) was capable of associating with poly(dG-dA)•poly(dC-dT) also at 
acidic pH to form triple-helical complexes in which T(U)•AT(U) and C+GC 
triplets are likely isomorphous. 6 
H H 
I I 
R-N N......._ /N"TTI 
\._N H ....... H I ~ 
/ 
0 
"H. £01 .N N / ·. H.· y '-R 
/ N N/ I 
Hoogsteen < I A .,.....H . ...-o 
N N N \ I I 
R H 
Watson-Crick 
U • AU Base Triplet C+GC Base Triplet 
Figure 1.2. Structure of the two base triplets present in a poly(rU-rC)2 • 
poly(rA-rG) triple-helical complex. 
Fiber diffraction studies of poly(rU)2 •poly(rA) and poly(dT)2 •poly(dA) 
suggested that triple-helical complexes have an A'-conformation in which 
the third strand is parallel to the purine strand of the duplex, and the sugars 
are in a C-3' endo conformation with anti-glycosidic bonds.7 Subsequent 
NMR, electron microscopy, circular dichroism and Raman spectroscopy 
experiments suggested that triple-helical complexes contain structural 
features of both A and B conformation depending on solution conditions and 
6 
sequence composition.8 Unfortunately, no high-resolution x-ray crystals of 
triplex DNA have been reported to date. 
Oligonucleotide-Directed Recognition of Double-Helical DNA. The 
observation that long polypyrimidine and polypurine strands can associate to 
form triple-helical complexes prompted the question whether short ( <18 base 
triplets) triple-helical complexes would be sufficiently stable to form in 
solution. Studies by Moser and Dervan demonstrated for the first time that a 
homopyrimidine oligodeoxyribonucleotide 15 nucleotides in length is capable 
of forming a stable local triple helix at a single site within a 4.06-kbp 
linearized plasmid (Figures 1.3 and 1.4).9 Affinity cleaving experiments (see 
below) indicated that the homopyrimidine strand binds in the major groove 
of DNA parallel to the homopurine strand by the formation of specific T • AT 
and C+GC triplets. In addition, it was observed that the stability of the triple 
helix is significantly decreased by the presence of a single base triplet 
mismatch. These findings are of pivotal importance as they suggested a new 
tool for the sequence-specific recognition of DNA. Because a 15-18-bp site on 
double-helical DNA is sufficient statistically to define a single site in 3x109-bp 
human genomic DNA (Table 1.1)/0 15-18mer oligonucleotides are in 
principle much more specific than restriction enzymes, which typically bind 
to 6-8-bp sites. The high specificity of oligonucleotides was demonstrated in 
experiments in which EDTA • Fe-modified pyrimidine oligodeoxyribo-
nucleotides were able to cleave total genomic bacteriophage, yeast, and 
mammalian DNA at a single site.12 These considerations alone suggest the 
power of oligonucleotide-directed triple helix formation as a method for the 
sequence-specific recognition of DNA. 
7 
3' 5' 3' 5' 
A-T 
/ 
T-A 
A-T 
G-C 
C-G 
3' T-A 
T•A-T 
C+G-C 
T•A-T 
C+G-C 
T•A-T 
p,., 
C+G-C ,.Q 
~ T•A-T 1.0 
0 C+G-C ~ 
T•A-T 
C+G-C 
T•A-T 
T•A-T 
T•A-T 
T•A-T 
*T•A-T 
5' T-A 
A-T 
T-A 
A-T 
T-A 
5' 3' 5' 3' 
Figure 1.3. Ribbon diagram of a triple-helical complex between a 4.06-
kbp DNA fragment and a Hoogsteen-bound EDTA • Fe-modified 15mer 
oligodeoxyribonucleotide. 
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Figure 1.4. Molecular model of a triple-helical complex. The third strand is 
depicted in gray. 
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Table 1.1. Relationship between duplex binding site and number of unique 
seguences. 
Binding Site Unique Binding Site Unique 
Size a Sequencesb Sizea Sequencesb 
4 136 12 8,390,656 
6 2080 15 536,870,912 
8 32,896 18 68,719,607,808 
10 524,800 21 2,199,023,300,000 
a The binding site size is given in number of base pairs. b The number of 
unique sequences is determined from 4" /2 when n (the binding site size) is 
odd, and (4" + 4"12)/2 when n is even.11 
Since Moser and Dervan's experiment, the phenomenon of triple helix 
formation has been the subject of extensive research.13 Kinetic studies have 
shown that triple helix formation is a slower process by as much as three 
orders of magnitude than double helix formation, although the rate of 
formation can be affected by pH and salt.14 Additional kinetic studies indicate 
that triple helices form by a "nucleation-zipping" process in which three to 
five base triplets constitute the nucleus. 14b UV melting curves,sb,Isa-ct melting 
temperature studies/5d and differential scanning calorimetry studies8b,ISc,e 
have been used to determine the thermodynamic parameters for pyrimidine-
purine-pyrimidine complex formation. Recently, studies on the effect of 
pH,16a salt16b and temperature16c have been carried out by quantitative affinity 
cleavage titrations, and have shown that triplex stability is increased by low 
pH (favoring protonation of the third strand cytidine) and temperature (as 
11 
might be expected for an associative process). The effects of salt concentration 
have been shown to vary depending on the cations present in solution. More 
recently, the thermodynamics of triple helix formation as a function of base 
triplet mismatches and oligonucleotide sequence composition were studied.17 
According to these experiments, a mismatch in the third strand is capable of 
destabilizing a local triple helix by at least 0.5 kcal• mol·1 (10 mM Bis-Tris • HCl, 
100 mM NaCl, 250 J.LM spermine, pH 7.0, 22 °C).17a In addition, measurement 
of the relative energetic contributions of the various dinucleotide units 
indicated that the stability of a triple helix is increased by a 5'-TT-3' and 
decreased by a 5'-mcmC-3' dinucleotide (me = 5-methyl-2'-deoxycytidine).17b 
In a second class of triple-helical complexes, purine-rich oligonucleotides 
bind in the major groove of DNA antiparallel to the homopurine strand by 
formation of specific G•GC and T•AT or A•AT base triplets (Figure 1.5).18 
These complexes are less sensitive to pH than pyrimidine-purine-pyrimidine 
ones, as protonation is not required for G•GC and T•AT or A•AT formation. 
Recently, a thermodynamic study of the stability of purine-purine-pyrimidine 
complexes as a function of sequence composition was reported.19 
While the pyrimidine and purine motifs provide a powerful method for 
the recognition of homopurine sites, the recognition of mixed purine-
pyrimidine sequences presents great difficulties. Towards this goal, several 
approaches have been undertaken. One approach involves the search for 
other base triplets such as G•TA (Figure 1.6).20 An ongoing approach 
involves the design and synthesis of novel nucleotides that can recognize CG 
or T A base pairs through the formation of new hydrogen bonding patterns 
and/or favorable steric interactions within the contours of the major groove. 
Progress in this area has been slow. For CG and TA recognition within the 
12 
Figure 1.5. Structure of G•GC, A•AT and T•AT base triplets found in the 
purine motif. The relative orientations of the strands are represented by the 
positive and negative signs. 
pyrimidine motif, the nonnatural intercalating base D3 (1-(2-deoxy-~-D­
ribofuranosyl)-4-(3-benzamido)phenylimidazole) seems to be the best 
solution presented to date (Figure 1.6).20b '21 For CG recognition within the 
purine motif, 2'-deoxynebularine seemed to be the most specific at first, 
although its specificity was later shown to be dependent on solution 
conditions and sequence composition. 22 A recently synthesized series of 
imidazole derivatives, designed to fit snugly into the major groove of DNA, 
N 
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Figure 1.6. Structure of the natural base triplet G•TA (top) and of the specific 
D3 •CG and D3•TA base triplets (bottom). D3 is believed to intercalate between 
two DNA base pairs. 
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displayed only weak CG and TA recognition.23 Lately, a nonnatural parallel 
N7-purine motif, in which the third strand orientation is reversed by moving 
the third strand deoxyribose from the N9 to the N7 position, was developed 
and may ultimately provide new leads for the recognition of CG and TA base 
pairs. 24 A description of this motif is presented in Chapter Seven. 
Although in principle the novel base design approach is very promising, 
the challenge of synthesizing novel heterocyclic compounds constitutes a 
limitation. In another, more synthetically feasible approach, oligonucleotides 
have been designed to cross-over the major groove, thus allowing the 
binding to mixed purine-pyrimidine sequences.25 Another strategy involves 
protein-mediated triple helix formation, as in the system described by Rao e t 
al. in which aRecA nucleoprotein filament containing single-stranded DNA 
promotes strand exchange with duplex DNA via a three-stranded DNA 
intermediate.26 
DNA Binding Assays. Two experimental techniques, DNA affinity 
cleaving and footprinting, are routinely used for analyzing the binding of 
oligonucleotides to DNA by triple helix formation (Figure 1.7).10 In affinity 
cleaving, a nonspecific DNA cleaving agent is covalently attached to a 
sequence-specific DNA binding oligonucleotide to afford a DNA sequence-
specific cleaving molecule. A commonly used nonspecific DNA cleaving 
molecule is EDTA • Fe which, in the presence of a reducing agent such as 
dithiothreitol, generates a diffusible oxidant capable of hydrogen a torn 
abstraction from the DNA backbone at locations near the bound site, leading 
to double strand cleavage. Functionalization of oligonucleotides with 
EDTA • Fe is achieved by the incorporation of a 5'-0-DMT -protected thymi-
dine-EDT A phosphorarnidite (T*) using automated DNA synthesis (Figure 
1.8).27 Analysis of the cleavage products from a 32P-end-labeled DNA 
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Figure 1.7. Schematic diagram of the DNA footprinting (A) and affinity 
cleaving (B) techniques used to determine the binding properties of a DNA-
binding ligand. Autoradiography (middle) of a high-resolution gel of 5'- and 
3'-32P-end-labeled DNA fragments shows the location and size of the binding 
site (left two lanes for footprinting; right two lanes for affinity cleaving). A 5'-
shift in the cleavage pattern indicates that a ligand is bound in the major 
groove. 
Figure 1.8. Structure of 5'-0-DMT -protected thymidine-EDT A phosphorami-
dite derivative (T*) used in affinity cleaving experiments and incorporated 
into oligonucleotides by automated DNA synthesis. 
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restriction fragment on an autoradiogram of a high-resolution, nondena-
turing gel gives information about the location and size of the binding site, 
and the orientation of the EDTA • Fe-modified molecule on double-helical 
DNA. Analysis of the asymmetric pattern of the cleavage bands provides 
direct information on the groove location (Figure 1.9). The fact that the 
intensity of the observed cleavage bands is proportional to the fractional 
occupancy allows a qualitative comparison of the differences in binding 
affinities of molecules equipped with EDTA • Fe. In addition, the recently 
developed quantitative affinity cleavage titrations technique allows the 
determination of the equilibrium association constants for oligonucleotides 
to duplex DNA by triple helix formation. 28 
In DNA footprinting,10 a 32P-end-labeled DNA fragment and the ligand of 
interest are incubated in solution, after which they are treated with a non-
specific DNA cleaving agent, such as DNase I or the synthetic reagent 
methidiumpropyl-EDTA (MPE), which cleaves DNA at every base position 
that is not protected by a bound ligand (Figure 1.7). Analysis of the cleavage 
products on an autoradiogram of a high-resolution, nondenaturing gel 
containing a sequencing lane shows the location and size of the binding site. 
Quantitation of the intensity of the footprint allows determination of the 
binding free energy for triple helix formation (quantitative DNase I foot-
printing).29 
Triple Helix-Mediated Control of Gene Expression. Despite its limitations, 
oligonucleotide-directed triple helix formation has already proven to be a 
powerful method for controlling gene expression in vitro. Oligonucleotides 
have been shown to inhibit the binding of proteins such as methylases, 
transcription factors, restriction enzymes, and polymerases, at sites 
overlapping with triplex binding sites.30 This ability was used to inhibit 
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Figure 1.9. Ribbon diagram showing the two types of cleavage patterns 
obtained by an EDTA-modified molecule bound in the major or minor 
groove of double-helical DNA. 
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transcription initiation and elongation in vitro.30b'31 These results suggest the 
possibility of using oligonucleotides for therapeutic purposes to control gene 
expression in diseases caused by improper gene expression. For this to occur, 
the great challenge, among many others, of designing and synthesizing 
oligonucleotides that are stable to nucleases and are capable of crossing 
membranes of specific cells must be solved. 
Other Work in the Area of Triple Helix Formation. To overcome the pH 
dependence of triple helix formation by cytidine- or 5-methyl-2'-deoxycyti-
dine-containing oligonucleotides, nonnatural bases such as 2'-0-methyl-
pseudoisocytidine,32a 6-methyl-8-oxo-deoxyadenosine, 32b 8-oxoadenosine,32' 
and 8-oxodeoxyadenosine,32' 1-(2-deoxy-~-D-ribofuranosyl)-3-methyl-5-amino-
1H-pyrazolo[4,3,-d]pyrimidone (P1),32d-f and a recently reported pyrazine 
analog32g were shown to recognize GC base pairs in a pH-independent 
manner (Figure 1.10). The synthesis of bases capable of K+-independent GC 
recognition is also an ongoing effort. 33 
To increase the stability of triple helices, their resistance to nucleases, 
and/ or improve their cellular uptake, oligonucleotides containing modified 
phosphate backbones have been constructed. While many oligonucleotide 
analogs of this type have been shown to hybridize with single-stranded DNA, 
few of those synthesized to date are capable of binding to double-helical DNA. 
These include oligonucleotides containing phosphorothioate-,34a phosphoro-
dithioate-, methyl phosphonate-,34b alkylphosphotriester-,34' formacetal-,34d 
and 3'-thioformacetal- modified backbones.34d Oligonucleotides with 
modifications in the ribose have also been synthesized (see Chapter Six). In 
addition, triplex formation by a-oligonucleotides,13 as well as by 
oligonucleotides covalently linked to intercalating agents, DNA cross-linking 
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Figure 1.10. Structure of protonated cytidine mimics designed for the pH-
independent GC recognition within the pyrimidine motif. (A) protonated 
cytidine. (B) 2'-0-methylpseudoisocytidine. (C) 6-methyl-8-oxo-2'-deoxy-
adenosine. (D) 1-(2-deoxy-~-D-ribofuranosyl)-3-methyl-5-amino-lH -pyrazolo-
[4,3,d]pyrimidone (Pl). (E) pyrazine analog. 
reagents, and DNA-cleaving reagents other than EDTA•Fe have also been 
reported.13..35 
Cooperative Oligonucleotide-Directed Triple Helix Formation. One of the 
challenges of oligonucleotide-directed triple helix formation is the develop-
ment of systems in which oligonucleotides bind to duplex DNA not only 
with high affinity, but also with high specificity. The easiest solution to 
increasing a pyrimidine oligonucleotide's affinity to DNA is to increase its 
length, or change the solution conditions to low pH and/or temperature. 
Nonetheless, increasing affinity without lowering the specificity is a difficult 
intellectual task as oligonucleotides with higher affinities to DNA target sites 
are inherently less sensitive to base mismatches than lower affinity ones. In 
addition, the ability to solve this task may be important from a therapeutic 
20 
stand point as well, as the side effects of nonspecific binding of 
oligonucleotides used in a therapeutic context would totally preclude their 
use. 
Nature's solution to increasing the sequence specificity and affinity of a 
DNA-binding ligand is cooperativity. Cooperative interactions between 
macromolecules, especially proteins, are ubiquitous in biological systems, and 
critically influence the regulation of gene expression.36 The two main 
mechanisms by which cooperative interactions occur are ligand-induced 
allosteric conformational change of a receptor, and dimerization between 
ligands. 36b These two mechanisms are conceptually different. In the first one, 
the binding of a ligand to a receptor causes a conformational change at a 
location distant from the binding site. In the second mechanism, generally 
leading to higher specificities, physical proximity between two ligands is 
required. 
Cooperative interactions occur most commonly between enzymes and 
their substrates, but also between hormones and hormone receptors, small 
molecules and proteins transporting these small molecules, and between ions 
and proteins. 37 The binding of oxygen to hemoglobin, of carbamoyl phos-
phate to aspartate in the pyrimidine biosynthesis, the self-assembly of lipid 
bilayers, and the stabilization of the triple-helical structure of collagen, are 
only few of the well studied cooperative processes naturally occurring in 
biological systems. Other more recently described cooperative systems 
involve the dimerization of transcription factors such as hepatocyte nuclear 
factor-la., the heterodimerization of low molecular weight molecules such as 
cyclosporin A and FK50638 and the cooperative binding of polyamides 
containing pyrroles and/ or imidazoles to DNA. 2m 
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Cooperative interactions have also been observed in nucleic acid systems. 
According to the well studied nucleation-zipping model for double helix 
formation, after the generation of the first, isolated and rather unstable base 
pair, additional base pairs form and stack onto one another, creating a nucleus 
leading to the spontaneous construction of the rest of the helix. 1 The binding 
of oligoinosines to a polycytidine template is believed to be cooperative.39a 
Cooperative interactions between short oligonucleotides bound to adjacent 
sites on DNA have been invoked in the nonenzymatic template-directed self-
replication of short RNA and DNA molecules39b-ct as well as in a recently 
described DNA sequencing methodology based on primer walking of strings 
of continuous hexamers.40 
The importance of cooperative ligand interactions in physiological 
processes has spurred an ongoing effort to explore these interactions in depth. 
Complex mathematical frameworks allowing for the analysis of ligand 
interactions in associative processes have been developed for representative 
cases in which either one type of ligand binds to a single class of identical 
sites, or two or more structurally different ligands bind to two or more sites.36b 
One of the best studied biological systems exemplifying the power of 
cooperativity is the phage A repressor system.36a During lysogeny, most genes 
of phage A are repressed, but can be efficiently switched on by external agents. 
The switch consists of a tripartite operator to which two different proteins 
bind (Figure 1.11). The binding of the first dimer repressor to one site on the 
operator enhances the binding of a second dimer repressor to a second site 
through protein-protein contacts, which in tum facilitates the binding of 
RNA polymerase to the third site. This system is remarkable in its dramatic 
sensitivity to changes in repressor concentration, allowing gene expression to 
be controlled very efficiently. Ptashne has illustrated the advantages of this 
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RNA Polymerase Repressor Dimers 
Figure 1.11. Schematic diagram of two dimer repressors and RNA polymerase 
bound cooperatively to DNA. 
cooperative system by comparing it to the corresponding noncooperative 
system.36a As shown in Figure 1.12A, repression is maintained in a lysogen 
over the first two- or three-fold drop in repressor concentration from an 
initial high level. This ensures that lysogens are not accidentally induced by 
possible fluctuations in repressor concentration. However, when the 
repressor concentration drops by a mere factor of five, repression is decreased 
by 50%. A noncooperative system in which the promoter is controlled by a 
single repressor-operator interaction would react much more sluggishly to 
changes in ligand concentration. Ptashne has also showed how the coopera-
tive binding of dimer repressor molecules to two sites on DNA increases the 
efficiency of repressor binding, compared with binding to a single site (Figure 
1.12B). If one assumes that each repressor binds to a single site with a free 
energy of -10 kcal•mol-1, and that the interaction energy between repressors 
bound to adjacent sites is -2 kcal• mol-1, 30 and 100 times more repressor 
would be required in the single-site case compared with the two-site system to 
A 
B 
c: 
0 
';; 
• ! 
a. 
II 
illll 
it 
1 
•oo 
.. 
.8 .6 
t 
23 
99.7'1. ,..,.._ulon 
! 
Repressor concentration 
10.. 10"' 10.. ~· 
....,..._ -•balluii(M) 
Figure 1.12. (A) Repression as a function of repressor concentration in a 
cooperative vs. noncooperative system. The cooperative system is much 
more sensitive to changes in repressor concentration than the noncoopera-
tive one. (B) Binding affinity of a ligand (repressor) to its target site (operator 
site) in a cooperative vs. noncooperative system. The ligand concentration 
required for 99% occupation of the target site drops by a factor of 30 when two 
ligands interact cooperatively. (Taken from Ptashne, M. A Genetic Switch; 
Blackwell Scientific Publications and Cell Press: Palo Alto, CA, 1986). 
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reach 99% and 99.9% level occupancy, respectively. This observation stems 
form the fact that cooperativity raises the ratio of specific to nonspecific 
binding by increasing the affinity of individual ligands to adjacent sites on 
DNA via cooperative ligand-ligand interactions. 
In the past six years there has been a considerable interest in exploiting the 
principles of cooperativity in systems involving triple-helical complexes. In 
1989, Strobel and Dervan reported the first example of a cooperative system in 
which two pyrimidine oligodeoxyribonucleotides 9 nucleotides in length bind 
cooperatively to adjacent homopurine sites on bacteriophage A genomic DNA 
by triple helix formation. 41 Stronger cooperative interactions were obtained 
by the addition of a dimerization domain capable of forming a short Watson-
Crick duplex to the juxtaposed 5'- and 3'-termini of two oligonucleotides 
bound to adjacent DNA sites, leading to the formation of a Y-shaped triple-
helical complex (Figure 1.13).42a,c In another study, Distefano and Dervan 
showed that the stability of the dimerization could be enhanced by the 
addition of a small molecule such as echinomycin targeted to the Watson-
Crick minihelix.42b This ligand-promoted dimerization of oligonucleotides 
may be thought of as analogous to the naturally occurring dimerization of 
proteins regulated by additional protein cofactors. Luebke and Dervan 
demonstrated that two oligonucleotides bound to adjacent sites on a DNA 
template are capable of being ligated by a phosphodiester or a pyrophosphate 
linkage by activation of the 5'-terminal phosphate of one oligonucleotide 
with BrCN, imidazole, and NiCl/3 Cooperative interactions have been 
invoked in the self-replication of oligonucleotides on a double-stranded DNA 
template by triple helix formation. 39b.c Cooperativity was also used to 
juxtapose two double-helical DNA fragments upon binding to a triple helix 
forming oligonucleotide, and ligate one or both strands by activation of 
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Figure 1.13. Schematic diagram of a Y -shaped triple-helical complex 
composed of two oligonucleotides, 1 and 2, binding cooperatively to 
double-helical DNA through the formation of a Watson-Crick 
minihelix. 
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the 5'-phosphate with N-cyanoimidazole.44 Froehler et al. observed the 
cooperative binding of oligonucleotides with a 3'-3' intemucleotide junction 
to opposite strands of duplex DNA by triple helix formation. 45 Finally, 
pyrimidine oligodeoxyribonucleotides were found to bind cooperatively to 
DNA by triple helix formation in the presence of intercalators such as 
benzo[ e ]pyridoindole derivatives.46 
Description of Thesis Work. This thesis describes studies designed to gain 
a deeper understanding of the phenomenon of cooperative binding of 
oligonucleotides to double-helical DNA by triple helix formation. Chapter 
Two illustrates experiments carried out to elucidate the origins of the 
cooperative binding of two pyrimidine oligodeoxyribonucleotides to adjacent 
sites on DNA.473 These experiments were the first to suggest that base 
stacking forces between the terminal bases at the triplex junction are greatly 
responsible for the observed cooperative interaction energy. Chapter Three 
reports the rigorous measurement of the energetics of the cooperative 
binding of two llmer oligonucleotides to DNA by triple helix formation by 
quantitative affinity cleavage titrations as a function of sequence composition 
at the junction.47b In addition, quantitative studies on the effect of 
mismatches on cooperativity are described. Results from these experiments 
demonstrated that a cooperative system is more sensitive to base mismatches 
than a noncooperative one.47b Addendums to both Chapters Two and Three 
describe unpublished experiments on the phenomenon of cooperativity as a 
function of sequence composition at the triplex junction. 
Chapter Four focuses on the synthetic strategies designed to increase the 
magnitude of cooperative interactions between pyrimidine oligonucleotides 
bound to abutting sites on DNA. It was reasoned that strong cooperative 
interactions would allow short (< 11 nt) oligonucleotides to bind to DNA. 
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The positive implications of this observation are two-fold: 1) a system in 
which short oligonucleotides bind to DNA would presumably be more 
specific than one in which longer oligonucleotides bind to DNA, and 2) the 
use of short oligonucleotides could presumably facilitate the application of 
cooperativity in therapeutics, as short, low molecular weight oligonucleotides 
could be more amenable to cell penetration and less toxic than longer, higher 
molecular weight ones. The described experiments show that the incorpora-
tion of nonnatural bases such as 5-(1-propynyl)-2'-deoxyuridine into pyrimi-
dine oligonucleotides increases cooperativity dramatically, allowing 8mers to 
bind to abutting sites on DNA at micromolar concentrations.48a In addition, 
the first example in which three oligonucleotides as short as 6mers bind 
cooperatively to DNA by triple helix formation is described.48b 
Chapter Five describes the cooperative binding of purine-rich oligonucleo-
tides to adjacent sites on DNA, and confirms that base stacking is greatly 
responsible for the observed cooperative interactions.49 
Chapters Six and Seven report studies not related to cooperativity. 
Chapter Six describes the synthesis of oligonucleotide analogs containing 5-(1-
propynyl)- and/or 2'-0-allyl-modified pyrimidine bases. Our goal was the 
determination of the energetics of triple helix formation by these 
oligonucleotide analogs and by the corresponding 2'-0-methyl analogs as 
well, with the hope of gaining a further understanding of how substituents at 
the 5- and 2'-position of oligonucleotides affect the stability of triple helices. 
Chapter Seven describes the progress towards the synthesis of a novel base, 
N 7-2'-deoxyisoinosine, designed to recognize AT base pairs within a parallel 
isomorphous N7-purine motif. A description of this new motif is presented 
in the introduction of this chapter. 
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CHAPTER TWO: 
Cooperative Oligonucleotide-Directed Triple Helix Formation 
at Adjacent DNA Sites. 
Introduction 
Cooperative interactions between proteins bound to DNA are essential for the 
regulation of gene expression.1 These cooperative interactions serve to increase 
the sequence specificity of DNA-binding proteins as well as the sensitivity of the 
binding equilibrium to concentration changes.2 When cooperative interactions 
occur between two (or more) ligands bound at neighboring sites on DNA, the 
specific binding of each ligand is enhanced. 
Oligodeoxyribonucleotide-directed triple helix formation is a powerful 
method for the sequence-specific recognition of double-helical DNA.3 To date, at 
least two classes of triple helix forming oligonucleotides have been identified. In 
one class, pyrimidine oligonucleotides bind in the major groove of double-helical 
DNA parallel to purine tracts by Hoogsteen hydrogen bond formation. 3a Specifi-
city is derived from thymine (T) recognition of adenine-thymine base pairs 
(T• AT base triplet) and protonated cytosine (C+) recognition of guanine-cytosine 
base pairs (C+GC base triplet).4 In another class of triple-helical structures, 
purine-rich oligonucleotides bind in the major groove anti parallel to the Watson-
Crick purine strand.3c,3e In this case, specificity is derived from G recognition of 
GC base pairs (G•GC base triplet) and A or T recognition of AT base pairs 
(A•AT and T•AT base triplets).5 
It has been demonstrated that oligonucleotides can bind cooperatively by triple 
helix formation to adjacent purine sites on double-helical DNA.6 For two 9-nt 
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oligonucleotides bound to adjacent 9-bp sites on an 18-bp purine tract, the 
binding enhancement at µM concentration was observed to be a factor of 3.5. 6 
Likely the adjacent sites were not fully occupied, and this qualitative observation 
is a minimum value. Cooperativity in oligonucleotide-directed sequence-specific 
recognition of DNA by triple helix formation can be dramatically enhanced by 
the addition of discrete dimerization domains to oligonucleotides.7 However, 
the maximum enhancement possible for the simplest case, involving directly 
abutting sites occupied by triple helix forming oligonucleotides, has yet to be 
determined. 
We report here the energetics of cooperative binding of pyrimidine oligo-
deoxyribonucleotides to adjacent sites on DNA by triple helix formation 
measured using quantitative affinity cleavage titrations.8 We find that pyri-
midine oligonucleotides bind cooperatively to abutting purine sites on double-
helical DNA. The equilibrium association constant of an oligonucleotide bound 
to an 11-bp site is measured in the absence and presence of a second oligo-
nucleotide occupying an adjacent, directly abutting site. The binding affinity of 
an 1 lmer in the presence of a neighboring bound pyrimidine oligonucleotide is 
enhanced by a factor of 20 at 24 °C and pH 7.0 (25 mM TrisOAc, 10 mM NaCl, 1 
mM spermine). 
Results 
The binding of oligonucleotides 1 and 2 to adjacent sites A and B on double-
helical DNA (D) forms the binary complexes l·D and 2-D, respectively, and the 
binding of either 1 to 2-D or 2 to l·D forms the ternary complex 1·2·D (Figure 2.1): 
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Figure 2.1 Schematic representation of a complex composed of two triple 
helix forming oligonucleotides binding at adjacent sites on double-helical 
DNA. Thick solid lines represent the DNA backbone of the target site and 
associated oligonucleotides. Thin solid lines represent Watson-Crick 
hydrogen bonds while dashed lines indicate Hoogsteen hydrogen bonds. 
Binding of the oligonucleotides is assessed by affinity cleavage using T*. 
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Kl 
1+2+ D ~ 1-D+2 
K2 r l K2+1 
K1+2 
1+2-D ~ 1·2·D 
Experiments were designed to measure K1, the binding of oligonucleotide 1 
to site A alone, and K1+2, the binding of the same oligonucleotide 1 to site A in 
the presence of oligonucleotide 2 bound to neighboring site B. This allowed us to 
determine the energetics of binding as a function of the occupancy of a 
neighboring site. 
Affinity cleavage reactions. Oligodeoxyribonucleotide 1, equipped with 
thymidine-EDTA at the 5'-position,9 was allowed to equilibrate with an 850-bp 
3'-32P-end-labeled duplex DNA fragment at 24 °C and pH 7.0 (25 mM TrisOAc, 
10 mM NaCl, 1 mM spermine) for 24 h followed by addition of dithiothreitol 
(DTT) to initiate cleavage. After 6 h the reactions were stopped by ethanol preci-
pitation, and the products were separated by denaturing polyacrylamide gel 
electrophoresis (Figure 2.2). The small amount of cleavage in a reaction 
containing 1 alone at 100 nM concentration indicates that 1 binds to the 11-bp 
target site weakly under these conditions (Figure 2.2, Lane 2). However, oligo-
nucleotide 1 at the same concentration (100 nM) in the presence of 1.0 µM 
concentration of oligonucleotide 2 produces a dramatic increase in cleavage 
(Figure 2.2, Lane 3). 
Cooperative Binding of llmer + 15mer at Directly Abutting Sites. To 
measure the magnitude of the cooperative enhancement, quantitative affinity 
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Figure 2.2. Autoradiogram of an 8% denaturing polyacrylamide gel of reaction 
products from affinity cleavage reactions with oligonucleotides 1 and 2 and a 
32P-labeled restriction fragment from pMD5152 containing the target site shown 
in Figure 2.1. The reactions were performed at 24 °C in 10 mM NaCl, 1 mM 
spermine, 25 mM Tris-Acetate, pH 7.0. Oligonucleotide 1 and 2 are present at 
100 nM and 1 µM concentrations, respectively. Lane 1, "A" specific sequencing 
reaction performed on 32P-labeled restriction fragment; Lane 2, oligonucleotide 
1; Lane 3, oligonucleotides 1 and 2; Lane 4, no oligonucleotide. 
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Figure 2.3. Autoradiogram of an 8% denaturing polyacrylamide gel of reaction 
products from affinity cleavage reactions with oligonucleotide 1 and a 32p_ 
labeled restriction fragment from pMD5152 containing the target site shown in 
Figure 2.1. The reactions were performed at 24 °C in 10 mM NaCl, 1 mM 
spermine, 25 mM Tris-Acetate, pH 7.0. Lanes 1 and 17, "A" specific sequencing 
reaction performed on 32P-labeled restriction fragment; Lanes 2-15, DNA affinity 
cleavage reaction products produced by 1 at various concentrations: 1 nM (Lane 
2); 2 nM (Lane 3); 5 nM (Lane 4); 10 nM (Lane 5); 20 nM (Lane 6); 50 nM (Lane 7); 
100 nM (Lane 8); 200 nM (Lane 9); 500 nM (Lane 10); 1 µM (Lane 11); 2 µM (Lane 
12); 5 µM (Lane 13); 10 µM (Lane 14); 20 µM (Lane 15); no oligonucleotide (Lane 
16). 
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Table 2.1: Equilibrium Association Constants for Two Triple Helix Forming 
Oligonucleotides Binding at Adjacent Sites on DNAa 
Oligonucleotide K (M-1) 
1 
1 + 2 (1 µM) 
1 + 4 (1 µM) 
1.2 (± 0.3 ) X 106 
2.3 (± 0.5) X lQ7 
2.4 (± 0.2) X lQ7 
-8.2 (± 0.2) 
-10.0 (± 0.2) 
-10.0 (± 0.1) 
a Values reported in the table are mean values measured from affinity cleavage 
titration experiments performed in Association buffer (10 mM NaCl, 1 mM 
spermine, 25 mM Tris-acetate, pH 7.0, 24 °C). 
cleavage titrations were performed over an extensive concentration range (Figure 
2.3). The extent of cleavage for each reaction is determined by phosphorimaging 
analysis10 and an equilibrium association constant, K, is obtained by fitting a 
Langmuir binding isotherm to the experimental data (Figure 2.4).8 Quantitative 
affinity cleavage titrations were carried out with 1 alone and with 1 in the 
presence of oligonucleotide 2 at a concentration sufficient to saturate the nearby 
15-bp site (24 °C, pH 7.0). The equilibrium constant for 3, an oligonucleotide 
with the same sequence as 2 but containing T* targeted to the 15-bp site B was 
found to be 1.3 (± 0.3) x 107 M-1. As the substitution of T* for T has a negligible 
influence on the binding affinity,8 we estimate that the 15-bp site should be 93% 
occupied by oligonucleotide 2 at 1 µM concentration. 
Analysis of cleavage data yielded equilibrium association constants of 1.2 (± 
0.3) x 106 M-1 for 1 binding alone (K1) and 2.3 (± 0.5) x 107 M-1 for 1 in the pres-
ence of 1.0 µM 2 (K1+2) (Table 2.1, Figure 2.4). The binding enhancement K1+2/ K1 
is a factor of 20. The free energies of binding (~G) at the 11-bp site for oligo-
nucleotide 1 in the absence and presence of oligonucleotide 2 are -8.2 (± 0.2) and 
-10.0 (± 0.2) kcal•mol-1, respectively, and the minimum free energy of interaction, 
~G1+2-~G1, is -1.8 (± 0.3) kcal•mol-1. 
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Figure 2.4. Binding isotherms obtained for oligonucleotide 1 alone (o), and in the 
presence of 1.0 µM oligonucleotide 2 ( • ), using quantitative affinity cleavage 
titration. A theoretical binding curve represented by the Langmuir equation 7 
(see Experimental Section) was used to fit the experimental data using lsat and K 
as adjustable parameters. Five (in the case of oligonucleotide 1) to six (in the case 
of oligonucleotide 1 in the presence of oligonucleotide 2) complete data sets were 
used to determine each association constant. The data points were divided by 
lsat to obtain 0app- Each data point represents the average of 5 to 6 individual 
experiments. 
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The Effect of a One Base Pair Gap Between Adjacent Sites. Quantitative 
affinity cleavage titrations were used to obtain isotherms for 1 binding in the 
presence and absence of 2 when the binding sites A and B are separated by one 
base pair (Figures 2.5 and 2.6). The association constants for the binding of 1 in 
the absence and presence of oligonucleotide 2 are K1 = 2.9 (± 0.2) x 106 M-1 and 
K1+2 = 2.5 (± 0.3) x 106 M-1 (Table 2.2). When the binding sites for the two oligo-
nucleotides are separated by one base pair there is no enhancement of the 
binding of 1 in the presence of 2. 
Table 2.2: Equilibrium Association Constants for Two Triple Helix Forming 
Oligonucleotides Binding on DNA where the Target Sites are Separated by One 
Base Paira 
Oligonucleotide 
1 
1 + 2 (1 µM) 
2.9 (± 0.2) X 106 
2.5 (± 0.3) X 106 
-8.8 (± 0.1) 
-8.7 (± 0.1) 
a Values reported in the table are mean values measured from affinity cleavage 
titration experiments performed in Association buffer (10 mM NaCl, 1 mM 
spermine, 25 mM Tris-Acetate, pH 7.0, 24 °C). 
Cooperative Binding of llmer + llmer at Directly Abutting Sites. The 
equilibrium binding constants for the binding of oligonucleotide 1 in the absence 
and presence of the llmer oligonucleotide 4 at 1.0 µM concentration to DNA are 
K 1 = 1.2 (± 0.3) x 106 M-1 and K1+4 = 2.4 (± 0.2) x 107 M-1 (Figures 2.7 and 2.8). 
This is a 20-fold increase in the binding of oligonucleotide 1 in the presence of the 
llmer oligonucleotide 4 (Table 2.1). The equilibrium binding constant of 5, an 
oligonucleotide with the same sequence as 4 but containing T* at the 3' -end, to 
the 11-bp site was shown to be 1.4 (± 0.5) x 106 M-1. Therefore, at 1 µM concentra-
tion, the 11-bp site should be 58% occupied by oligonucleotide 4 in the absence of 
bound 1.8 
5' 
3' 
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Figure 2.5. Schematic representation of a complex composed of two triple 
helix forming oligonucleotides binding on double-helical DNA where the 
two target sites are separated by one base pair. Thick solid lines represent 
the DNA backbone of the target site and associated oligonucleotides. Thin 
solid lines represent Watson-Crick hydrogen bonds while dashed lines 
indicate Hoogsteen hydrogen bonds. 
46 
1.2 
0 
1.0 
0 
-• ···· o · 
0.8 .i 
0.6 
.'i 
e 
app 0.4 
0.2 
0.0 
-0.2 
1 o-10 10-9 10-8 10-7 10-6 10-5 10-4 
[1] (M) 
Figure 2.6. Binding isotherms obtained for oligonucleotide 1 alone (o), and in the 
presence of 1.0 µM oligonucleotide 2 ( • ) bound to DNA where the two target 
sites are separated by one base pair. The solid sigmoidal curve represents the 
titration binding isotherm obtained for oligonucleotide 1 alone; the dashed 
sigmoidal curve represents the titration binding isotherm obtained for oligo-
nucleotide 1 in the presence of oligonucleotide 2. The data shown was obtained 
using the quantitative affinity cleavage titration method as described above (see 
Figure 2.4). 
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Figure 2.7. Schematic representation of a complex composed of two 11-nt 
triple helix forming oligonucleotides binding at adjacent sites on double-
helical DNA. Thick solid lines represent the DNA backbone of the target 
site and associated oligonucleotides. Thin solid lines represent Watson-
Crick hydrogen bonds while dashed lines indicate Hoogsteen hydrogen 
bonds. 
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Figure 2.8. Binding isotherms obtained for oligonucleotide 1 alone (o), in the 
presence of 1.0 µM oligonucleotide 2 ( • ), and in the presence of 1.0 µM oligo-
nucleotide 4 (D.). The solid sigmoidal curves represent the titration binding 
isotherm obtained for oligonucleotide 1 alone, and oligonucleotide 1 in the 
presence of oligonucleotide 2; the dashed sigmoidal curve represents the titration 
binding isotherm obtained for oligonucleotide 1 in the presence of 
oligonucleotide 4. 
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Discussion 
There is a 20-fold difference in the association constants for the binding of 1 in 
the absence versus the presence of oligonucleotide 2 at 1.0 µM concentration 
(Table 2.1). In the presence of 1 µM concentration of 2, the 15-bp site is at least 
93% saturated with the adjacent 11-bp site being unoccupied. The observed 1.8 
kcal•mol-1 energy difference represents the minimum free energy of interaction 
between 1 and 2. To determine the full magnitude of cooperativity between 1 
and 2, a model which takes into account the extent of occupation of the adjacent 
15-bp site allows calculation of the total cooperative interaction energy. 
Heterodimeric Cooperative Systems. Hill has derived a grand partition 
function (~) for a heterodimeric cooperative system in which two different 
ligands, LA and LB, bind uniquely to two distinct sites and each ligand perturbs 
the binding equilibrium at the noncognate site:2b 
(1) 
where KA and KB are equilibrium association constants for LA and LB binding in 
the absence of each other, and y is related to the interaction energy, Ecoop, 
between LA and LB by: 
y = exp(-Ecoop / RT) (2) 
The fractional occupancy of site A by LA is given by: 
(3) 
where 
1 + yKB[LB] 
<I>= 1+ KB[LB] 
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(4) 
Equations 2 and 4 can be combined and rearranged to give the following 
expression for the interaction energy: 
<l>(l + KB[LB]) - 1 
Ecoop = -RTln KB[LB] (5) 
Energetics of Cooperatively Binding Oligonucleotides: llmer + 15mer. 
This simple model requires that two conditions be satisfied: the ligands do not 
interact in solution, and, under experimental conditions chosen, LA does not 
bind to site Band LB does not bind to site A. The sequences of the 11- and 15-bp 
sites were chosen to maximize the binding specificities of oligonucleotides 1 and 
2 for their designated sites. For oligonucleotide 1 at ::Q0 µM concentrations, there 
was no detectable cleavage in the 15-bp target site region, evidence that 1 has low 
affinity for the 15-bp site. For oligonucleotide 2, at :S::1.0 µM, there was no 
detectable binding in the 11-bp target site region. Since 1 and 2 do not dimerize 
significantly in solution and since neither oligonucleotide shows any detectable 
affinity for its noncognate site under the conditions chosen,11,12 the model 
described above can be reliably used to determine Ecoop· For the cooperatively 
binding oligonucleotides described here LA is oligonucleotide 1, site A is the 11-
bp site and KA is K1. Similarly, LB is oligonucleotide 2, site Bis the 15-bp site and 
KB is Kz. Comparison of the Langmuir expression (see below Experimental 
Section, equation 7) and equation 3 shows that K1+2 in the former equals <l>K1 in 
the latter. Thus, <1>1.0 = K1+2/ K1 = 20 where <I>i.o is the value of <l> when [2] = 1.0 
µM. Substitution of the values 20 (± 6), 1.3 (± 0.3) x 107 M-1, and 1.0 (± 0.1) x 10-6 
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M for <I>, K2, and [2], respectively, in equation 5 affords a value of -1.8 (± 0.2) 
kcal• mol-1 for Ecoop between the 1 lmer 1 and the 15mer 2. The correspondence 
of this value with ~G1+2-~G1= -1.8 kcal•mol-1 can be explained by the fact that 
the 15-bp site is likely fully saturated (>93% occupied) by oligonucleotide 2 in the 
presence of 1. 
Energetics of Cooperatively Binding Oligonucleotides: llmer + llmer. 
Under the conditions used for quantitative affinity cleavage titrations, and in the 
absence of any cooperative energetic benefit, oligonucleotide 4 at 1 µM concen-
tration occupies the 11-bp site 58%. For the cooperatively binding oligonucleo-
tides described here LA is oligonucleotide 1, site A is the 11-bp site and KA is K1. 
Similarly, LB is oligonucleotide 4, site Bis the designated 11-bp site and KB is Ks. 
Substitution of the values 20 (± 5), 1.4 (± 0.5) x 106 M-1, and 1.0 (± 0.1) x lo-6 M for 
<I>, Ks, and [4], respectively, in equation 5 affords a value of -2.1 (± 0.2) 
kcal•mol-1 for Ecoop between the llmers 1 and 4. This value is the same within 
experimental uncertainty as that obtained when 1 lmer 1 and 15mer 2 fully 
saturate the adjacent sites on DNA. This suggests that the binding site of 
oligonucleotide 4 is more than 58% occupied at 1 µM concentration and likely 
saturated due to the binding of oligonucleotide 1 to its designated site A. From 
quantitative affinity cleavage titrations, we found that the binding of 1 lmer 1 to 
its site is increased 20-fold in the presence of directly abutting oligonucleotide 4. 
In the presence of 1 µM 1, the occupancy level of oligonucleotide 4 at site B is 
calculated to be 97%. 
Origin of Cooperative Binding Forces. Two oligonucleotides bind 
cooperatively to duplex DNA with an interaction energy of 1.8-2.1 kcal•mol-1. 
Potential sources for this cooperative interaction energy include propagation of a 
conformational transition between adjacent sites and base stacking of the 
terminal thymines. Early fiber diffraction studies, 13a and chemical footprinting 
52 
experiments l 3b,l3c are consistent with a B- to A' -form conformational change 
upon formation of a triple-helical complex. However, IR, CD and NMR studies 
suggest that DNA triplexes contain structural features of both A- and B- confor-
mations.14 One would anticipate that triplex formation at site A would be 
facilitated by a structural transition at site B. Because the cooperative enhance-
ment was not observed when triple helix binding sites were separated by one 
base pair, our data suggests that either there are no significant propagated 
structural changes beyond the immediately neighboring base pair, or that a one 
base pair gap creates a junction that prevents the propagation. 
The free energy of base stacking, which arises from induced dipole 
interactions,15 and hydrophobic forces16 has been shown to range from -0.5 
kcal•mol-1 to -3 kcal•mol-1 for monomer nucleosides associating in aqueous 
solution, depending on solution, salt conditions, nucleoside identity, concentra-
tion, and temperature.15 To date, no value for the free energy change associated 
with stacking interactions between contiguous bases of a triple helix forming 
oligonucleotide has been reported. The structure at the interface of oligonucleo-
tides 1 and 2 bound on neighboring sites is likely similar to that of the corre-
sponding contiguous triplex. The 1.8-2.1 kcal•mol-1 interaction energy between 
oligonucleotides 1 and 2 when binding to adjacent sites on DNA at 24 °C and pH 
7.0 (25 mM TrisOAc, 10 mM NaCl, 1 rnM spermine) may reflect a significant 
contribution from a T-T stack in the third strand of triple helices.17 Under these 
conditions, if this is true, we would anticipate that the 1.8-2.1 kcal•mol- 1 
cooperative effect is sequence dependent. The energetics of a CT, TC and CC 
stack at the junction will be necessary to answer this question (see Chapter 
Three). 
Implications. Pyrimidine oligodeoxyribonucleotides can bind cooperatively 
to abutting sites on double-helical DNA with an interaction energy of 1.8-2.1 
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kcal•mol-1 for TAT triplets at the triple helix junction (Figure 2.9) . Thus, for 
oligonucleotide-directed sequence specific recognition of DNA, cooperative 
interactions may allow for significant reduction in the length of oligonucleotides 
with little decrease in the binding affinity or specificity. 
54 
5' 3' 
Site C 
22-bp Site 
Site A 
3' 5' 
Figure 2.9. Ribbon model of oligonucleotides 1 and 4 bound at adjacent 
sites on duplex DNA by triple helix formation. The Watson-Crick duplex 
strands are shown as white ribbons, and the triple helix forming 
oiligonucleotides are shown as dark ribbons. 
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Addendum to Chapter Two: 
Influence of Terminal Phosphates at the 
Triplex Junction on Cooperativity 
In addition to induced conformational changes and base stacking, we cannot 
rule out that hydrogen bonding between hydroxyl groups on the terminal sugars 
may be responsible for the observed cooperativity, although the energetic 
contribution of such bonds in the aqueous environment are likely small. In an 
effort to determine the effect of hydrogen bonding between the hydroxyl groups 
of the terminal sugars on cooperativity, quantitative affinity cleavage titrations 
were carried out with oligonucleotide 1 binding to site A in the absence and 
presence of the 5'-phosphate derivative of 2 (oligonucleotide 6) at 1 µM, and with 
the 3'-phosphate derivative of 1 (oligonucleotide 7) binding to site A in the 
absence and presence of 1 µM 2 (Figure 2.10). The binding constants of 
oligonucleotide 1 binding to site A in the absence and presence of 1 µM 6 are K1 = 
1.2 (± 0.3) x 106 M-1 and .K1+6 = 1.1 (± 0.3) x 1()7 M-1, respectively, and the binding 
enhancement is K1+6 / K1 = 9.6 (Table 2.3). The binding constants of oligonucleo-
tide 7 binding to site A in the absence and presence of 1 µM 2 are K7 = 5.1 (± 0.7) 
x 106 Ml and K7+2 = 3.1 (± 0.7) x 107 M-1, respectively, and the binding 
enhancement is K7+2 I K7 = 6.1 (Table 2.3). These results suggest that replacing 
the 5' -OH of oligonucleotide 2 or the 3' -OH of 1 with a phosphate group 
decreases the binding enhancements arising from cooperativity. Nonetheless, it 
is important to note that replacement of the terminal hydroxyl with phosphate 
groups still allows for hydrogen bonding between the sugars located at the 
triplex junction. Further studies should be carried out to determine conclusively 
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Figure 2.10. Schematic representation of a complex composed of two 
triple helix forming oligonucleotides binding at adjacent sites on DNA in 
the presence of a phosphate group at the 3'-side (A) or 5'-side (B) of the 
triplex junction. me designates 5-methyl-2'-deoxycytidine. 
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Table 2.3: Equilibrium Association Constants for Two Triple Helix Forming 
Oligonucleotides Binding to DNA in the Presence of Phosphate Groups at the 
Triplex Junctiona 
Oligonucleotide 
1 
1 + 6 (1 µM) 
7 
7 + 2 (1 µM) 
K (M-1) 
1.2 (± 0.3) X 106 
1.1 (± 0.3) X 107 
5.1 (± 0.7) X 1Q6 
3.1 (± 0.7) X 107 
K11+11IK11 
9.2 
6.1 
a Values reported in the table are mean values measured from affinity cleavage 
titration experiments performed in Association buffer (10 mM NaCl, 1 mM 
spermine, 25 mM Tris-Acetate, pH 7.0, 24 °C). 
the effects on cooperativity of hydrogen bonding between the terminal sugars of 
oligonucleotides bound at adjacent sites on DNA. 
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Experimental Section 
General. E. coli JMll0 was obtained from Stratagene. Qiagen plasmid kits 
were purchased from Qiagen Inc. Sonicated, deproteinized calf thymus DNA 
was purchased from Pharmacia. Nucleotide triphosphates were obtained from 
Pharmacia. Nucleotide triphosphates labeled with 32p (~ 3000 Ci/mmol) were 
purchased from Amersham. Restriction endonucleases were purchased from 
New England Biolabs, and used according to the suggested protocol in the 
provided buffer. Thymidine and 5-methyl-2'-deoxycytidine phosphoramidites 
were obtained from ABI and Cruachem, respectively. Sephadex resins were 
obtained from Pharmacia. Sequenase Version 2.0 was obtained from United 
States Biochemical. 
Construction of pMD5152 and pMD5354. These plasmids were prepared by 
standard methods. 18 Briefly, pMD5152 was prepared by hybridization of two 
synthetic oligonucleotides, 5' -d(ACGTTCCTAAAAAAGGAAAAAAAAGAGA-
GAGAGATCTG)-3' and 5' -d(GATCCAGATCTCTCTCTCTTTTTTTTCCTTTTTT-
AGGA)-3', followed by ligation of the resulting duplex with pUC18 DNA 
previously digested with Hindlll and BamHI; this ligation mixture was used to 
transform E. coli JMll0 (Stratagene). Plasmid DNA from ampicillin resistant, 
white colonies was isolated and the presence of the desired insert confirmed by 
restriction analysis and Sanger sequencing. Preparative isolation of plasmid 
DNA was performed using a Qiagen plasmid kit. Plasmid pMD5354 was 
prepared using a similar procedure with the oligonucleotides 5' -d(AGCTTCC-
TAAAAAAGGAAAAAAAAAGAGAGAGAGATCTG)-3' and 5' -d(GATCCAG-
ATCTCTCTCTCTTTTTTTTTCCTTTTTT AGGA)-3'. 
Oligonucleotide Preparation. Oligonucleotides were synthesized by 
standard automated solid-support chemistry on an Applied Biosystems Model 
380B DNA synthesizer using 0-cyanoethyl-N,N-diisopropyl phosphoramidites.19 
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The phosphoramidite of thymidine-EDTA (T*) was prepared according to 
published procedures. 9 Controlled pore glass derivatized with T* was prepared 
as described by Strobel.20 Oligonucleotides 6 (the 5'-phosphate derivative of 
oligonucleotide 2) and 7 (the 3'-phosphate derivative of oligonucleotide 1) were 
synthesized by incorporation of the chemical 5'- and 3'-phosphorylation reagent 
2-[2-(dimethoxytrityloxy)ethyl-(2-cyanoethyl)-(N,N-diisopropyl)-phosphoramidi-
te purchased from Glen Research. Oligonucleotides 1, 3, 5, and 7 containing T* 
were deprotected with 0.1 N NaOH at 55 cc for 24 h, neutralized with glacial 
acetic acid, desalted on Pharmacia Sephadex (G-10-120) spin columns, and dried 
in vacuo. Oligonucleotides 2, 4, and 6 were deprotected with concentrated 
ammonium hydroxide at 55 cc for 24 h, and dried in vacuo. The crude 5'-
terminal-dimethoxytrityl protected oligonucleotides were purified by reverse 
phase FPLC on a ProRPC 10/10 (C2-Cs) column (Pharmacia LKB) and a gradient 
of 0-40% CH3CN in 0.1 M triethylammonium acetate, pH 7.0, detritylated in 80% 
AcOH, and chromatographed a second time. Triethylammonium acetate was 
removed via repeated resuspensions of the oligonucleotides in water followed by 
lyophilization. Oligonucleotide concentrations were determined by UV 
absorbance at 260 nm using extinction coefficients (M-1 cm-1) of 8800 (T and T*) 
and 5700 (IDC). 
Preparation of Labeled Restriction Fragment. The 3'-32P-labeled duplex was 
prepared by digestion of the plasmid pMD5152 (or pMD5354) with EcoRI, 
followed by treatment with a-32P-dATP and a-32P-TTP in the presence of 
Sequenase. To remove nonincorporated radioactivity, the fragment was passed 
through a Pharmacia NICK column. The DNA was then digested with Xmnl, 
followed by separation of the resulting products on a 5% nondenaturing 
polyacrylamide gel (19:1, monomer/bis). The gel band corresponding to the 
desired 850-bp fragment (851-bp for pMD5354) was visualized by auto-
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radiography, excised, crushed, and soaked in 10 mM Tris, pH 8.0, and 20 mM 
EDTA, at 37 °C for 12 h. The resulting suspension was filtered through a 0.45-µm 
filter, and the eluted DNA present in the supernatant was precipitated with 
NaOAc/EtOH. The DNA pellet was washed with 70% EtOH, dried in vacuo, 
resuspended in TE buffer (10 mM Tris, pH 8.0, 1 mM EDTA), extracted five times 
with phenol, twice with 24:1 CHCl3/isoamyl alcohol, and reprecipitated with 
NaOAc/EtOH. The DNA pellet was washed with 70% EtOH, dried in vacuo, and 
resuspended in 25 mM Tris-acetate, 100 mM NaCl, pH 7.0 at a final activity of 
100,000 cpm/µL, and was stored at -20 °C. 
Quantitative Affinity Cleavage Titrations. In a typical experiment, a 5 nmol 
aliquot of the desired oligonucleotide-EDTA was dissolved in 50 µL of aqueous 
200 µM Fe(N~)2(SO4)2•6H2O to produce a solution that was 100 µMin oligo-
nucleotide. This solution was then diluted serially to yield 100 µM, 10 µM, 1 µM, 
100 nM, 10 nM, and 1 nM solutions. The appropriate volume of these solutions 
was then distributed among 15-17 1.5 mL microcentrifuge tubes at the appro-
priate concentrations. A stock solution containing labeled target DNA, Tris-
Acetate buffer, NaCl, calf thymus DNA, the second oligonucleotide where 
needed, and water, was distributed to each reaction tube in 12 µL aliquots, and 
the appropriate volume of water and 4 µL of 10 mM spermine were added to 
each tube to bring the total volume to 36 µL. The oligonucleotide-EDTA•Fe(II) 
and the DNA were allowed to equilibrate for 24 h at 24 °C. The cleavage 
reactions were initiated by the addition of 4 µL of a 40 mM aqueous DTT solution 
to each tube. Final reaction conditions in 40 µL of Association buffer were 25 
mM TrisOAc at pH 7.0, 10 mM NaCl, 1 mM spermine, 100 µM bp calf thymus 
DNA, 4 mM DTT, and approximately 10,000 cpm labeled DNA. The reactions 
were incubated for 6 h at 24 °C. Cleavage reactions were terminated by 
NaOAc/EtOH precipitation and the reaction tubes were then stored at -20 °C for 
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30 minutes before centrifugation. The DNA cleavage products were washed 
with 70% aqueous EtOH, dissolved in 50 µL of water, and dried in vacuo. The 
DNA was then resuspended in 10 µL of formamide-TBE loading buffer, heated at 
55 °C for 10 minutes to effect dissolution, and transferred to a new tube. The 
Cerenkov radioactivity of the solutions was measured with a scintillation 
counter, followed by dilution to the same cpm/µL with more formamide-TBE 
buffer. The DNA was denatured at 95 °C for 3 minutes, and 5 µL from each 
sample were loaded onto a 8% denaturing polyacrylamide gel. 
Construction of Titration Binding Isotherms. Gels were exposed to 
photostimulable storage phosphor imaging plates (Kodak Storage Phosphor 
Screen S0230 obtained from Molecular Dynamics) in the dark at 24 °C for 5-12 
h.12 A Molecular Dynamics 400S Phosphorlmager was used to obtain data from 
the phosphorimaging screens. Rectangles of the same dimensions were drawn 
around the cleavage bands at the target and at the references sites. The 
ImageQuant v. 3.0 program running on an AST Premium 386/33 computer was 
used to integrate the volume of each rectangle. 
Affinity Cleavage Titration Fitting Procedure. A detailed description of the 
affinity cleavage titration procedure has been published.8 The relative cleavage 
efficiencies at the target site for each oligonucleotide concentration were deter-
mined by using the following equation: 
lsite = ltot-Jdref (6) 
where ltot and lref are the intensities of the cleavage bands at the target site and 
at the reference site, respectively, and A is a scaling parameter defined as the ratio 
ltotllref at the lowest oligonucleotide concentration. A theoretical binding 
curve, represented by equation 7 where lsat is the apparent maximum cleavage, 
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Ki the equilibrium association constant for oligonucleotide i, and [Oltot the 
oligonucleotide-EDTA concentration, was used to fit the experimental data using 
Isat and Ki as adjustable parameters: 
Ki[Oltot 
lfit = Isat 1 + Ki[UJtot (7) 
KaleidaGraph software (version 2.1, Abelweck Software) running on a 
Macintosh IIfx computer was used to minimize the difference between lfit and 
Isite for all data points. All values reported in the text are the means of three to 
six experimental observations± SEM, unless otherwise indicated. For graphical 
representation and comparison, Isite values were converted to apparent 
fractional occupancies ( 0app) by dividing Isite by Isat-
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CHAPTER THREE: 
Cooperative Triple Helix Formation at Adjacent DNA Sites: 
Sequence Composition Dependence at the Junction 
Introduction 
Cooperative interactions between proteins bound to DNA are essential for the 
regulation of gene expression. These cooperative interactions serve to increase 
the sequence specificity of DNA-binding proteins as well as the sensitivity of the 
binding equilibrium to concentration changes.I When cooperative interactions 
occur between two (or more) oligonucleotides bound at neighboring sites on 
double-helical DNA, the specific binding of each oligonucleotide is enhanced.2,3 
Pyrimidine oligodeoxyribonucleotides 11 nucleotides (nt) in length are known to 
bind cooperatively to abutting sites on double-helical DNA by triple helix 
formation, resulting in a 1.8 kcal •mol-1 interaction energy between the oligo-
nucleotides. 2b This interaction energy likely arises from 1t-stacking between the 
thymines at the triple-helical junction. An increase in cooperativity between 
triple helix forming oligonucleotides was achieved by the use of modified bases 
such as 5-(1-propynyl)-2'-deoxyuridine, which allow greater stacking interactions 
in the third strand (see Chapter Four).2c,4 Even stronger cooperative interactions 
were obtained by the addition of dimerization domains to oligonucleotides such 
as those capable of forming a short Watson-Crick helix or intercalators.3,5 
The nature of the cooperative interactions between triple helix forming oligo-
nucleotides binding to adjacent sites on DNA is still not well understood. A one 
base-pair gap between the adjacent triple helix sites abolishes cooperativity, 
suggesting that cooperative interactions largely arise from stacking between the 
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bases at the triplex junction.2 Based on these results, the interaction energy 
between cooperatively binding oligonucleotides should depend on the nature of 
the base stack at the junction. Here we report the energetics of cooperative 
binding of pyrimidine oligodeoxyribonucleotides to adjacent sites on DNA by 
triple helix formation as a function of sequence composition at the junction (base 
stacks 5'-TT-3', 5'-IDCT-3', 5'-TmC-3', and S'JnCmC-3') (me designates 5-methyl-
2'-deoxycytidine). The equilibrium association constants of four oligonucleotides 
binding to four 11-bp sites paired as four different neighbors are measured in the 
absence and presence of a second 1 lmer oligonucleotide occupying an adjacent, 
directly abutting site by quantitative affinity cleavage titrations (QACT).6 The 
effect of a single base mismatch at the junction on the cooperative energy between 
two triple helix forming oligonucleotides reveals that hydrogen bonding 
between the third strand and the target site is important for proper base stacking 
in the third strand. Finally, we determine the equilibrium association constant of 
a 22mer oligonucleotide targeted to two abutting 11-bp sites in the presence and 
absence of a single-base mismatch. This data allows us to compare the sensitivity 
to single-base mismatches of oligonucleotides binding cooperatively to DNA 
with that of a longer oligonucleotide binding noncooperatively to the same two 
abutting sites on DNA. 
Results 
A system was designed to allow determination of the interaction energies 
between two oligonucleotides when a 5'-TT-3', 5'-TIDC-3', 5'-IDCT-3' or S'JnCmC-3' 
stack is formed at the junction (Figure 3.1). Two 11-nt oligodeoxyribonucleo-
tides, 5'-d(*TTTTTTmcmcTTT)-3' (1) or 5'-d(*TTTTTTmcmcTTIDC)-3' (3) and 5'-
d(TTTTTIDCTmCTmCT)-3' (2) or 5'-d(mCTTTTIDCTmCTmCT)-3' (4) bind site-
specifically to adjacent sites A (or C) and B (or D) on an 850-bp 3'-32P-end-labeled 
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Figure 3.1. Schematic representation of a complex composed of two triple helix 
forming oligonucleotides binding at adjacent sites on double-helical DNA 
wherein a 5'-TT-3' (A), 5'-TmC-3' (B), 5'-mCT-3' (C), or a 5'-mcmc-3' (D) stack is 
formed. Thick solid lines represent the DNA backbone of the target site and 
associated oligonucleotides. Thin solid lines represent Watson-Crick hydrogen 
bonds while dashed lines indicate Hoogsteen hydrogen bonds. Binding of each 
oligonucleotide is assessed by affinity cleavage.6 
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' . ' . ' . ' . ' . .. ' .. 
~: 1 1 1 1 r r 1 1 1 1 1 1 1 1 1 1 1 1 1 r r 1 ~: 
A 
Oligonucleotide 1 Oligonucleotide 2 
m m m m m 
5•.:"T T T T T T C C T TT T T T T T C T C T C T -3' 
5'- A A A A AG GA A A AA A A AG AG A GA -3' 
3'- T T T T TC C T T T TT T T T C T C TC T -5' 
Site A Site B 
B 
Oligonucleotide 1 Oligonucleotide 4 
mm m m m m 
5'.:"T T T T T T C C T TT CT T T T C T CT C T -3' 
5'- AAAAAGGAAA GAAAAGAGAGA-3' 
3'- T T T T T C C T TT CT T T T C T C T CT -5' 
Site A Site D 
C 
Oligonucleotide 3 Oligonucleotide 2 
mm m m m m 
5•.:"T T T T T T C C T TC T T T T T C T CT C T -3' 
5'- AAAAAGGAAG AAAAAGAGAGA-3' 
3'- T T T T T C C T TC TT T T T C T C T CT -5' 
Site C Site B 
D 
Oligonucleotide 3 Oligonucleotide 4 
mm mm mm m 
5•.:"T T T T T T C C T T C CT T T T C T CT C T -3' 
5'- AA A A AGG A AG GA A AAGAGAGA-3' 
3'- TT TT TC CT TC CT T TT CT CT CT -5' 
Site C Site D 
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duplex DNA fragment (24 °C, pH 7.0). Thymidine-EDTA (T*)7,8 was incorpora-
ted at the 5' -terminus of oligonucleotides 1 and 3 to allow determination of their 
equilibrium association constants to site A and C, respectively, in the absence or 
presence of 2 or 4, using the QACT method.6 The cooperative interaction energy 
Ecoop is determined from the experimental data through the following 
expression, as described in Chapter Two: 
<l>(l + KB[LB]) - 1 
Ecoop = -RTln KB[LB] (1) 
For the cooperatively binding oligonucleotides described LB is oligonucleotide 2 
or 4, and KB is the association constant of 2 or 4 to its respective site. As 
explained in Chapter Two, <I> = KA+BIKA, where KA+B is the equilibrium 
association constant for oligonucleotide 1 or 3 binding to its respective site in the 
presence of oligonucleotide 2 or 4. For ease of discussion, duplex DNA 
containing a 5'-AA-3', 5'-AG-3', 5'-GA-3', or 5'-GG-3' sequence at the triplex 
junction site will be referred to as the AA, AG, GA or GG DNA fragments, 
respectively. 
Cooperative Binding of Two llmers in the Presence of a 5' -TT-3' Stack. 
Analysis of cleavage data performed on the AA DNA fragment yielded equili-
brium association constants of 1.3 x 106 M-1 for 1 binding alone (K1,AA) and 1.5 x 
107 M-1 for 1 binding in the presence of 5.0 µM 2 (K1+2,AA) (Table 3.1, Figure 
3.lA). The equilibrium association constant of 5, an oligonucleotide with the 
same sequence as 2 but containing T* at the 3'-end targeted to the 11-bp site B, 
was found to be 2.8 x 106 M-1. The binding enhancement K1+2,AAI K1,AA is a 
factor of 12. Substitution of the values 12, 2.8 x 106 M-1, and 5 x 10-6 M-1 for <I>, 
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Table 3.1: Equilibrium Association Constants for Two Triple Helix 
Forming Oligonucleotides Binding at Adjacent Sites on DNA as a 
Function of Four Different Base Stacksa 
Stack Oligo- K K11+11IK11 Ecoop 
nucleotide (M-1) (kcal•moI-1) 
5'-TT-3' 1 1.3 (± 0.2) X 106 12 (± 2) 1.5 (± 0.1) 
1 + 2 (5 µM) 1.5 (± 0.2) X 107 
5'-TC-3' 1 4.6 (± 0.8) X 1Q6 61 (± 12) 2.5 (± 0.2) 
1 + 4 (5 µM) 2.8 (± 0.3) X 108 
5'-CT-3' 3 1.1 (± 0.1) X 1Q6 127 (± 21) 2.9 (± 0.1) 
3 + 2 (5 µM) 1.4 (± 0.2) X 108 
5'-CC-3' 3 1.9 (± 0.7) X 106 17 (± 6) 1.7 (± 0.2) 
3 + 4 (5 µM) 3.2 (± 0.3) X 107 
a Values reported in the table are mean values measured from affinity 
cleavage titration experiments performed in Association buffer (10 
mM Bis-Tris•HCl, 10 mM NaCl, 250 µM spermine, pH 7.0, 24 °C). C 
designates 5-methyl-2' -deoxycytidine. 
KB, and [LB], respectively, in equation 1 affords a value of 1.5 kcal •mol-1 for 
Ecoop between oligonucleotides 1 and 2. 
Cooperative Binding of Two llmers in the Presence of a 5' -TmC-3' Stack. 
Analysis of cleavage data performed on the AG DNA fragment yielded 
equilibrium association constants of 4.6 x 106 M-1 for 1 binding alone (K1,AG) and 
2.8 x 108 M-1 for 1 binding in the presence of 5.0 µM 4 (K1+4,AG) (Table 3.1, Figure 
3.lB). The equilibrium association constant of 6, an oligonucleotide with the 
same sequence as 4 but containing T* at the 3'-end targeted to the 11-bp site B, 
was found to be 5.4 x 106 M-1. The binding enhancement K1+4,AGI K1,AG is a 
factor of 61. Substitution of the values 61, 5.4 x 106 M-1, and 5 x 10-6M-l for <I>, 
KB, and [LB], respectively, in equation 1 affords a value of 2.5 kcal •mol-1 for 
Ecoop between oligonucleotides 1 and 4. 
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Cooperative Binding of Two llmers in the Presence of a 5' _mCT-3' Stack. 
Analysis of cleavage data performed on the GA DNA fragment yielded 
equilibrium association constants of 1.1 x 106 M-1 for 3 binding alone (K3,GA) and 
1.4 x 108 M-1 for 3 binding in the presence of 5.0 µM 2 (K3+2,GA) (Table 3.1, Figure 
3.lC). The equilibrium association constant of 5 was found to be 4.3 x 106 M-1. 
The binding enhancement K3+2,GAI K3,GA is a factor of 127. Substitution of the 
values 127, 4.3 x 106 M-1, and 5 x 10-6 M-1 for <P, KB, and [LB], respectively, in 
equation 1 affords a value of 2.9 kcal•mol-1 for Ecoop between oligonucleotides 3 
and 2. 
Cooperative Binding of Two llmers in the Presence of a 5' -mcmC-3' Stack. 
Analysis of cleavage data performed on the GG DNA fragment yielded 
equilibrium association constants of 1.9 x 106 M-1 for 3 binding alone (K3,GG) and 
3.2 x 107 M-1 for 3 binding in the presence of 5.0 µM 4 (K3+4,GG) (Table 3.1, Figure 
3.lD). The equilibrium association constant of 6 was found to be 7.1 x 106 M-1. 
The binding enhancement K3+4,GGI K3,GG is a factor of 17. Substitution of the 
values 17, 7.1 x 106 M-1, and 5 x 10-6 M-1 for <P, KB, and [LB], respectively, in 
equation 1 affords a value of 1.7 kcal•mol-1 for Ecoop between oligonucleotides 3 
and 4. 
Binding of a 22mer Oligonucleotide Targeted to Two Abutting 11-bp Sites 
on DNA. The equilibrium association constant of a 22mer oligonucleotide with 
sequence 5'-d(TTTTTTmcmcTTTTTT'fTIDCTmcTmCT*)-3' targeted to sites A and 
B (Figure 3.lA) was found to be 1.4 x 108 M-1. The affinity of the 22mer is 
therefore ca. one order of magnitude higher than that of 1 lmer oligonucleotide 1 
binding to site A in the presence of 2 bound to site B. 
Effect of Mismatches on a 5' -TT-3' Stack. Due to the right-handed nature of 
DNA, we would expect a hydrogen-bond mismatch to affect a stack at the triplex 
junction differently depending on whether the mismatch is on the 5' - or 3' - side 
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of the junction. We investigated the effect of mismatches on both sides of the 
junction on cooperativity. To determine the effect of a mismatch on the 5' -side of 
the junction on cooperative interactions involving a 5' -TT-3' stack, we measured 
the association constants for oligonucleotide 1 binding to site A alone (Ki,GA) 
and in the presence of 5.0 µM 2 (K1+2,GA) on the non-complementary GA DNA 
fragment (Figure 3.2A). In this case, a T•GC mismatch is formed at the 3'-end of 
oligonucleotide 1. We found that the binding enhancement K1+2,GAIK1,GA is a 
factor of 2.5, and little cooperativity was observed (Table 3.2). Analysis of Table 
3.2 shows that the association constant of 1 binding in the presence of 2 is 
lowered by a factor of 29 from 1.5 x 107 M-1 in the absence of any mismatch to 
5.2 x 105 M-1 in the presence of a mismatch.9a To determine the effect of a 
mismatch on the 3'-side of the junction on a 5'-TT-3' stack, we measured the 
association constants for oligonucleotide 1 binding to site A alone (K1,AG) and in 
the presence of 5.0 µM 2 (K1+2,AG) on the non-complementary AG DNA 
fragment (Figure 3.2B). In this case, a T•GC mismatch is formed at the 5'-end of 
oligonucleotide 3, and no cooperativity was observed (Table 3.2).9b 
Effect of Mismatches on a 5'-mCT-3' Stack. We also investigated the effect of 
mismatches on cooperative interactions involving the very strong 5' _mCT-3' 
stack. To determine the effect of a mismatch on the 5' -side of the junction, we 
measured the association constants for oligonucleotide 3 binding to site A alone 
(K3,AG) and in the presence of 5.0 µM 4 (K3+4,AG) on the non-complementary AG 
DNA fragment (Figure 3.2C). A mc•AT mismatch is formed at the 3'-end of 
oligonucleotide 3. The binding enhancement K3+4
1
AGI K3,AG is a factor of 17, 
corresponding to an Ecoop of 1.7 kcal •moI-1 (Table 3.3).9c To determine the effect 
of a mismatch on the 3' -side of the junction on a 5' _mCT-3' stack, we measured 
the association constants for oligonucleotide 3 binding to site A alone (K3,GG) 
and in the presence of 5.0 µM 4 (K3+4,GG) on the non-complementary GG 
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Figure 3.2. Schematic representation of a complex composed of two triple helix 
forming oligonucleotides binding at adjacent sites on double-helical DNA in the 
presence of a single-base mismatch at the triplex junction. (A) A 5'-TT-3' stack is 
formed at the junction in the presence of a T•GC mismatch on the 5'- side of the 
junction. (B) A 5'-TT-3' stack is formed at the junction in the presence of a T•GC 
mismatch on the 3'- side of the junction. (C) A 5'-mCT-3' stack is formed at the 
junction in the presence of a me• AT mismatch on the 5'- side of the junction. (D) 
A 5'-IDCT-3' stack is formed at the junction in the presence of a T•GC mismatch 
on the 3'- side of the junction. Thick solid lines represent the DNA backbone of 
the target site and assodated oligonucleotides. Thin solid lines represent 
Watson-Crick hydrogen bonds while dashed lines indicate Hoogsteen hydrogen 
bonds. Binding of the oligonucleotides is assessed by affinity cleavage.6 
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Mismatch 
' 5'@ . . . . . . . . ....... 3' .. ' ' ' .. . ' ....... ' ' 
~: i i i i i i i i i i . i i i i i ·1 ·1 1· i ·1 ~: 
5'-TT-3' Stack: 
A 
Oligonucleotide 1 Oligonucleotide 2 
5'-*T T T T T T C C T T T T T T T T C T C T C T -3' 
5'- A A A A A AG GA AG AA A A AG AG A GA -3' 
3'- TT T T T T C C T T C TT T T T C T C T CT -5' 
Site C Site B 
B 
Oligonucleotide 1 Oligonucleotide 2 
5'-*T T T T T T C C T T T T T T T T C T C T C T -3' 
5'-AAA A AAGG AA A GA A AAGAG AGA -3' 
3'- T T T T T CC T T T CT T T TC T C T CT -5' 
Site A Site D 
5•.mcT-3' Stack: 
C 
Oligonucleotide 3 Oligonucleotide 2 
5'-*T T T T T T C C T TC T T T T T C T C T C T -3' 
5'-AAA A AAGG AAA AA A AAGAG AGA-3' 
3'- T T T T T C C T TT TT T T T C T C T CT -5' 
SiteC Site B 
D 
Oligonucleotide 3 Oligonucleotide 2 
5'-*T T T T T T C C T T C TT T T T C T C T C T -3' 
5'-AA A A AAGG AAG GA A AAG AG AGA -3' 
3'- T T T T T T C C T T C CT T T T C T C T CT -5' 
SiteC Site D 
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Table 3.2: Effect of Mismatches on a 5'-TT-3' Stack: Equilibrium 
Association Constants for Two Triple Helix Forming 
Oligonucleotides Binding at Adjacent Sites on DNA in the Presence 
of a Mismatch at the Junctiona 
Mismatch Oligo- K Ku+ulKu Ecoop 
nucleotide (M-1) (kcal • mol-1) 
5'-T T-3' 
1 2.1 (± 0.2) X 105 
5'-GA-3' 2.5 (± 0.8) 0.6 (± 0.2) 
3'-CT-5' 1 + 2 (5 µM) 5.2 (± 1.2) X 105 
5'-TT-3' 1 4.6 (± 0.8) X 1Q6 
5'-AG-3' 1.0 (± 0.9) 0 
3'-TC-5' 1 + 2 (5 µM) 5.3 (± 0.6) X 106 
a Values reported in the table are mean values measured from 
affinity cleavage titration experiments performed in Association 
buffer (10 mM Bis-Tris • HCl, 10 mM NaCl, 250 µM spermine, pH 7.0, 
24 °C). 
DNA fragment (Figure 3.2D). In this case, a T•GC mismatch is formed at the 5'-
end of oligonucleotide 4, and no cooperativity was observed.9d Analysis of Table 
3.3 reveals that the association constant of 3 binding in the presence of 2 is 
lowered by a factor of 64 from 1.4 x 108 M-1 in the absence of any mismatch to 2.2 
x 1Q6 M-1 in the presence of the mismatch. 
Effect of Mismatches on the Binding of a 22mer targeted to sites A and B. 
The sensitivity to single-base mismatches of a noncooperative system compared 
to that of a cooperative one was examined. The sensitivity to single-base mis-
matches of the cooperative binding of two 1 lmers 1 and 2 targeted to sites C and 
B, respectively (Figure 3.2A) was compared to the binding of the corresponding 
22mer oligonucleotide with sequence 5'-d(TTTTTTrnCrnCTTTTTTTTrnCTmCT-
mcT*)-3 ' targeted to the 22-bp site (B + C). In both cases, a T• GC mismatch is 
present at the 3'-end of site C. The association constants of the 22mer in the 
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Table 3.3: Effect of Mismatches on a 5'-mCT-3' Stack: Equilibrium 
Association Constants for Two Triple Helix Forming 
Oligonucleotides Binding at Adjacent Sites on DNA in the Presence 
of a Mismatch at the Junctiona 
Mismatch Oligo- K K11+11IK11 Ecoop 
nucleotide (M-1) (kcal •moI-1) 
5'-CT-3' 3 1.3 (± 0.1) X 105 
5'-AA-3' 17 (± 3) 1.7 (± 0.1) 
3'-TT-5' 3 + 2 (5 µM) 2.2 (± 0.4) X lQ6 
5'-CT-3' 3 1.9 (± 0.7) X 106 
5'-GG-3' 1.0 (± 0.5) 0 
3'-CC-5' 3 + 2 (5 µM) 1.3 (± 0.1) X lQ6 
a Values reported in the table are mean values measured from 
affinity cleavage titration experiments performed in Association 
buffer (10 mM Bis-Tris•HCl, 10 mM NaCl, 250 µM spermine, pH 7.0, 
24 °C). C designates 5-methyl-2' -deoxycytidine. 
absence and presence of the T•GC mismatch are 1.8 x 108 M-1 and 7.2 x 1()7 M-1, 
respectively. The association constants of oligonucleotide 1 binding coopera-
tively in the presence of 2 in the absence and presence of the same mismatch are 
1.5 x 107 M-1 and 5.2 x 1()5 M-1, respectively, as mentioned above. 
Discussion 
Two pyrimidine oligonucleotides bind cooperatively to adjacent sites on 
double-helical DNA with an interaction energy ranging from 1.5 kcal • mol-1 to 
2.9 kcal•mol-1, depending on the sequence composition at the triplex junction 
(Table 3.1). Cooperative interactions may arise from propagation of a conforma-
tional transition between adjacent sites and from base stacking of the terminal 
bases. Previous experiments show that when the two target sites are separated 
by one base pair, no cooperativity is observed, suggesting that base stacking is 
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the major contributor to the cooperative interaction energy.2b The experimental 
results reported here are consistent with this model. 
Base stacking is dominated by electrostatic, polarization, and dispersion 
forces. 10 According to optimized potential calculations, dispersion and polari-
zation interactions determine the magnitude of the total interaction energy, 
whereas electrostatic forces determine orientational preferences.lOd In an 
attempt to explain the differences in interaction energies observed when coopera-
tively binding oligonucleotides interact through different base stacks, the 
electrostatic potentials of protonated Nl-methyl-5-methylcytosine (Nmc) andNl-
methylthymine (NmT), model compounds of the protonated 5-methylcytosine 
and thymine, respectively, were analyzed using the program Spartan.11 These 
calculations do not take into account the change in charge distribution of the 
bases due to hydrogen bonding to the purine strand. The AMl electrostatic 
potentials were calculated at the semi-empirical level and mapped onto the 
electron-density surface of each molecule (Figure 3.3). Regions of electrostatic 
potential greater than or equal to 155.3 (kcal•mol-1 ) for Nmc and 36.14 
(kcal•mol-1) for NmT are shown in blue, and regions of electrostatic potential less 
than or equal to 22.25 for Nmc and -65.51 for NmT are shown in red. The lower 
and higher end of the color scale were chosen such as to highlight the charge 
distributions in the two molecules, and therefore the scale values in the two 
molecules are different. On the basis of these scale values, Nmc (22.25 ➔ 155.3) 
is more polarized than NmT (-65.51 ➔ 36.14). Nmc contains a region of low 
electrostatic potential (electron-deficient) localized around the protonated 
nitrogen, and a region of high positive electrostatic potential (electron-rich) 
localized on the carbonyl oxygen. NmT contains an electron-deficient region 
extending over half of its ring opposite to the two carbonyl groups. 
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Figure 3.3. Representation of the calculated AMl electrostatic potential surfaces 
of model compounds Nl-methyl-5-methylcytidine (NmC) and Nl-methylthyrni-
dine (NmT). The range of electrostatic potential values calculated for each mole-
cule are shown under the surfaces. Electrostatic potentials values are shown 
colorirnetrically, and range from 22.25 (red) to 155.3 (blue) kcal•mol-1 for Nmc, 
and from -65.51 (red) to 36.14 (blue) kcal•mol-1 for NmT. 
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(22.25 -- 155.3) (-65.51 -- 36.14) 
Nmc 
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The four base stacking configurations 5'-TT-3', 5'-TmC-3', 5'-IDCT-3' and 5'-
mcmC-3' drawn on the basis of the structure proposed for DNA triple helix 
(T • A T)n are shown in Figure 3.4.12 These base stacks are characterized by four 
different charge-charge interactions, depending on the electrostatic distribution 
of the individual bases, and the relative positioning of the bases with respect to 
each other. Our data suggests that the weakest interactions are a 5' _memC-3' and 
a 5'-TT-3' stack, which are comparable (Table 3.1). Although we usually depict 
me as protonated when bound to DNA in a triple-helical complex, under the 
conditions used (pH 7.0) it may not be protonated at every position. An analysis 
of the electronic distribution of Nmc and NmT reveals that there are no favorable 
charge-charge interactions in a 5' _mcmC-3' or 5'-TT-3' stack. The 1.5-1.7 
kcal• mol-1 cooperative energy observed when either a 5' JnCme-3' or a 5' -TT-3' 
stack is formed may reflect generally favorable polarization interactions between 
the two bases across the junction. 
Stronger interaction energies between two oligonucleotides binding to 
adjacent sites on DNA are observed when a 5'-TmC-3' or a 5'-mCT-3' stack is 
formed at the junction (Table 3.1). An analysis of the electronic distribution of 
NmT and Nme reveals that in both 5'-Tme-3'and 5'..IDCT-3' stacks, there may be a 
favorable charge-charge interaction between the electron-deficient exocyclic 
amino group on me and the electron-rich e4 carbonyl group on T. This inter-
action may explain why cooperative interactions may be stronger when a 5' -
Tmc-3'or a 5'_meT-3' stack is formed rather than a 5'-TT-3' or 5'.JnCme-3' stack. 
A comparison between the 5' -Tme-3' and 5' _mCT-3' stacking configurations 
themselves in terms of the charge distribution of the individual bases and their 
interactions reveals information about the relative strength of the two stacks. 
The data suggest that a 5' _mCT-3' stack is significantly stronger than a 5' -TmC-3' 
stack. In the latter stack, the highly polarized region of me faces away from T, 
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Figure 3.4. Base stacking configurations of S'JnCmC-3', 5'-TT-3', 5'-TmC-3', and 
5'..mc:T-3' triples drawn on the basis of the structure proposed for DNA triple 
helix (T• AT)n.12 The Cl' atoms of the deoxyribose sugars are represented by the 
open circles. The larger filled circles represent methyl groups. The 5'➔ 3' 
polarity of the strands is indicated by the@ symbols (into the plane of the page) 
and 0 (out of the plane of the page). 
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5'-mcmC-3' Stack: 
0--N 
5' #: + NH2 
3'ifN~~ 3) 
5'-TT-3' Stack: 
O ~- / x 
5' ~3·• 
0--NJ ~ 
5, ~•>=o ( 0%0 Ml 5' 
3'if Nn~H 3) 
5'-TmC-3' Stack: 
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and no strong charge-charge interactions occur. In contrast, in a 5' -rncT-3' stack 
the highly polarized region of me is located directly above T, allowing the 
electron-deficient region of T to interact favorably with the electron-rich oxygen 
of me, In addition, there may be a favorable interaction between the positively 
charged ring nitrogen of me and the electron-rich e4 carbonyl group of T. 
Effect of Mismatches on Cooperativity. Based on experimental data, the 
cooperative interaction energy between two triple helix forming oligonucleotides 
likely arises from base stacking at the triplex junction. The question arises as to 
what degree base stacking is sensitive to hydrogen-bond mismatches at the 
junction. A mismatch could presumably disrupt base stacking by either 
preventing a base from aligning favorably with respect to the other base across 
the junction, disrupting favorable electrostatic interactions, or by changing the 
electronic distribution of the mismatched base itself. Experiments were carried 
out to determine the degree to which cooperativity is disrupted by a single-base 
mismatch on either side of the triplex junction. The effect of a mismatch on 
cooperativity was examined in the cases where the moderately strong 5'-TT-3' 
stack and the very strong 5'-meT-3' stack are formed. In the case of a 5'-TT-3' 
stack, a T•GC mismatch on the 3'- side of the junction (Figure 3.2A) significantly 
reduces cooperative interactions, whereas a T•Ge mismatch on the 5'-side 
virtually destroys cooperativity (Figure 3.2B). The disruption of cooperativity 
may indicate that either the electron distribution or the relative position of T with 
respect to the adjacent T across the junction do not allow stacking between the 
two bases. In the case of the strong 5'-meT-3' stack, a me•AT mismatch on the 
5'-side of the junction (Figure 3.2e) decreases the cooperative interaction energy 
between oligonucleotides 3 and 2 by 1.7 kcal•mol-1, whereas a T•GC mismatch 
on the 3'-side of the junction completely destroys cooperativity (Figure 3.2D). 
Therefore, in this system, cooperativity is affected differently depending on the 
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nature of the mismatch and/ or the location of the mismatch with respect to the 
junction. 
Sensitivity of a Cooperative vs. Noncooperative System to Single-Base 
Mismatches. Analysis of the data shows that the equilibrium association 
constant of a 22mer of sequence 5'-d(TTTTTTIDCmCTTTTTTT'fIDCTmcTmCT*)-3' 
in the absence and presence of a T•GC mismatch are 1.8 x 1Q8 M-1 and 7.2 x 107 
M-1, respectively. The association constants of 11mer oligonucleotide 1 binding 
cooperatively in the presence of 2 to the same sites in the absence and presence of 
the same mismatch are 1.5 x 10 7 M-1 and 5.2 x 105 M-1, respectively. Therefore, 
the same mismatch decreases the binding constant of the 22mer by a factor of 2, 
whereas it lowers the association constant of cooperatively binding 1 lmer 1 by a 
factor of 29. This observation suggests that the cooperative system is more 
specific than the noncooperative one. 
Summary. Pyrimidine oligonucleotides bind cooperatively to abutting sites 
on double-helical DNA with an interaction energy of 1.5-2.9 kcal•mol-1 
depending on the sequence of the base stack at the triple helix junction. Base 
stacking appears to be the major source of the positive cooperativity. Knowledge 
of the relative strength of base stacks in the third strand of a triple helix may 
serve as a baseline for the design of artificial cooperative systems containing 
novel structural domains for stabilizing interactions. 
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Addendum to Chapter Three: 
Additional Sequence Composition Effects at the Junction 
The studies described above show that electrostatic rather than hydrophobic 
forces play a crucial role in the base stacking interactions observed in the 
cooperative systems that were analyzed. Nonetheless, previous experiments on 
the cooperative binding of oligonucleotide analogs containing 5-(1-propynyl)-
modified bases to DNA suggested that hydrophobic n-n stacking interactions 
between the propyne-substituted nucleotides at the triplex junction are greatly 
responsible for the significant increase observed in cooperativity (see Chapter 
Four). In light of these results, further experiments were carried out with the aim 
of elucidating the chemical forces majorly responsible for the observed 
cooperative interactions between oligonucleotides. 
Results and Discussion 
Cooperative Binding of Two llmers in the Presence of a 5' _PUT-3' or 5' -
TPU-3' Stack (PU = 5-(1-Propynyl)-2'-deoxyuridine). The cooperative binding of 
two llmer oligonucleotides in the presence of a 5-propynyl-substituted 2'-deoxy-
uridine located either at the 5'- or 3'-end of the junction was examined. To study 
the effect on cooperativity of a propynyl-substituted base at the 5 '-end of the 
junction, the equilibrium association constants for oligonucleotide 7 (5'-d(*TTTT-
TTmcmcTTPU)-3') binding to site A on the AA DNA fragment alone and in the 
presence of oligonucleotide 2 were measured. Analysis of cleavage data 
performed on the AA DNA fragment yielded equilibrium association constants 
of 7.8 x 10s M-1 for 7 binding alone (K7,AA) and 1.6 x 107 M-1 for 7 binding in the 
presence of 5.0 µM 2 (K7+2,AA) (Table 3.4, Figure 3.5A). The binding enhance-
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5'@ . . . . . . . . '. ( w,,,' . . . . , . . . . . 3' 
5' : : : : : : : : : : 7 :, : : : : : : : : : : 3' 
3• 1111111111 llii!j 11111111115. 
A 
Oligonucleotide 7 Oligonucleotide 2 
mm P m m m 
5'-*T T T T T T C C T T U TT T T T C T C T C T -3' 
5'- AA'kAAGGAAA AAAAAGAGAGA-3' 
3'- T T T To t G CT TT TT T T J .C TC TC T -5' 
Site A Site B 
B 
Oligonucleotide 1 Oligonucleotide 8 
mm p m m m 
5'-*T T T T T T C C T TT UT T T TC T C T C T -3' 
5'- AAAAAGGAAA AAAAAGAGAGA-3' 
3'- . T T T"T. TC C T TT TT T T l; C T G TC T -5' 
Site A Site B 
Figure 3.5. Schematic representation of a complex composed of two triple 
helix forming oligonucleotides binding at adjacent sites on DNA wherein a 
5'-PUT-3' (A) or a 5'-TPU-3' (B) stack is formed at the junction. PU 
designates 5-(1-propynyl)-2'-deoxyuridine. 
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Table 3.4: Equilibrium Association Constants for Two Triple Helix 
Forming Oligonucleotides Binding at Adjacent Sites on DNA as a 
Function of a Single 5-(1-Propynyl)-substituted Base at the Junctiona 
Stack Oligo- K K11+11IK11 Ecoop 
nucleotide (M-1) (kcal • mol-1) 
5'-TT-3' 1 1.3 X lQ6 12 1.5 
1 + 2 (5 µM) 1.5 X 107 
S'_pUT-3' 7 7.8 X 10
5 
21 1.8 
7 + 2 (5 µM) 1.6 X 107 
5'-TPU-3' 1 1.3 X 10
6 
25 1.9 
1 + 8 (5 µM) 2.8 X 107 
a Values reported in the table are mean values measured from affinity 
cleavage titration experiments performed in Association buffer (10 mM 
Bis-Tris • HCl, 10 mM NaCl, 250 µM spermine, pH 7.0, 24 °C). Pu 
designates 5-(1-propynyl)-2' -deoxyuridine. 
ment K7+2 AAI K7 AA is a factor of 21. Substitution of the values 21, 2.8 x 106 M-1, 
' ' 
and 5 x 10-6 M-1 for <I>, KB, and [LB], respectively, in equation 1 affords a value of 
1.8 kcal•mol-1 for Ecoop between oligonucleotides 7 and 2. 
To study the effect on cooperativity of a propynyl-substituted base at the 3 '-
end of the junction, the equilibrium association constants for oligonucleotide 1 
binding to site A on the AA DNA fragment alone and in the presence of 
oligonucleotide 8 (5'-d(PUTTTTmcTmCTmCT)-3') were measured. Analysis of 
cleavage data performed on the AA DNA fragment yielded equilibrium asso-
ciation constants of 1.3 x 106 M-1 for 1 binding alone (K1,AA) and 2.8 x 107M-1 for 
1 binding in the presence of 5.0 µM 8 (K1+8,AA) (Table 3.4, Figure 3.5B). The 
equilibrium association constant of 9, an oligonucleotide with the same sequence 
as 8 but containing T* at the 3'-end targeted to the 11-bp site B, was found to be 
3.5 x 106 M-1. The binding enhancement K1+8,AAI K1,AA is a factor of 25. 
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Substitution of the values 25, 3.5 x 106 M-1, and 5 x 10-6 M-1 for <I>, KB, and [LB], 
respectively, in equation 1 affords a value of 1.9 kcal•mol-1 for Ecoop between 
oligonucleotides 1 and 8. 
Cooperative Binding of Two llmers in the Presence of a 5'-mcdU-3', 5'-
mcT-3', or 5'-mcPU-3' Stack (dU = 2'-Deoxyuridine). Further experiments were 
carried out to learn more about the importance of hydrophobic 1t-1t stacking 
interactions in cooperativity. More specifically, we were interested in studying 
the relative energetic contributions to cooperative interactions of a series of 
hydrophobic groups present at the triplex junction. We chose to conduct this 
study in a system in which a 5'-mCU-3' stack, where U designates a uridine 
derivative, is formed at the triplex junction. Analysis of the stacking configu-
ration of a 5'-mcu -3' stack reveals that substituents at the 5-position of U are 
located directly above the heterocyclic portion of me (Figure 3.6). If hydrophobic 
interactions greatly influence cooperativity, one would anticipate a strong 
dependence of cooperativity on the nature of the 5-substituent. Hence, experi-
ments were carried out in which a hydrogen, a methyl, or a propynyl group is 
present at the 5-position of U (Figures 3.6 and 3.7). 
Cooperative Binding of Two llmers in the Presence of a 5' _m CdU-3' Stack. 
Analysis of cleavage data performed on the GA DNA fragment yielded 
equilibrium association constants of 1.1 x 106 M-1 for 3 binding alone (K3,GA) and 
6.2 x 107 M-1 for 3 binding in the presence of 5.0 µM 10 (5'-d(dUTTT'fIDC-
TIDCTmCT)-3') (K3+10,GA) (Table 3.5, Figure 3.7 A). The equilibrium association 
constant of 11, an oligonucleotide with the same sequence as 10 but containing T* 
at the 3'-end targeted to the 11-bp site B, was found to be 1.8 x 105 M-1. The 
binding enhancement K3+10,GAI K1,GA is a factor of 56. Substitution of the values 
56, 1.8 x 10s M-1, and 5 x 10-6 M-1 for <I>, KB, and [LB], respectively, in equation 1 
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5'-mCT-3' Stack: 
0-N~NH2 5' ,?': + 
( O:?' 0 
3'ifNnNH 
0 
5' 3' 
~
0-N NH2 
5' ,?': 
( 0 0 
3'ifNnNH 
0 
5' 3' 
~
Figure 3.6. Base stacking configurations of S'_mCdU-3', 5'..IDCT-3', and 5'-mCPU-3' 
triples drawn on the basis of the structure proposed for DNA triple helix 
(T•AT)n.12 The Cl' atoms of the deoxyribose sugars are represented by the open 
circles. The larger filled circles represent methyl groups. The 5'"-7 3' polarity of 
the strands is indicated by the® symbols (into the plane of the page) and 0 (out 
of the plane of the page). 
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Site C Site B 
Figure 3.7. Schematic representation of a complex composed of two triple 
helix forming oligonucleotides binding at adjacent sites on DNA wherein 
a 5'-mCdU-3' (A), a 5'-mCT-3' (B), or a 5'-mCPU-3' (C) stack is formed at the 
junction. du designates 2'-deoxyuridine. PU designates 5-(1-propynyl)-2'-
deoxyuridine. 
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Table 3.5: Equilibrium Association Constants for Two Triple Helix 
Forming Oligonucleotides Binding at Adjacent Sites on DNA as a Function 
of a Series of 5-Substituted Bases at the 3'-End of the Junctiona 
Stack Oligo- K K11+11IK11 Ecoop 
nucleotide (M-1) (kcal • moI-1) 
5'-mCdU-3' 3 1.1 X 10
6 
56 2.8 
3 + 10 (5 µM) 6.2 X 107 
5'-IDCT-3' 3 1.1 X 10
6 
127 2.9 
3 + 2 (5 µM) 1.4 X 108 
5'-mcPU-3' 3 1.1 X 10
6 
204 3.2 
3 + 8 (5 µM) 2.2 X 108 
a Values reported in the table are mean values measured from affinity 
cleavage titration experiments performed in Association buffer (10 mM 
Bis-Tris•HCl, 10 mM NaCl, 250 µM spermine, pH 7.0, 24 °C). dU 
designates 2'-deoxyuridine; Pu designates 5-(1-propynyl)-2' -deoxyuridine. 
affords a value of 2.8 kcal •mol-1 for Ecoop between oligonucleotides 3 and 10. 
Cooperative Binding of Two llmers in the Presence of a 5'-mCT-3' Stack. Data 
pertaining to this system is described in the Results section of this chapter. 
Briefly, the binding enhancement K3+2,GAI K3,GA is a factor of 127, and Ecoop 
between oligonucleotides 3 and 2 is 2.9 kcal • mol-1 (Table 3.5, Figure 3.7B). 
Cooperative Binding of Two 11mers in the Presence of a 5'-mcPU-3 ' Stack. 
Analysis of cleavage data performed on the GA DNA fragment yielded 
equilibrium association constants of 1.1 x 106 M-1 for 3 binding alone (K3,GA) and 
2.2 x 108 M-1 for 3 binding in the presence of 5.0 µM 8 (K3+8,GA) (Table 3.5, Figure 
3.7C). The equilibrium association constant of 9 was found to be 3.8 x 106 M-1. 
The binding enhancement K3+8,GA I K1,GA is a factor of 204. Substitution of the 
values 204, 3.8 x 1Q6 M-1, and 5 x 10-6 M-1 for <I>, KB, and [LB], respectively, in 
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equation 1 affords a value of 3.2 kcal• mol-1 for Ecoop between oligonucleotides 3 
and 8. 
Summary. The results described above indicate that the effect of a propynyl 
group located at either the 5'- or 3'-end of the triplex junction on the observed 
interaction energy is significant, although not to a great extent (Table 3.4).13 In 
addition, the cooperative interaction energy between oligonucleotides bound at 
adjacent DNA sites does not change greatly when the 5-substituent of the base at 
the 3'-side of the junction is changed from a hydrogen to a methyl and finally to a 
propynyl group (Table 3.5). These combined results are consistent with the 
hypothesis that hydrophobic interactions may not be as important as electrostatic 
ones to the cooperative binding of oligonucleotides at adjacent DNA sites by 
triple helix formation. The idea that aromatic stacking interactions in aqueous 
solutions arise mostly from charge-charge interactions rather than classical 
hydrophobic effects or dispersion forces has been reported recently.14 
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Experimental Section 
General. E. coli JMll0 was obtained from Stratagene. Qiagen plasmid kits 
were purchased from Qiagen Inc. Sonicated, deproteinized calf thymus DNA 
was purchased from Pharmacia. Nucleotide triphosphates were obtained from 
Pharmacia. Nucleotide triphosphates labeled with 32P (~ 3000 Ci/ mmol) were 
purchased from Amersham. Restriction endonucleases were purchased from 
New England Biolabs or Boehringer Mannheim, and used according to the 
suggested protocol in the provided buffer. Thymidine, 5-methyl-2'-deoxycyti-
dine, and 2'-deoxyuridine phosphoramidites were obtained from Glen Research. 
The 5'-O-DMT-protected phosphoramidite derivative of 5-(1-propynyl)-2'-
deoxyuridine was synthesized as described (see also Chapter Four).15 Sephadex 
resins were obtained from Pharmacia. Sequenase Version 2.0 was obtained from 
United States Biochemical. 
Construction of pMD5152, pNCAG, pNCGA, and pNCGG. These plasmids 
were prepared by standard methods.1 6 Briefly, pMD5152 was prepared by 
hybridization of two synthetic oligonucleotides, 5' -d(ACGTTCCT AAAAAAGG-
AAAAAAAAGAGAGAGAGATCTG)-3' and 5' -d(GATCCAGATCTCTCTCTCT-
TTTTTTTCCTTTTTTAGGA)-3', followed by ligation of the resulting duplex with 
pUC18 DNA previously digested with HindIII and BamHI; this ligation mixture 
was used to transform E.coli JMll0 (Stratagene). Plasmid DNA from ampicillin 
resistant, white colonies was isolated and the presence of the desired insert 
confirmed by restriction analysis and Sanger sequencing. Preparative isolation 
of plasmid DNA was performed using a Qiagen plasmid kit. Similar procedures 
were used to prepare plasmid pNCAG with the oligonucleotides 5' -d(AGCTTC-
CTAAAAAAGGAAAGAAAAAGAGAGAGAGATCTG)-3' and 5' -d(GATCCA-
GATCTCTCTCTCTTTTTCTTTCCTTTTTTAGGA)-3', plasmid pNCGA with the 
oligonucleotides 5' -d(AGCTTCCTAAAAAAGGAAGAAAAAAGAGAGAGAG-
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ATCTG)-3' and 5' -d(GATCCAGATCTCTCTCTCTTTTTTCTTCCTTTTTT AG-
GA)-3', and plasmid pNCGG with the oligonucleotides 5' -d(AGCTTCCTAAAA-
AAGGAAGGAAAAAGAGAGAGAGATCTG)-3' and 5' -d(GATCCAGATCTCT-
CTCTCTTTTCCTTTCCTTTTTTAGGA)-3'. 
Oligonucleotide Preparation. Oligonucleotides were synthesized by 
standard automated solid-support chemistry on an Applied Biosystems Model 
380B DNA synthesizer using O-cyanoethyl-N,N-diisopropyl phosphoramiditesP 
The phosphoramidite of the Amino-Modifier-dT (5'-dimethoxytrityl-5-[N-
trifluoroacetylaminoethyl)-3-acrylirnido]-2'-deoxyuridine,3'-[(2-cyanoethyl)-
(N,N-diisopropyl]-phosphoramidite) purchased from Glen Research was 
incorporated at the 5'-terminus of oligonucleotides 1 and 3 during 
oligonucleotide synthesis. Controlled pore glass derivatized with thymidine-
EDTA (T*) was prepared as described by Strobel.18 All oligonucleotides except 
5, 6, 7, 9, and 11, were deprotected with concentrated ammonium hydroxide at 55 
°C for 24 h, and dried in vacuo. Oligonucleotides 5, 6, 7, 9, and 11 containing T* at 
the 3'-end were deprotected with 0.1 N NaOH at 55 °C for 24 h. The crude 5'-
terminal-dirnethoxytrityl protected oligonucleotides were purified by reverse 
phase FPLC on a ProRPCl0/10 (C2-Cs) column (Pharmacia LKB) and a gradient 
of 0-40% CH3CN in 0.1 M triethylammoniurn acetate, pH 7.0, detritylated in 80% 
AcOH, and chromatographed a second time. Oligonucleotides 1 and 3 
containing the Amino-Modifier-dT were dissolved in a 0.4 M NaHCO3 solution, 
and added to an Eppendorf tube containing 13.6 mg (50 µmol) of EDT A-
monoanhydride. The reaction mixtures were vortexed at room temperature for 
30 minutes, filtered through Centrex, and purified by ion-exchange FPLC on a 
Mono Q 10/10 column (Pharmacia LKB) and a gradient of 0.2-2 M NH4OAc, pH 
7.0. Oligonucleotides 1 and 3 were desalted on Pharmacia NAP-25 columns and 
dried in vacuo. All other oligonucleotides were desalted via repeated 
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resuspensions of the oligonucleotides in water followed by lyophilization. 
Concentrations of oligonucleotides not containing 5-(1-propynyl)-2'-deoxy-
uridine were determined by UV absorbance at 260 nm using extinction 
coefficients (M-1 cm-1) of 8800 (dU, T and T* derivative from Glen Research's 
Amino-Modifier-dT) and 5700 (IDC). Concentrations of oligonucleotides 
containing 5-(1-propynyl)-2'-deoxyuridine were determined by UV absorbance at 
280 nm using extinction coefficients (M-1 cm-1) of 6400 (T and T* derivative from 
Glen Research's Amino-Modifier-dT), 8300 (IDC), and 9700 (PU). 
Preparation of Labeled Restriction Fragment. The 3'-32P-labeled duplex was 
prepared by digestion of the desired plasmid with EcoRI, followed by treatment 
with a-32P-dATP and a-32P-TTP in the presence of Sequenase. To remove 
nonincorporated radioactivity, the fragment was passed through a Pharmacia 
NICK column. The DNA was then digested with Xmnl, followed by separation 
of the resulting products on a 5% nondenaturing polyacrylamide gel (19:1, 
monomer /bis). The gel band corresponding to the desired 850-bp fragment was 
visualized by autoradiography, excised, crushed, and soaked in 10 mM Tris, pH 
8.0, and 20 mM EDTA, at 37 °C for 15-18 h. The resulting suspension was filtered 
through a 0.45-µm filter, and the eluted DNA present in the supernatant was 
precipitated with NaOAc/EtOH. The DNA pellet was washed with 70% EtOH, 
dried in vacuo, resuspended in TE buffer (10 mM Tris, pH 8.0, 1 mM EDTA), 
extracted four times with phenol, twice with 24:1 CHCb/isoamyl alcohol, and 
reprecipitated with NaOAc/EtOH. The DNA pellet was washed with 70% 
EtOH, dried in vacuo, and resuspended in 10 mM Bis-Tris•HCl, 100 mM NaCl, 
pH 7.0 at a final activity of 100,000 cpm/µL, and was stored at -20 °C. 
Quantitative Affinity Cleavage Titrations. In a typical experiment, a 5 nrnol 
aliquot of the desired oligonucleotide-EDTA was dissolved in 50 µL of aqueous 
200 µM Fe(NH4)2(SO4)2 • 6H2O to produce a solution that was 100 µM in 
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oligonucleotide. This solution was then diluted serially to yield 100 µM, 10 µM, 1 
µM, 100 nM, 10 nM, 1 nM and 100 pM solutions. The appropriate volume of 
these solutions was then distributed among 14-16 1.5 mL microcentrifuge tubes 
at the appropriate concentrations. A stock solution containing labeled target 
DNA, Bis-Tris•HCl buffer, NaCl, calf thymus DNA, the second oligonucleotide 
where needed, and water, was distributed to each reaction tube in 12 µL aliquots, 
and the appropriate volume of water and 4 µL of 250 µM spermine were added 
to each tube to bring the total volume to 36 µL. The oligonucleotide-
EDTA • Fe(II) and the DNA were allowed to equilibrate for 24 h at 24 °C. After 21 
h, 2 µL of 100 µM Fe(N~)2(SO4)2•6H2O were added to each tube. The cleavage 
reactions were initiated by the addition of 2 µL of a 80 mM aqueous DTT solution 
to each tube. Final reaction conditions in 40 µL of Association buffer were 10 
mM Bis-Tris•HCl at pH 7.0, 10 mM NaCl, 250 µM spermine, 100 µM bp calf 
thymus DNA, 4 mM DTT, and approximately 10,000 cpm labeled DNA. The 
reactions were incubated for 2 hat 24 °C. Cleavage reactions were terminated 
by NaOAc/EtOH precipitation. The precipitated DNA cleavage products were 
dissolved in 35 µL of water, and dried in vacuo. The DNA was then resuspended 
in 10 µL of formamide-TBE loading buffer, and heated at 55 °C for 10 minutes to 
effect dissolution. The Cerenkov radioactivity of the solutions was measured 
with a scintillation counter. The DNA was denatured at 95 °C for 3 minutes, and 
5 µL from each sample were loaded onto a 8% denaturing polyacrylamide gel. 
Construction of Titration Binding Isotherms. Gels were exposed to 
photostimulable storage phosphor imaging plates (Kodak Storage Phosphor 
Screen S0230 obtained from Molecular Dynamics) in the dark at 24 °C for 8-24 
h.19 A Molecular Dynamics 400S Phosphorlmager was used to obtain data from 
the phosphorimaging screens. Rectangles of the same dimensions were drawn 
around the cleavage bands at the target and at the references sites. The 
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ImageQuant v. 3.0 program running on an AST Premium 386/33 computer was 
used to integrate the volume of each rectangle. 
Affinity Cleavage Titration Fitting Procedure. For a detailed description of 
the affinity cleavage titration procedure, see Chapter Two.6 
Electrostatic Potential Calculations. AMl electrostatic potential surfaces 
calculations were performed at the semi-empirical level using the program 
Spartan running on a Silicon Graphics computer. 
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CHAPTER FOUR: 
Cooperative Binding of Short Oligonucleotides Containing 
5-(1-Propynyl)-2'-deoxyuridine to Adjacent DNA Sites 
by Triple Helix Formation. 
Introduction 
The design of cooperative domains between DNA binding ligands for 
modulation of the kinetics and thermodynamics of ligand-nucleic acid 
interactions is at an early stage of development.1-4 Pyrimidine oligodeoxyribo-
nucleotides 11-nt in length are known to bind cooperatively to abutting sites on 
double-helical DNA by triple helix formation, resulting in a 20-fold increase in 
the association constant for one oligonucleotide in the presence of the neigh-
boring oligonucleotide. 3 This 1.8 kcal• moJ-1 interaction energy may arise from n-
stacking between the bases at the triple-helical junction.3 The incorporation of 
discrete dimerization domains to oligonucleotides such as those capable of 
forming a short Watson-Crick helix produces a cooperative interaction and 
results in a 44-fold enhancement in the association constant of one oligonucleo-
tide in the presence of a neighbor.2 
An alternative approach to increasing cooperativity by the addition of 
dimerization domains is the use of modified bases, which could allow greater 
interactions between bases at the triple-helical junction. It is known that 
replacing 2' -deoxycytidine in the third strand with 5-rnethyl-2' -deoxycytidines, 
and replacing 2' -deoxyuridines with thymidines, 5-ethynyl-2' -deoxyuridines or 
5-(1-propynyl)-2' -deoxyuridines increases the stability of triple-helical 
complexes.5,6 If this enhanced stability is due to increased stacking in the third 
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strand, one might expect similar effects at triple helix junctions. We report here 
that two short oligodeoxyribonucleotides containing 5-(1-propynyl)-substituted 
2' -deoxyuridine (PU) and 5-methyl-2' -deoxycytidine (mC) bind cooperatively to 
adjacent sites on double-helical DNA at micromolar concentrations (10 mM Bis-
Tris•HCl at pH 7.0, 10 mM NaCl, 1 mM spermine, 24 cc) (Figure 4.1). These 
results prompted the question whether the strong cooperative forces between 
8mer oligonucleotides containing 5-(1-propynyl)-modified bases would allow 
even shorter oligonucleotide analogs to bind cooperatively to three consecutive 
sites on DNA. We describe here the first example of a system in which three 
hexamers containing 5-(1-propynyl)-2' -deoxyuridines bind cooperatively to three 
adjacent sites covering a specific 18-bp region on double-helical DNA by triple 
helix formation at near micromolar concentrations (10 mM Bis-Tris•HCl at pH 
7.0, 10 mM NaCl, 1 mM spermine, 24 cc) (Figure 4.2). 
Results 
Cooperative Binding of Two 8mer Oligonucleotide Analogs Containing 5-
(1-Propynyl)-2'-deoxyuridine. A system was designed in which two 8-nt 
oligodeoxyribonucleotides, 1 and 2, bind site-specifically to adjacent sites on an 
850-bp 3'-32P-end-labeled duplex DNA fragment via specific Hoogsteen 
hydrogen bonding (PU•AT and mc+GC) (Figure 4.1). Thymidine-EDTA (T*) 
was incorporated at the 5' -terminus of oligonucleotide 1 to allow thermodynamic 
analysis of site-specific binding using the quantitative affinity cleavage titration 
method.7,8 To determine the interaction energy between oligonucleotides 1 and 
2, the equilibrium association constants K1 for 1 binding to site A alone, and K1+2 
for 1 binding to site A in the presence of 1.0 µM 2 bound to neighboring site B 
were measured. 3,8 Analysis of cleavage data yielded equilibrium association 
constants of< 2 x 104 M-1 for 1 binding alone (K1) and 8.0 (± 2.1) x 105 M-1 for 1 in 
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◄ I C":\F ◄ ... 5 ~~:_: ______ _ ... ' 3' 
5' 
3' 
' . . . ' ' .. ' . . . . . 3' 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 5• 
8-bp Site A 8-bp Site B 
5'-A A A A fit A G GA A A A A A A AG AG AG AG A-3' 
3'-T TT TT TCC TT TT 1f TT TC TCT C TC T-5' 
pmmpppp ppppmpm 
1 5'-*TUCCUUUU 2 5'-UUUUCUCT 
mm m m 
3 5'- *TTCCTTTT 4 5'-TTTTCTCT 
Figure 4.1. Schematic representation of a complex composed of two triple helix 
forming oligonucleotides binding at adjacent sites on double-helical DNA Thick 
solid lines represent the DNA backbone of the target site and associated oligo-
nucleotides. Thin solid lines represent Watson-Crick hydrogen bonds while 
dashed lines indicate Hoogsteen hydrogen bonds. Binding of the oligonucleo-
tides is assessed by affinity cleavage using T*. Pu and me represent 5-(1-
propynyl)-2' -deoxyuridine and 5-methyl-2' -deoxycytidine nucleotides, 
respectively. 
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C D E 
(:"\ ◄ 5' ~,_: _: ___ _ ... ... ... ... ... 3' 
. . . . . . . . . ' . . 
::-1 .......... , 1 ......... 1 .......... , 1 ....... 1 .......... 1 I...,._I l~l ~I 1-1 -1 1-1 -1 1 :: 
6-bp Site C 6-bp Site D 6-bp Site E 
5'-AAA AA,GA.A GltGAGAGA-3' 
3'-T TT T :r'f:CT'T T c :T:G TC TC T -5' 
ppmmP 
5 5'-*TUUCCU 
ppmppp 
6 5'-UUCUUU 
pmpmpm 
7 UCUCUC-3' 
Figure 4.2. Schematic representation of a complex composed of three 
triple helix forming oligonucleotides binding to adjacent sites on 
double-helical DNA. PU and me designate 5-(1-propynyl)-2'-
deoxyuridine and 5-methyl-2'-deoxycytidine, respectively. 
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Table 4.1: Equilibrium Association Constants for 8mer 
Modified Triple Helix Forming Oligonucleotides Binding 
at Adjacent Sites on DNA a 
Oligonucleotide 
1 
1 + 2 (1.0 µM) 
1 + 4 (1.0 µM) 
3 
3 + 2 (1.0 µM) 
< 2 X 104 
8.0 (± 2.1) X lQS 
< 2 X 104 
< 2 X 104 
9.7 (± 0.6) X lQ4 
a Values reported in the table are mean values measured 
from affinity cleavage titration experiments performed in 
Association buffer (10 mM Bis-Tris•HCl, 10 mM NaCl, 1 
mM spermine, pH 7.0, 24 °C). 
the presence of 1.0 µM 2 (K1+2), resulting in a dramatic binding enhancement 
K1+2! K1 > 40 (Table 4.1, Figure 4.3).9 This corresponds to a cooperative 
interaction energy of> 4.5 kcal•mo1-1_10 
For comparison, binding of the corresponding unmodified oligonucleotides 3 
and 4, containing a methyl (thymidine) instead of a propynyl group at the 5-
position of 2' -deoxyuridine, was analyzed under the same conditions (Figure 
4.1). Oligonucleotide 3 at :s; 100 µM both in the absence and in the presence of 1.0 
µM 4 did not produce any observable cleavage, and therefore no cooperativity 
could be measured.11,12 
Cooperative Binding of Three 6mer Oligonucleotide Analogs Containing 5-
(1-Propynyl)-2'-deoxyuridine. A system was designed in which three hexa-
nucleotides, 5, 6, and 7, bind site-specifically to adjacent sites on an 850-bp 3' -32P-
end-labeled duplex DNA fragment via specific Hoogsteen hydrogen bonding 
(PU•AT and mc+GC) (Figure 4.2). T* was incorporated at the 5'-terminus of 
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1.0 
0.8 
0.6 e 
app0.4 
0.2 
• • 
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10-10 10·9 10·8 10·7 10"6 10-5 10-4 10·3 10·2 10·1 
[1] (M) 
Figure 4.3. Binding isotherms obtained for oligonucleotide 1 alone (dashed line), 
and in the presence of 1.0 µM oligonucleotide 2 bound to DNA ( • ). The dashed 
sigmoidal curve represents the theoretical titration binding isotherm obtained for 
oligonucleotide 1 binding alone; the solid sigmoidal curve represents the titration 
binding isotherm obtained for oligonucleotide 1 binding in the presence of 
oligonucleotide 2. The data shown was obtained using the quantitative affinity 
cleavage titration method as described in Chapter Two. 
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oligonucleotide 5 to allow thermodynamic analysis of site-specific binding using 
the quantitative affinity cleavage titration method. 7,8 Affinity cleavage 
experiments show that oligonucleotide 5 at <10 µM, and in the presence of 
nonneighboring 7 (1.0 µM) does not produce any observable binding and 
cleavage (Figure 4.4, Lane 10). Reaction of 1.0 µM 5 in the presence of 1.0 µM 6 
affords very low levels of binding and cleavage, revealing that some coopera-
tivity occurs between the two adjacent 6mer oligonucleotides at 1.0 µM each 
(Figure 4.4, Lane 2). Upon addition of 1 nM and 10 nM 7, very little cleavage is 
produced (Figure 4.4, Lanes 3 and 4) . Upon addition of 100 nM 7, a dramatic 
increase in cleavage by 6mer 5 occurs (Figure 4.4, Lane 5). At 1.0 µMand 10 µM 
7, further increases in cleavage are observed (Figure 4.4, Lanes 6 and 7). Thus a 
modest increase in the concentration of 7 can significantly increase the affinities 
of oligonucleotides 5 and 6 for their sites. 
To determine the magnitude of the binding enhancements, the equilibrium 
association constants Ks for 5 binding to site C alone, Ks+6 for 5 binding to site C 
in the presence of 5.0 µM 6 bound to neighboring site D, and Ks+6+7 for 5 binding 
in the presence of both 5.0 µM 6 and 7 were measured.8 Analysis of cleavage 
data yielded values of <104 M-1 (Ks), 2.1 (± 0.2) x lOS M-1 (Ks+6), and 8.9 (± 0.2) x 
10s M-1 (Ks+6+7), respectively (Table 4.2). These results show that the presence of 
5 µM oligonucleotide 6 increases the affinity of 5 for its site at least 21-fold. The 
addition of 5 µM oligonucleotide 7 further enhances the binding of 5 by a factor 
of 4.2. 
Discussion 
Possible sources for the cooperative interaction between oligonucleotides 
containing 5-(1-propynyl)-2' -deoxyuridines include a structural transition 
between adjacent sites on DNA and increased base stacking between the 
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Figure 4.4. Autoradiogram of an 8% denaturing polyacrylamide gel of reaction 
products from affinity cleavage reactions with oligonucleotides 5, 6, and 7 and a 
32P-labeled restriction fragment containing the target sites shown in Figure 4.2. 
The reactions were performed at 24 °C in 10 mM Bis-Tris•HCl at pH 7.0, 10 mM 
NaCl, 1 mM spermine. Lane 1, A-specific sequencing reaction; lane 2, oligo-
nucleotides 5 and 6 at 1 µMeach; lane 3, oligonucleotides 5 and 6 at 1 µMeach, 
oligonucleotide 7 at 1 nM; lane 4, oligonucleotides 5 and 6 at 1 µM each, oligo-
nucleotide 7 at 10 nM; lane 5, oligonucleotides 5 and 6 at 1 µMeach, oligonucleo-
tide 7 at 100 nM; lane 6, oligonucleotides 5 and 6 at 1 µMeach, oligonucleotide 7 
at 1 µM; lane 7, oligonucleotides 5 and 6 at 1 µMeach, oligonucleotide 7 at 10 
µM; lane 8, no oligonucleotides; lane 9, A-specific sequencing reaction; lane 10, 
oligonucleotides 5 and 7 at 1 µM each. 
Oligo 5 
Oligo 6 
Oligo 7 
Site C 
Site D 
Site E 
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Table 4.2: Equilibrium Association Constants for 6mer 5 
Binding in the Absence and Presence of 6mers 6 and 7 to 
DNA by Triple Helix Formationa 
Oligonucleotide 
5 
5 + 6 (5.0 µM) 
5 + 6 (5.0 µM) + 7 (5.0 µM) 
< 104 
2.1 (± 0.2) X lQ5 
8.9 (± 0.2) X lQ5 
a Values reported in the table are mean values measured 
from affinity cleavage titration experiments performed in 
Association buffer (10 mM Bis-Tris • HCl, 10 mM NaCl, 1 
mM spermine, pH 7.0, 24 °C). 
propyne-substituted 2' -deoxyuridines. 13J 4 Additional experiments showing that 
separation of sites A and B (Figure 4.1) by a one base pair gap abolishes the 
binding enhancement of oligonucleotide 1 in the presence of oligonucleotide 2 
suggest that stacking interactions are likely to play an important role in 
cooperativity. This idea is supported by experiments indicating that the 
cooperativity between oligonucleotides bound at adjacent DNA sites is 
dependent on the sequence composition at the triplex junction (see Chapter 
Three).15 
-Toe right-handed nature of the triplex allows stacking of the propyne group 
of the base on the 3' -side of the junction onto the 5' -base across the junction, but 
not the stacking of the propyne group at the 5' -side of the junction onto the 3' -
adjacent base (Figure 4.5) . It is reasonable to believe that a 5' -TPU-3' stack 
(Figure 4.5A) is more favorable than a 5' YlJT-3' stack (Figure 4.SB) due to greater 
interactions between delocalized n-orbitals in the former rather than in the 
latter.16 
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A 
5' 
) 
B 
5' 
) 
Figure 4.5. Base stacking configuration of two PU•AT triples drawn 
based on the structure proposed for DNA triple helix (T•AT)n.17 The 
Cl' atoms of the deoxyribose sugars are represented by the open 
circles. The 5'➔ 3' polarity of the strands is indicated by the symbols @ 
(into the plane of the page) and 0 (out of the plane of the page). 
114 
To test this model, experiments were carried out to determine the interaction 
energies observed when 5-(1-propynyl)-modified oligonucleotide 1 binds to the 
5' -side of the triple-helical junction (site A, Figure 4.1) in the presence of 1.0 µM 
unmodified oligonucleotide 4 bound to the 3'-side (site B, Figure 4.1), and when 
unmodified oligonucleotide 3 binds to the 5' -side in the presence of 1.0 µM 
modified oligonucleotide 2 bound to the 3'-side (Figure 4.1). In both cases, site B 
should be < 2% occupied by 1.0 µM oligonucleotide 2 or 4 in the absence of 
bound 1 or 3. Under the titration conditions, modified oligonucleotide 1 at :::; 20 
µM in the presence of 1.0 µM unmodified 4 produced minimal cleavage, and its 
equilibrium constant for binding to site A could not be measured. In contrast, 
unmodified oligonucleotide 3 bound to site A in the presence of 1.0 µM modified 
2 with an increased association constant (K3+2 = 9.7 (± 0.6) x 104 M-1) (Table 4.1). 
These results are consistent with a model wherein cooperativity between a 
modified and an unmodified oligonucleotide is dramatically affected by the 
position (3' - or 5' -) of the modified oligonucleotide with respect to the triple-
helical junction due to two stacking arrangements (Figure 4.5). This suggests 
that some significant contribution to the interaction energy between 1 and 2 
originates from stacking between the modified bases at the triplex junction. It is 
reasonable to believe that the same phenomenon occurs in the trimeric 
cooperative system described. Thus, according to this model, the binding of 
oligonucleotide 7 to site E enhances the binding of 6 to site D through n-stacking 
interactions, which in turn enhances the binding of 5 to its site (Figures 4.2 and 
4.6). This model is supported by experiments described above wherein 
increasing concentrations of 7 in the presence of a constant concentration of 5 and 
6 lead to greater cleavage by 5. 
Implications. Cooperativity can be used to allow modified 8mer 
oligonucleotides in the molecular weight range of 2500 to bind to adjacent sites 
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3' 5' 
18-bp Site Site D 
Site C 
3' 5' 
Figure 4.6. Ribbon model of oligonucleotides 5, 6, and 7 bound at 
adjacent sites on duplex DNA by triple helix formation. The Watson-
Crick duplex strands are shown as white ribbons, and the triple helix 
forming oligonucleotides are shown as dark ribbons. 
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on double-helical DNA at micromolar concentrations. In addition, it allows even 
shorter (MW ~ 1600) oligonucleotides to bind to three adjacent sites on DNA 
(Figure 4.6). These findings carry several important implications. First of all, the 
use of cooperativity has allowed us to design a system in which three ligands 
bind cooperatively to DNA. The functioning of many biological systems relies 
on the cooperative interactions between two or more ligands, as these can lead to 
highly specific DNA-protein binding interactions and, as a result, to the highly 
efficient control of gene expression. This principle is exemplified by the natural 
trimeric phage 'A, repressor system, in which cooperative interactions occur 
between proteins bound to three tandem operator sites.18 The nucleic acid 
system described here could presumably be highly specific as well. Studies on 
the cooperative binding of oligonucleotides to DNA have shown that a 
cooperative system in which two oligonucleotides bind to DNA is more sensitive 
to single-base mismatches than the corresponding noncooperative system in 
which a longer oligonucleotide binds to DNA (see Chapter Three).1 5 On this 
basis, it is reasonable to believe that even higher specificities could be achieved in 
systems in which still shorter oligonucleotides bind to DNA. 
In addition to leading to higher specificities, cooperative interactions between 
short oligonucleotides may facilitate the application of cooperativity in 
therapeutics, as low molecular weight oligonucleotides are presumably more 
amenable to cell penetration and are less toxic than longer, higher molecular 
weight ones. 
Experimental Section 
General. E. coli JMl 10 was obtained from Stratagene. Qiagen plasmid kits 
were purchased from Qiagen Inc. Sonicated, deproteinized calf thymus DNA 
was purchased from Pharmacia. Nucleotide triphosphates were obtained from 
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Pharmacia. Nucleotide triphosphates labeled with 32p (~ 3000 Ci/mmol) were 
purchased from Amersham. Restriction endonucleases were purchased from 
New England Biolabs, and used according to the suggested protocol in the 
provided buffer. Thymidine and 5-methyl-2'-deoxycytidine phosphoramidites 
were obtained from ABI and Cruachem, respectively. The 5'-O-DMT-protected 
5-(1-propynyl)-2'-deoxyuridine phosphoramidite derivative (now commercially 
available) (Figure 4.7) and controlled pore glass derivatized with 5-(1-propynyl)-
2'-deoxyuridine (Figure 4.8) were synthesized according to published procedures 
(see below). Sephadex resins were obtained from Pharmacia. Sequenase Version 
2.0 was obtained from United States Biochemical. 
5-(1-Propynyl)-2'-deoxyuridine (II). A mixture of 5-iodo-2'-deoxyuridine 
(3.54 g, 10.0 mmol), Cul (0.38 g, 2.0 mmol), tetrakis(triphenylphosphine)-
palladium (0) (1.16 g, 1.0 mmol), and triethylamine (3.0 mL, 21 mmol) in dry 
DMF (50 mL) was stirred under argon. Propyne (see below) was bubbled 
through the mixture for 6.5 h. The mixture was allowed to stir at room 
temperature for 18 h. To the reaction mixture were added methanol (28 mL), 
methylene chloride (28 mL), and NaHCO3 (4.1 g). After 30 minutes, the mixture 
was filtered through Celite, and concentrated in vacuo. The resulting residue was 
dissolved in CH2Cl2 (300 mL), and extracted with water (3x300 mL). The 
aqueous layers were combined, and concentrated under reduced pressure. The 
residue was suspended in acetone, and the resulting precipitate was collected by 
filtration to give 1.30 g (49% yield) of product in the form of a white solid. The 
filtrate was concentrated in vacuo, and crystallized from 98% EtOH to give an 
additional 0.91 g of pure product (34% yield). The mother liquor was 
concentrated in vacuo, and purified through flash chromatography (100% EtOAc) 
to afford 0.17 g (6.4% yield) of product. The total yield was 2.38 g (89% yield). 
lH NMR (DMSO) d 1.94 (s, 3H), 2.06 (m, 2H), 3.50-3.61 (m, 2H), 3.73-3.79 (m, lH), 
0 
:Y' O;lN 
HO~ 
HO 
I 
0 
III 
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, Et3N, HN 
OAN 
Pd (0), Cul 
DMF 
HO~ 18 h, 24 °C 
89% 
2-Cyanoethyl-N,N-
diisopropylchloro-
phosphoramidite , 
Et3N 
CH2Cl2 
1 h, 24 °C, 79% 
HO 
II 
~ 
DMTCI, pyr 
2 h, 24 °C 
80% 
Figure 4.7. Synthesis of the 5'-O-DMT-protected 5-(1-propynyl)-2' -deoxyuridine 
phosphoramidite derivative IV _6a 5-(1-Propynyl)-2'-deoxyuridine (II) was 
obtained in 89% yield from the palladium catalyzed coupling of 5-iodo-2' -deoxy-
uridine (I) with propyne as described by De Clercq.19 
0 
III 
p-nitrophenol 
DCC, pyr 
THF 
24 h, 24 °C 
CPG, Et3N 
DMF 
48 h, 24 °C 
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lo 
~ ,DMAP 
0 
pyr 
24 h, 24 °C 
95% 
0 
0 
VII 
Figure 4.8. Synthesis of controlled pore glass derivatized with 5-(1-propynyl)-2'-
deoxyuridine (VII). 20 
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4.16-4.22 (m, lH), 5.05-5.08 (m, lH), 5.20-5.23 (m, lH), 6.07 (t, lH, J = 6.7 Hz), 8.07 
(s, lH), 11.52 (bs, lH); FABMS m/e (relative intensity) 267.0991 (M + H, 267.0981 
calcd. for C12H1sN2O5). 
Propyne. To a refluxing solution of KOH (90.0 g, 1.6 mol) in dry nBuOH (400 
mL) was added dropwise 1,2-dibromopropane (52 mL, 0.50 mol) over a period of 
6 h. The gaseous propyne was bubbled through a pipette into the reaction 
mixture of 5-iodo-2' -deoxyuridine at room temperature. 
5-(1-Propynyl)-5'-0-(4,4'-dimethoxytrityl)-2'-deoxyuridine (III). A solution 
of 5-(1-propynyl)-2'-deoxyuridine (II) (300 mg, 1.13 mmol) and dimethoxytrityl 
chloride (517 mg, 1.52 rnrnol) was allowed to stir in dry pyridine (5.0 mL) under 
argon at room temperature for 2 h . Methanol (8 mL) was added, and the 
solution was stirred at room temperature for 1 h. The solution was concentrated 
in vacuo, and excess pyridine was removed by coevaporation with heptane. The 
resulting residue was dissolved in methylene chloride (200 mL), washed with 
water (3x200 mL), dried (Na2S 04), and concentrated in vacuo . Flash 
chromatography (0-1.5% MeOH/CH2Cli) afforded 520 mg (80% yield) of 
product in the form of a white solid. 1H NMR (CDCl3) d 1.74 (s, 3H), 2.31-2.33 
(m, lH), 2.48-2.49 (m, 1 H), 3.39 (d, 2H, J = 3.0 Hz), 3.81 (s, 6 H), 4.51 (m, 1 H), 
4.57 (t, 1 H, J = 2.8 Hz), 6.34 (m, 1 H), 6.86 (d, 4 H), 7.23-7.47 (m, 9 H), 8.01 (s, 1 H); 
FABMS m/e (relative intensity) 568.2215 (M + H, 567.2210 calcd. for 
C33H33N2O7). 
5-(1-Propynyl)-3'-(2-cyanoethyl-N,N-diisopropylphosphoramidite)-5'-0-
(4,4'-dimethoxytrityl)cytidine (IV). A solution of 5-(1-propynyl)-5' -0-( 4,4' -
dimethoxytrityl)-2'-deoxyuridine (III) (0.30 g, 0.528 rnrnol) in dry CH2Cl2 (5 mL) 
was cooled to O 0 C, and to it were added dry Et3N (0.22 mL, 1.584 rnrnol) and 2-
cyanoethyl-N,N-diisopropylchlorophosphorarnidite (0.18 mL, 0.792 mmol). The 
solution was allowed to stir under argon at O °C for 10 minutes, after which it 
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was allowed to warm to room temperature. After 50 minutes, it was diluted 
with 50 mL of methylene chloride, washed with a saturated solution of NaHCO3 
(2x50 mL), dried (Na2SO4), and concentrated in vacuo. Flash chromatography 
(1:1 EtOAc/petroleum ether) afforded 0.319 g (79% yield) of product in the form 
of a white foam. FABMS m/e (relative intensity) 769.3354 (M + H, 769.3366 calcd. 
for C42HsoN4O3P). 
5-(1-Propynyl)-3'-succinyl-5'-0-(4,4'-dimethoxytrityl)cytidine (VI). A 
solution of 5-(1-propynyl)-5' -0-( 4,4' -dimethoxytrityl)-2' -deoxyuridine (III) (0.30 
g, 0.528 mmol), succinic anhydride (0.079 g, 0.79 mmol), and DMAP (0.065 g, 
0.528 mmol) in dry pyridine (1 mL) was allowed to stir under argon at room 
temperature for 24 h. The solution was concentrated in vacuo, azeotroped from 
toluene, and reconcentrated. It was then dissolved in CH2Ch (30 mL), washed 
with cold 10% citric acid (2x15 mL), and water (2x15 mL). The aqueous layers 
were extracted with CH2Cb, after which the combined organic layers were dried 
(Na2SO4), and concentrated in vacuo. The solid residue was dissolved in CH2Cl2 
(3 mL), and precipitated into rapidly stirring hexanes (125 mL). The precipitate 
was separated by filtration, and the precipitation process was repeated three 
times to afford 0.336 g (95% yield) of slightly impure product in the form of a 
yellowish foam which was used without further purification. 
5-(1-Propynyl)-5' -0-(4,4' -dimethoxytrityl)-2' -deoxyuridine-derivatized CPG 
(VII). A solution of VI (0.336 g, 0.50 mmol), p-nitrophenol (0.070 g, 0.5 mmol), 
dicyclohexylcarbodiimide (0.258 g, 1.25 mmol), and dry pyridine (0.1 mL) in dry 
THF (2.5 mL) was allowed to stir under argon at room temperature for 24 h. The 
resulting precipitate was isolated by filtration through a Nylon filter, and 
washed with DMF. It was immediately added to a mixture of CPG (Sigma, 0.61 
g) in dry DMF (1.6 mL), to which dry Et3N (0.15 mL) was subsequently added. 
The mixture was allowed to stir at room temperature for 48 h. The derivatized 
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CPG was then separated by filtration, washed with DMF (3x50 mL), methanol 
(3x50 mL), and ether (3x50 mL), after which it was dried under air and then 
under vacuum. Nucleotide loadings were determined to be 26 µmol/ g of 
support by a DMT deprotection assay. 20 The uncoupled amine groups on the 
CPG were capped by treatment with DMAP (0.0203 g) and acetic anhydride (0.4 
mL) in pyridine (4 mL) for 30 minutes at room temperature. The support was 
then filtered, washed first with methanol and then with ether, and finally dried 
zn vacuo. 
Construction of pMD5152 and pMD5354. These plasmids were prepared by 
standard methods. 21 Briefly, pMD5152 was prepared by hybridization of two 
synthetic oligonucleotides, 5' -d(ACGTTCCT AAAAAAGGAAAAAAAAGAGA-
GAGAGATCTG)-3' and 5' -d(GATCCAGATCTCTCTCTCTTTTTTTTCCTTTTTT-
AGGA)-3 ', followed by ligation of the resulting duplex with pUC18 DNA 
previously digested with HindIII and BamHI; this ligation mixture was used to 
transform E. coli JMll0 (Stratagene). Plasmid DNA from ampicillin resistant, 
white colonies was isolated and the presence of the desired insert confirmed by 
restriction analysis and Sanger sequencing. Preparative isolation of plasmid 
DNA was performed using a Qiagen plasmid kit. Plasmid pMD5354 (used in the 
one base pair gap experiment) was prepared using a similar procedure with the 
oligonucleotides 5' -d(AGCTTCCT AAAAAAGGAAAAAAAAAGAGAGAGAG 
ATCTG)-3' and 5' -d(GATCCAGA TCTCTCTCTCTTTTTTTTTCCTTTTTTAGG 
A)-3'. 
Oligonucleotide Preparation. Oligonucleotides were synthesized by 
standard automated solid-support chemistry on an Applied Biosystems Model 
380B DNA synthesizer using O-cyanoethyl-N,N-diisopropyl phosphoramidites.22 
The phosphoramidite of thymidine-EDTA (T*) was prepared according to 
published procedures. 7 Controlled pore glass derivatized with T* was prepared 
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as described by Strobel. 20 Oligonucleotides 1, 3, and 5 containing T* were 
deprotected with 0.1 N NaOH at 55 cc for 24 h, neutralized with glacial acetic 
acid, desalted on Pharmacia Sephadex (G-10-120) spin columns, and dried in 
vacuo. Oligonucleotides 2, 4, 6, and 7 were deprotected with concentrated 
ammonium hydroxide at 55 cc for 24 h, and dried in vacuo. The crude 5'-
terminal-dimethoxytrityl protected oligonucleotides were purified by reverse 
phase FPLC on a ProRPC 10/10 (C2-Cs) column (Pharmacia LKB) and a gradient 
of 0-40% CH3CN in 0.1 M triethylammonium acetate, pH 7.0, detritylated in 80% 
AcOH, and chromatographed a second time. Triethylammonium acetate was 
removed via repeated resuspensions of the oligonucleotides in water followed by 
lyophilization. Concentrations of oligonucleotides not containing 5-(1-
propynyl)-2'-deoxyuridine were determined by UV absorbance at 260 nm using 
extinction coefficients (M-1 cm- 1) of 8800 (T and T*) and 5700 (IDC). 
Concentrations of oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine 
were determined by UV absorbance at 280 nm using extinction coefficients (M-1 
cm-1) of 6400 (T and T*), 8300 (me), and 9700 (PU). 
HPLC Analysis of Oligonucleotides Containing 5-(1-Propynyl)-2'-deoxy-
uridine. Oligonucleotides 1 and 2 were subjected to standard enzyme 
degradation and HPLC analysis for purity confirmation with a Hewlett-Packard 
1090 liquid chromatograph using a reverse phase Vydac RP C18 90A 
pharmaceutical column (4.6 x 250 mm, 5 µm C18-derivatized gel). Mobile phase 
A: 20 mM ammonium acetate, 1 mM EDTA in water, pH 5.0. B: 20 mM 
ammonium acetate, 1 mM EDTA in 40% aqueous acetonitrile, pH 5.0. Flow rate: 
1.0 mL/ rnin. Pressure: 120 bar. 
Preparation of Labeled Restriction Fragment. This is fully described in the 
Experimental Section of Chapter Two. 
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Quantitative Affinity Cleavage Titrations. These are fully described in the 
Experimental Section of Chapter Two. 
Construction of Titration Binding Isotherms. See the Experimental Section 
of Chapter Two for a detailed description. 
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CHAPTER FIVE: 
Cooperative Binding of Purine-Rich Oligonucleotides 
to Adjacent DNA Sites by Triple Helix Formation 
Introduction 
Cooperative interactions between DNA-binding proteins have been shown to 
be important for the regulation of gene expression.I These cooperative 
interactions result in higher sequence specificity as well as greater sensitivity to 
concentration changes.I When cooperative interactions occur between two or 
more oligonucleotides bound at neighboring DNA sites, the specific binding of 
each oligonucleotide is enhanced.2'3 Pyrimidine oligodeoxyribonucleotides 11 
nucleotides in length are known to bind cooperatively by triple helix formation 
to adjacent purine sites on double-helical DNA, resulting in a 12-fold to 127-fold 
increase in the association constant for one oligonucleotide in the presence of a 
neighboring bound oligonucleotide depending on the sequence composition at 
the junction.3a,c This 1.5~2.9 kcal•mol-1 interaction energy likely arises from 
favorable polarization and charge-charge interactions between the terminal bases 
at the triple-helical junction. We have subsequently shown that the use of 
modified bases, such as 5-(1-propynyl)-2'-deoxyuridine, increases cooperativity 
between oligonucleotides bound to adjacent sites on DNA, presumably due to an 
increased stacking energy between the modified bases at the triplex junction.3b 
The addition of dimerization domains to oligonucleotides such as those capable 
of forming a short Watson-Crick helix or intercalators were shown to result in 
strong cooperative interactions as well.2b-ct,4 
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The notion that base stacking is greatly responsible for the observed 
cooperative interactions is consistent with results indicating that when two 
pyrimidine oligonucleotides bind on duplex DNA to sites that are separated by 
one base pair, no cooperativity is observed.3a,b The finding that cooperative 
interactions between oligonucleotides bound to double-helical DNA depend on 
the nature of the base stack at the junction led us to investigate cooperative 
interactions between purine-rich oligonucleotides bound to abutting DNA sites 
when a purine-purine stack is formed at the junction. Purine-rich oligonucleo-
tides bind in the major groove antiparallel to the Watson-Crick purine strand 
through the formation of reverse Hoogsteen hydrogen bonds (G • GC and A • AT 
or T• AT base triplets) .5 Here we report the energetics of cooperative binding of 
purine-rich oligodeoxyribonucleotides to adjacent sites on DNA by triple helix 
formation when a 5' -GG-3' stack is formed at the junction. The equilibrium 
association constant of one oligonucleotide bound to an 11-base pair (bp) homo-
purine site is measured in the absence and presence of a second oligonucleotide 
occupying an adjacent 11-bp site by quantitative DNase footprinting titrations. 6'7 
In addition, we determine the equilibrium association constant of the same 
1 lmer binding in the absence and presence of a second oligonucleotide when the 
binding sites for the two oligonucleotides are separated by one base pair. 
Results 
A system was designed in which two purine-rich oligonucleotides, 1 and 2, 
bind to abutting sites on a 648-bp 3'-32P-end-labeled duplex DNA fragment at 
24 °C and pH 7.0 (50 mM TrisOAc, 10 mM NaCl, 10 mM MgCb) via specific 
reverse Hoogsteen hydrogen bonding (T • AT and G • GC) (Figure 5.1). To 
measure the interaction energy between 1 and 2, the equilibrium association 
constant K1 of 1 binding to site A alone, K2 of 2 binding to site B alone, and K1+2 
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11-bp Site B 11-bp Site A 
5' GGAGi'~GGGJ\GG GGGGP.'AGGAG1G-3' 
3' CCTC'TCCCT'CCCCCC:TTCCTO:C 5' 
1 5'- GGTGGTTGGGG 
2 5'- GGTGGGTGTGG 
Figure 5.1. Schematic representation of a complex composed of two 
purine-rich triple helix forming oligonucleotides binding at adjacent sites 
on double-helical DNA. Thick solid lines represent the DNA backbone of 
the target site and associated oligonucleotides. Thin solid lines represent 
Watson-Crick hydrogen bonds while dashed lines indicate Hoogsteen 
hydrogen bonds. Binding of the oligonucleotides is assessed by 
quantitative DNase footprinting titrations. 
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of 1 binding to site A in the presence of 5.0 µM 2 bound to site B were measured 
using quantitative DNase footprinting titrations. The cooperative interaction 
energy Ecoop between oligonucleotides 1 and 2 can be determined from the 
experimental data through the following expression, as described in Chapter 
Two:3a 
<l>(l + KB[LB]) - 1 
Ecoop = -RTln KB[LB] (1) 
For the cooperatively binding oligonucleotides described here LB is oligonucleo-
tide 2, and KB is the association constant of 2 to its site. As explained in Chapter 
Two, <I> = KA+BI KA, where KA+B and KA are the association constants of oligo-
nucleotide 1 binding to site A in the presence and absence of 2, respectively. 
Cooperative Binding of Two llmers in the Presence of a 5'-GG-3' Stack. 
Analysis of the footprinting data performed on a 648-bp 3'-32P-end-labeled 
duplex DNA fragment yielded equilibrium association constants of 2.8 x 10s M-1 
for 1 binding to site A alone (K1), 1.5 x 106 M-1 for 2 binding to site B alone (K2), 
and 2.2 x 107 M-1 for 1 binding to site A in the presence of 5 µM 2 (K1+2) (Figure 
5.2, Table 5.1). The binding enhancement K1+2/ K1 was observed to be 81 (± 12). 
This corresponds to an interaction energy Ecoop of 2.7 (± 0.1) kcal • mol-1. 
Effect of a One Base Pair Gap Between Adjacent Sites. Quantitative DNase 
footprinting titrations were used to obtain equilibrium association constants for 1 
binding in the absence and presence of 2 when the binding sites A and B are 
separated by one base pair (Figures 5.3 and 5.4, Table 5.2). The association 
constants for the binding of 1 to DNA in the absence and presence of oligo-
nucleotide 2 areK1 = 2.8 x 105 M-1 and K1+2 = 3.9 x 105 M-1, respectively. Hence, 
when the binding sites are separated by one base pair, there is no enhancement 
of the binding of 1 in the presence of 2 within experimental error. 
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Figure 5.2. Binding isotherms obtained for oligonucleotide 1 alone (o), and in 
the presence of 5.0 µM oligonucleotide 2 ( • ), using quantitative DNase foot-
printing titrations. Four complete data sets were used to determine each 
association constant. 
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11-bp Site B 11-bp Site A 
5' GGAGAGGGAGGGGGGGAAGGiAG -3' 
3' CCTCTCCCT CCCCCCCTTC CTC -5' 
1 5'- GGTGGTTGGGG 
2 5'- GGTGGGTGTGG 
Figure 5.3. Schematic representation of a complex composed of two 
purine-rich triple helix forming oligonucleotides binding on double-
helical DNA where the two target sites are separated by one base pair. 
Thick solid lines represent the DNA backbone of the target site and 
associated oligonucleotides. Thin solid lines represent Watson-Crick 
hydrogen bonds while dashed lines indicate Hoogsteen hydrogen bonds. 
Binding of the oligonucleotides is assessed by quantitative DNase 
footprinting titrations. 
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Figure 5.4. Binding isotherms obtained for oligonucleotide 1 alone (o), and in the 
presence of 5.0 µM oligonucleotide 2 ( •) bound to DNA where the two target 
sites are separated by one base pair. Three to four complete data sets were used 
to determine each association constant. 
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Table 5.1: Equilibrium Association Constants for Two Purine-rich Triple 
Helix Forming Oligonucleotides Binding at Adjacent Sites on DNAa 
Oligonucleotide K (M-1) LiG (kcal•mol-1) 
1 
2 
1 + 2 (5 µM) 
2.8 (± 0.2) X 105 -7.4 (± 0.1) 
1.5 (± 0.1) X 106 -8.4 (± 0.1) 
2.2 (± 0.3) X 107 -10.0 (± 0.1) 
a Values reported in the table are mean values measured from DNase 
footprinting titration experiments performed in Association buffer (10 mM 
NaCl, 10 mM MgCl2, 50 mM Tris-acetate, pH 7.0, 24 °C). 
Table 5.2: Equilibrium Association Constants for Two Purine-rich Triple 
Helix Forming Oligonucleotides Binding on DNA where the Target Sites 
are Separated by One Base Paira 
Oligonucleotide 
1 
1 + 2 (5 µM) 
2.8 (± 0.6) X 105 
3.9 (± 0.5) X 105 
-7.4 (± 0.1) 
-7.6 (± 0.1) 
a Values reported in the table are mean values measured from DNase 
footprinting titration experiments performed in Association buffer (10 mM 
NaCl, 10 mM MgCb, 50 mM Tris-acetate, pH 7.0, 24 °C). 
Discussion 
Two purine-rich oligonucleotides bind cooperatively to adjacent DNA sites 
with an interaction energy of 2.7 kcal•mol-1. Cooperative interactions between 
oligonucleotides may arise from a structural transition between adjacent sites on 
DNA and increased base stacking between the terminal bases at the triplex 
junction. Recent data shows that cooperativity between pyrimidine oligonucleo-
tides greatly varies from 1.5 (± 0.1) kcal•mol-1 to 2.9 (± 0.1) kcal•mol-1 depen-
ding on the sequence composition of the stack between the bases at the junction.3c 
Previous experiments show that when two pyrimidine oligonucleotides bind on 
duplex DNA by triple helix formation to sites that are separated by one base pair, 
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no cooperativity is observed.3a,b The results reported here show that a one base 
pair gap between adjacent triple helix sites abolishes cooperativity between 
purine-rich oligonucleotides, suggesting that there are no significant propagated 
structural changes beyond the immediately neighboring base pair in the purine 
motif as well. These combined results suggest that base stacking is the major 
contributor to cooperative interactions between pyrimidine and purine-rich triple 
helix forming oligonucleotides. 
Base stacking interactions in aqueous solution arise from electrostatic, polari-
zation, and dispersion forces .8 Optimized potential calculations show that 
dispersion and polarization interactions determine the magnitude of the total 
interaction energy, whereas electrostatic forces determine orientational prefe-
rences. sct The free energy of base stacking for monomer nucleosides associating 
in aqueous solution has been reported to vary between -0.5 kcal •mol-1 and -3.0 
kcal•mol-1, depending on solution, salt conditions, nucleoside identity, concen-
tration and temperature.sa-i While it is not clear to what extent hydrophobic 
forces, dispersion forces or interactions between partial charges dominate the 
free energy of base stacking, it is generally agreed that base stacking depends 
primarily on the size of the 1t-electron systems.8£,g The strong cooperativity 
observed between purine-rich oligonucleotides is consistent with the notion that 
a larger mobile 1t-electron system does contribute to a high free energy of 
stacking, which likely arises from favorable induced dipole and hydrophobic 
interactions between the terminal guanines at the triplex junction (Figure 5.5). 
The importance of maximal GG stacking interactions has been invoked in many 
biological systems, including genomic replication.9 
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3' 5' 
Site B 
22-bp Site 
Site A 
5' 
Figure S.S. Ribbon model of oligonucleotides 1 and 2 bound at adjacent 
sites on duplex DNA by triple helix formation. The Watson-Crick 
duplex strands are shown as white ribbons, and the triple helix forming 
oligonucleotides are shown as dark ribbons. 
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Experimental Section 
General. E. coli JMll0 was obtained from Stratagene. Qiagen plasmid kits 
were purchased from Qiagen Inc. Sonicated, deproteinized calf thymus DNA 
was purchased from Pharmacia. Nucleotide triphosphates were obtained from 
Pharmacia. Nucleotide triphosphates labeled with 32P (~ 3000 Ci/ mmol) were 
purchased from Amersham. Restriction endonucleases were purchased from 
New England Biolabs, and used according to the suggested protocol in the 
provided buffer. Thymidine and 2' -deoxyguanosine phosphoramidites were 
obtained from Glen Research. Sephadex resins were obtained from Pharmacia. 
Sequenase Version 2.0 was obtained from United States Biochemical. DNase was 
purchased from Pharmacia. 
Construction of pNC107 A and pNC200. This plasmid was prepared by 
standard methods. 10 Briefly, pNC107 A was prepared by hybridization of two 
synthetic oligonucleotides, 5' -d(AATTCTCTCTAAAAGGAGAGGGAGGGGGG-
AAGGAGGAAAACTCTCT)-3' and 5' -d(CTAGAGAGAGTTTTCCTCCTTCCCC-
CCTCCCTCTCCTTTTAGAGAG)-3', followed by ligation of the resulting duplex 
with pUC19 DNA previously digested with EcoRI and Xbal; this ligation mixture 
was used to transform E. coli JMll0 (Stratagene). Plasmid DNA from ampicillin 
resistant white colonies was isolated and the presence of the desired insert 
confirmed by restriction analysis and Sanger sequencing. Preparative isolation 
of plasmid DNA was performed using a Qiagen plasmid kit. Plasmid pNC200 
was prepared using a similar procedure with the oligonucleotides 5'-
d(AA TTCTCTCT AAAAGGAGAGGGAGGGGGGGAAGGAGGAAAACTCTC-
T)-3' and 5' -d(CT AGAGAGAGTTTTCCTCCTTCCCCCCCTCCCTC1CCTTTT A-
GAGAG)-3'. 
Oligonucleotide Preparation. Oligonucleotides were synthesized by 
standard automated solid-support chemistry on an Applied Biosystems Model 
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380B DNA synthesizer using O-cyanoethyl-N,N-diisopropyl phosphoramidites.11 
Oligonucleotides were deprotected with concentrated ammonium hydroxide at 
55 °C for 24 h, and dried in vacuo. The crude 5'-terminal-dimethoxytrityl-pro-
tected oligonucleotides were heated at 90 °C for 5 minutes to prevent structure 
formation, purified by reverse phase FPLC on a ProRPC 10/10 (C2-Cs) column 
(Pharmacia LKB) and a gradient of 0-40% CH3CN in 0.1 M triethylammoniurn 
acetate, pH 7.0, detritylated in 80% AcOH, and chromatographed a second time. 
The purified products were desalted on a NAP 25 column (Pharmacia) and dried 
in vacuo. Oligonucleotide concentrations were determined by UV absorbance at 
260 nm using extinction coefficients (M-1 cm-1) of 8800 (T) and 11700 (G). 
Preparation of Labeled Restriction Fragment. The 3'-32P-labeled duplex was 
prepared by digestion of the plasmid pNC107 A with HindlII, followed by 
treatment with a-32P-dATP, a-32P-dCTP, a-32P-dGTP, and a-32P-TTP in the 
presence of Sequenase. To remove nonincorporated radioactivity, the fragment 
was passed through a Pharmacia NICK column. The DNA was then digested 
with SspI, followed by separation of the resulting products on a 5% nondena-
turing polyacrylamide gel (19:1, monomer /bis). The gel band corresponding to 
the desired 648-bp fragment was visualized by autoradiography, excised, 
crushed, and soaked in 10 mM Tris, pH 8.0, and 20 mM EDTA, at 37 °C for 15-18 
h. The resulting suspension was filtered through a 0.45-µrn filter, and the eluted 
DNA present in the supernatant was precipitated with NaOAc/EtOH. The DNA 
pellet was washed with 70% EtOH, dried in vacuo, resuspended in TE buffer (10 
mM Tris, pH 8.0, 1 mM EDTA), extracted five times with phenol, twice with 24:1 
CHCl3/isoarnyl alcohol, and reprecipitated with NaOAc/EtOH. The DNA pellet 
was washed with 70% EtOH, dried in vacuo, and desalted on a Pharmacia NICK 
column. The precipitated pellet was resuspended in 25 rnM Tris-acetate, 100 
rnM NaCl, pH 7.0 at a final activity of 100,000 cpm/µL, and was stored at -20 °C. 
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Quantitative DNase Footprinting Titrations. In a typical experiment, a 5-
nmol aliquot of the desired oligonucleotide was dissolved in 50 µL of water to 
produce a solution that was 100 µM in oligonucleotide. This solution was then 
diluted serially to yield 100 µM, 10 µM, 1 µM, 100 nM, 10 nM, and 1 nM solu-
tions. The appropriate volume of these solutions was then distributed among 10-
14 1.5 mL microcentrifuge tubes at the appropriate concentrations. A stock solu-
tion containing labeled target DNA, Tris-Acetate buffer, NaCl, MgCb, and calf 
thymus DNA, the second oligonucleotide where needed, and water, was distri-
buted to each reaction tube in 12-µL aliquots, and the appropriate volume of 
water were added to each tube to bring the total volume to 36 µL. After the 
oligonucleotide and the DNA were allowed to equilibrate for 24-48 h at 24 °C, the 
DNase footprinting reactions were initiated. A stock solution containing DNase 
(0.2 mU/µL) in Activity buffer (40 mM Tris•HCl, 6 mM MgCl2, 2 mM CaCl2, pH 
7.0), 300 mM CaCl2, 15 mM MgCb, and 15 µM nonspecific oligonucleotide was 
prepared and distributed (4 µL/tube) . Final reaction conditions in 40 µL of 
Association buffer were 50 mM TrisOAc at pH 7.0, 10 mM NaCl, 10 mM MgCl2, 
100 µM bp calf thymus DNA, and approximately 10,000 cpm labeled DNA. 
Control experiments have been carried out showing that the concentration of calf 
thymus DNA does not affect the equilibrium association constants of llmer 
oligonucleotides binding to double-helical DNA due to their high specificity. 
The cleavage reactions were allowed to proceed for 8 minutes, and terminated by 
the addition of 8 µL of 250 mM EDTA followed by NaOAc/EtOH precipitation. 
The DNA cleavage products were washed with 70% aqueous EtOH, dissolved in 
35 µL of water, and dried in vacuo. The DNA was then resuspended in 10 µL of 
formamide-TBE loading buffer and heated at 55 °C for 10 minutes to effect disso-
lution. The Cerenkov radioactivity of the solutions was measured with a scin-
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tillation counter. The DNA was denatured at 95 °C for 3 minutes, and 5 µL from 
each sample were loaded onto a 8% denaturing polyacrylamide gel. 
Construction of Titration Binding Isotherms. Gels were exposed to photo-
stimulable storage phosphor imaging plates (Kodak Storage Phosphor Screen 
S0230 obtained from Molecular Dynamics) in the dark at 24 °C for 9-18 h.12 A 
Molecular Dynamics 400S Phosphorlmager was used to obtain data from the 
phosphorimaging screens. Rectangles of the same dimensions were drawn 
around the target site and at the reference site. The ImageQuant v. 3.3 program 
running on a 66 MHz AST Premium 486/33 computer was used to integrate the 
volume of each rectangle. 
The apparent occupancy of the sites in a given lane was determined from the 
cleavage data using the following equation of Ackers and coworkers:7 
lsite I Iref 
Yapp= 1 - l 0 site I l0 ref (2) 
where lsite and Iref are the intensities of the cleavage bands at the target site and 
at the reference site, respectively, and 1°site and I 0ref are the corresponding 
intensities from a control lane to which no oligonucleotide has been added. The 
data was fit using an unweighted nonlinear least square procedure with three 
adjustable parameters. The following equation was used in the fitting procedure: 
KT[O]tot 
Yapp= 0min + (8max- 8min) 1 + KT[O]tot (3) 
where 0min and 8max represent the experimentally observed values of Yapp at 0 
= 0 and 0 = 1, respectively, Ky is the equilibrium association constant for triple 
helix formation, and [O1tot is the oligonucleotide concentration. All data from a 
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gel were used unless visual inspection revealed a flaw in the gel at either the 
target or reference site. The goodness of fit of the binding curve was judged by 
the reduced chi-squared criterion. Fits with x2n > 1.5 were discarded. Fits which 
met this criterion had correlation coefficients greater than 0.95. All Ky values 
reported in the text or tables are the means of four experimental observations 
plus or minus the standard error of the mean. 
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CHAPTER SIX: 
Synthesis of Oligonucleotide Analogs Containing 
5-(1-Propynyl) and 2'-0-Allyl Substituents. 
Introduction 
The reduction in size of oligonucleotides targeted to DNA sequences is 
biologically relevant as it may facilitate oligonucleotide penetration through cell 
membranes in vivo, and improve the specificity of oligonucleotides by increasing 
their sensitivity to single-base pair mismatches. Experiments have shown that 
short ( < 11 nucleotides) pyrimidine oligonucleotides comprising unmodified 
bases are not able to bind DNA at micromolar concentrations at pH 7.0, 24 °C (see 
Chapter Four). Consequently, there has been a great interest in this laboratory 
and others in designing and synthesizing short oligonucleotide analogs 
containing nonnatural bases that bind double-helical DNA with high affinities. 
In order to improve the strength of hybridization to RNA and DNA targets, 
oligonucleotides modified in the phosphate backbone, sugar moiety or 
heterocyclic base have been synthesized, and their properties regarding 
hybridization, nuclease resistance, and cellular uptake have been studied.1' 2 
Modifications of the phosphate backbone include replacement of the phospho-
diester group by alkyl phosphonates, phosphorothioates, phosphoramidates, 
sulfones, sulfonates, sulfonamides, and methylhydroxylamines.1-2 Modifications 
of the sugar include opening of the ring,3a replacement of the furanose by a 
hexose ring3b,c or a carbocyclic ring,3ct and alkylation of the 2' -hydroxyl group. 
Modifications of the base aimed at improving pairing or stacking include 
extensive substitutions in both the aromatic nuclei and exocyclic functionalities. 2 
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Among modifications in the sugar moiety, 2' -0-alkylation of oligonucleotides 
has shown to improve hybridization properties. More specifically, oligonucleo-
tides containing 2' -0-alkyl substituents have shown to lead to enhanced double 
helix formation from single strand RNA and DNA. Methylation at the 2' -
position has resulted in increased thermal stability of double-stranded 
polyadenylic acid complexes,43 2'-0-methylribonucleoside-RNA com-
plexes,4b,4c,4e,4h and triple-stranded 2'-0-methylribonucleoside • DNA-DNA 
complexes.4g Methyl substitution at the 2' -OH has also rendered oligonucleo-
tides less susceptible towards nuclease degradation than unmodified oligo-
nucleotides.4b,4d,4e Finally, 2' -0-methylribonucleoside-RNA duplexes have shown 
to be RNase H substrates, suggesting that 2' -0-methyl analogs may be suited as 
antisense probes.4c,4f In an effort to understand why methylation of the 2'-
hydroxyl confers greater stability to the modified double- and triple-helical 
hybrids, several observations regarding how a 2' -0-methyl substituent affects the 
sugar puckering and the orientation of the base relative to the sugar have been 
put forth. 43'4g,s However, while it is agreed that methylation may cause slight 
changes in the stacking interactions and rigidity of the backbone in a helical 
complex, the structure of complexes containing 2' -0-methylated analogs has not 
been unambiguously established_4a,4b,4g,s 
Oligonucleotides containing a 2' -0 -allyl substituent have even higher affinity 
and specificity for single strand RNA than the corresponding 2'-0-methyl 
analogs.4e,6 Unlike 2' -0-methyl analogs, 2' -0-allyl analogs were found to be 
completely resistant to certain RNA and DNA nucleases.4e'6 Moreover, 2' -0-allyl-
substituted oligonucleotides were found to bind to complementary RNA 
sequences in crude HeLa cell nuclear extracts much more rapidly and selectively 
than the corresponding 2' -0-methyl-substituted or unmodified oligonucleo-
tides. 4e The high specificity of 2'-0-allyl relative to 2'-0-methyl derivatives in 
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crude nuclear extracts is presumably due to a greater steric hindrance imposed 
on protein binding by the bulkier allyl group. In other experiments, oligo-
nucleotides with an even bulkier substituent, such as a 2' -0-(3,3-dimethylallyl) 
group, were found to be more resistant to nuclease degradation, but could not 
form stable hybrids with complementary RNA sequences, possibly because of 
steric hindrance.4e The improved hybridization and nuclease resistance 
properties of 2' -0-allyl substituted oligonucleotides indicated that these may be 
useful for antisense inhibition. 
Among modifications in the heterocyclic base, alkyl and alkenyl substitutions 
at the 5-position of 2'-deoxypyrimidines have resulted in increased binding 
affinity of oligodeoxyribonucleotides to single- and double-stranded DNA. 7'8 
Pyrimidine 2' -deoxynucleosides with unsaturated substituents at the 5-position 
have shown antiviral and anticancer properties.9 Thermal denaturation studies 
revealed that 5-(1-propynyl)-2' -deoxyuridine significantly enhances double and 
triple helix formation on DNA (see also Chapter Four).10 It was proposed that 
the propynyl group, which is planar with the heterocycle, may both increase the 
enthalpy of binding by enhancing base stacking, and favor the entropy of 
binding due to the greater hydrophobicity and bulkiness of the propynyl relative 
to the methyl group. Interestingly, it was also shown that a 1-propynyl 
substituent at the 5-position of deoxycytidine destabilizes triple-helical 
complexes, while stabilizing double-helical ones, presumably due to a decrease 
in pKa of the nucleotide. 10 In addition, it was observed that the increased 
hydrophobicity of the 5-(1-propynyl)-substituted heterocycle may facilitate 
oligonucleotide penetration through cell membranes. The greater stability of 
double-helical 5-(1-propynyl)ribonucleoside• DNA and triple-helical 5-(1-
propynyl)ribonucleoside• DNA-DNA structures indicated that 5-(1-propynyl)-
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substituted oligonucleotides may in fact be useful for the sequence-specific 
recognition of short DNA tracts. 
Research Design 
In light of previous studies showing that a 2'-0-allyl- or 5-(1-propynyl)-
substitution increases the stability of triple helices, we decided to synthesize 
modified nucleosides containing both 2' -0-allyl and 5-(1-propynyl) substitutions 
(Figure 6.1). At the time the decision was made, no complete thermodynamic 
characterization of triplexes containing 2' -0-allyl- and/ or 5-(1-propynyl)-
substituted oligonucleotides had been reported. In order to elucidate the factors 
contributing to the higher stability of triplexes containing 2'-0-allyl and 5-(1-
propynyl) derivatives, we proposed to determine the energetics of oligo-
nucleotide-directed triple helix formation for pyrimidine oligonucleotide analogs 
containing the 5-(1-propynyl)- and the 2'-0-allyl-modified nucleosides shown in 
Figure 6.1 using quantitative affinity cleavage titrations. 7a 
Figure 6.2 shows the pyrimidine oligonucleotide analogs proposed to be 
synthesized and their DNA target site. The equilibrium association constant of 
the oligodeoxyribonucleotide-EDTA • Fe conjugate 5' -d(*TTTrrmcTmcrmcTmC-
TIDCT)-3' (1, Figure 6.2) binding to duplex DNA at 22 °C, pH 7.0 (100 mM NaCl, 
1 mM spermine) had been previously determined using quantitative affinity 
cleavage titrations. 7a The equilibrium association constant of oligonucleotide-
EDT A• Fe conjugate analog 2 containing 5-(1-propynyl)-2' -deoxyuridine (I) 
instead of T would provide information regarding the influence of the propynyl 
substitution of U on triple helix formation. Similarly, the equilibrium association 
constant of oligonucleotide analog 3 containing 5-methyl-2' -0-allyluridine (II) 
and 5-methyl-2' -0-allylcytidine (III) instead of T and me, respectively, would 
provide information regarding the influence of the allyl substitution of U and 
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IV 
Figure 6.1. Nucleoside analogs bearing 5-(1-propynyl)- and/or 2'-0-allyl-
substituents. I: 5-(1-propynyl)-2'-deoxyuridine; II: 5-methyl-2'-0-allyluridine; III: 
5-methyl-2'-0-allylcytidine; IV: 5-(1-propynyl)-2'-0-allyluridine. 
me on triple helix formation. Finally, the equilibrium association constant of 
oligonucleotide 4 containing 5-(1-propynyl)-2' -0-allyluridine (IV) and 5-methyl-
2' -0-allylcytidine (III) instead of T and me, respectively, would provide 
information regarding the influence of the simultaneous presence of the allyl and 
propynyl groups on triple helix formation. In addition, work towards the 
synthesis of the 2' -0-methyl and 5-(1- propynyl) derivatives of 1 was being 
undertaken in our laboratory as well. The combined results of these experiments 
would give information on the relative energetic contributions of the 2' -0-
methyl, 2' -0-allyl, and 5-(1-propynyl) groups to the stability of triplexes. 
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s·@~: ------------. 3' 
5' _,.....,...,._,..._ __ .,.._. - · --·- ·-· --· ... ·-·- · - · ... ·-·-· - · ----
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 :: 3' 
15-bp Site 
5'-AAGGAAAAAAAAGAGAGAGAGA TC T G-3' 
3'-T TCC T TTT TTTTCTC TCTCTCT AG A C-5' 
m m m m m 
1 5'- *T TT TT C T C T C T C T C T 
PPPPmPmPmPmPm 
2 5'- *T U U U U C U C U C U C U C T 
aaaaaaaaaaaaa 
3 5'- *T U U U U C U C U C U C U C T 
alp alp alp alp a alp a alp a alp a alp a 
4 5'- *T U U U U C U C U C U C U C T 
Figure 6.2. Schematic representation of a 15-nt oligonucleotide binding to 
double-helical DNA by triple helix formation. me = 5-methyl-2'-deoxy-
cytidine; PU = 5-(1-propynyl)-2'-deoxyuridine; au = 2'-0-allyluridine; ac = 
5-methyl-2'-0-allylcytidine; a/pu = 5-(1-propynyl)-2'-0-allyluridine. 
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The syntheses of 5-(1-propynyl)-2'-deoxyuridine (I) and of its 5'-0-DMT-
protected phosphoramidite derivative, now commercially available, are 
described in Chapter Four. The syntheses of the 5'-0-DMT-protected phosphor-
amidites of 5-methyl-2'-0-allyluridine, 5-methyl-2'-0-allylcytidine, and 5-(1-pro-
pynyl)-2'-0-allyluridine, and of oligonucleotides 1, 2, 3, and 4, are described 
below. The thermodynamic analysis of the binding of oligonucleotides 1, 2, 3, 
and 4 to double-helical DNA by triple helix formation has not been carried out 
yet. 
Synthesis of Nucleosides 
The synthesis of 5-(1-propynyl)-2' -0-allyluridine is shown in Figure 6.3. N3-
Benzoyl protection of 5-iodouridine11 followed by treatment of VI with l,3-
dichloro-1,1,3,3-tetraisopropyldisiloxane4h afforded the sugar-protected 
compound VII, which was then coupled to propyne in the presence of palladium 
to afford the 5-(1-propynyl)-substituted derivative VIII in 92% yield. Treatment 
of VIII with allyl bromide in the presence of Ag20
4
b afforded the 2'-0-allyl 
derivative IX in 45% yield. Removal of the benzoyl group with dilute NH40H,
4
b 
followed by deprotection of the sugar hydroxyls with 0.5 N HC14b afforded 5-(1-
propynyl)-2'-0-allyluridine IV, which was converted into the 5'-0-DMT-
protected phosphoramidite derivative XII according to standard protocols. 
The 5'-0-DMT-protected phosphoramidite derivatives of 5-methyl-2'-0-
allyluridine (XXII) (Figure 6.4) and 5-methyl-2'-0-allylcytidine (XXVII) (Figure 
6.5) were synthesized in an analogous manner to that used by Froehler et al. for 
the syntheses of 2'-0-allyluridine and 2'-0-allykytidine. 12 Reaction of ~-D-
ribofuranose-1-acetate-2,3,5-tribenzoate (XIII) with thymine in the presence of 
N,0-bis(trimethylsilyl)acetamide and stannic chloride, followed by deprotection 
of the sugar hydroxyls with NaOH afforded 5-methyluridine (XVI) in 85% 
Pd (0), Cul 
DMF 
10 h, 24 °C 
92% 
dil.NH4OH, 
dioxane 
5 h, 24 °C 
88% 
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Figure 6.3. Synthesis of the 5'-0-DMT-protected phosphorarnidite of 5-(1-
propyny 1 )-2' -0-ally 1 uridine. 
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Figure 6.4. Synthesis of the 5'-0-DMT-protected phosphoramidite of 5-methyl-
2'-0-allyluridine. 
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NH3,CH3CN 
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diisopropylchloro-
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60% 
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Figure 6.5 Synthesis of the 5'-0-DMT-protected phosphorarnidite of 5-rnethyl-2'-
0-ally lcytidine. 
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overall yield. Treatment of XVI with l,3-dichloro-1,1,3,3-tetraisopropyldisilo-
xane followed by protection of the C4 carbonyl group with 2,6-dichlorophenol13 
afforded compound XVIII in 82% yield. Reaction of adduct XVIII with ally! 
ethyl carbonate14 in the presence of palladium15 afforded the 2'-O-allyl derivative 
XIX in 84%. Removal of the 2,6-dichlorophenyl group with 2-pyridinealdoxime12 
followed by deprotection of the 3'- and 5'-sugar hydroxyls with TBAF afforded 5-
methyl-2'-O-allyuridine (II) in excellent overall yield. 5-Methyl-2'-O-allyluridine 
was converted into the corresponding 5'-O-DMT-protected phosphoramidite 
derivative XXII according to standard procedures. 
The synthesis of the 5'-O-DMT-protected phosphoramidite of 5-methyl-2'-O-
allylcytidine (XXVII) is shown in Figure 6.5. Reaction of the 2'-O-allyl derivative 
XIX with gaseous ammonia 12 followed by protection of the exocyclic amino 
group with benzoyl chloride 11 and removal of the disiloxane group afforded N4-
benzoyl-5-methyl-2'-O-allylcytidine (XXV) in very good yield. The correspon-
ding 5'-O-DMT-protected phosphoramidite derivative XXVII was synthesized 
according to standard procedures. 
Experimental Section· 
General. 1H and 13C NMR spectra were recorded on a General Electric QE 300 
NMR spectrometer and chemical shifts are reported in ppm using the solvent 
peak (DMSO, 2.49 ppm; CDC131 7.26 ppm) as internal standard. Mass spectra 
were obtained from the mass spectroscopy facility at the University of California, 
Riverside. Flash chromatography was carried out under positive air pressure 
using EM Science Kieselgel 60 (230-400 mesh size). 
Materials. Dry DMF and dry nBuOH were obtained from Aldrich. Pyridine 
and triethylamine were distilled from CaH2 • Commercially available propyne 
was purchased from Lancaster. Dimethoxytrityl chloride, 1,3-dichloro-l,l,3,3-
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tetraisopropyldisiloxane, and Dowex lx2 resin (Cl- form, 100-200 mesh) were 
obtained from Fluka. 5-Iodo-2' -deoxyuridine, 5-iodouridine, Cul, tetrakis-
(triphenylphosphine)palladium (0), 1,2-dibromopropane, trimethylsilyl chloride, 
benzoyl chloride, and allyl bromide were obtained from Aldrich . 
.N3-Benzoyl-5-iodouridine (VI). After coevaporation with pyridine (3x), 5-
iodouridine (10.0 g, 27.0 mmol) was dissolved in dry pyridine (100 mL) under 
argon. Trimethylsilyl chloride (24 mL, 0.19 mol) was slowly added, and the 
resulting suspension was allowed to stir at room temperature for 30 minutes. 
After addition of benzoyl chloride (15.6 mL, 0.13 mol), the reaction mixture was 
allowed to stir at room temperature for 2.5 h . The reaction mixture was cooled in 
an ice bath, water (20 mL) was added, and the suspension was stirred at 4 °C for 
5 minutes. Concentrated NH4OH (20 mL, 2 N final concentration) was added, 
and the mixture was allowed to stir at room temperature for 15 minutes. The 
mixture was concentrated in vacuo, suspended in EtOAc (600 mL), and washed 
with a saturated solution of NaHCO3 (600 mL). The organic layers were dried 
(Na2SO4), and concentrated. Flash chromatography (6% MeOH/CH2Cli) 
afforded 8.73 g (68% yield) of product in the form of a white solid. 1H NMR 
(DMSO) o 3.43-3.63 (m, 1 H), 3.70-3.80 (m, 1 H), 3.85-3.92 (m, 1 H), 4.02-4.08 (m, 2 
H), 5.13-5.18 (m, 1 H), 5.38-5.39 (m, 1 H), 5.52-5.54 (m, 1 H), 5.67-5.68 (m, 1 H), 
7.57-7.59 (m, 2 H), 7.62-7.79 (m, 1 H), 8.02-8.04 (m, 1 H), 8.76 (s, 1 H). 13C NMR 
(DMSO) o 59.88, 69.01, 74.35, 84.88, 89.61, 115.45, 115.96, 129.73, 130.81, 130.92, 
135.02, 146.08; FABMS m/e (relative intensity) 475.0030 (M + H, 475.0002 calcd. 
for C16H16IN2O7) . 
.N3-Benzoyl-5-iodo-3' ,5' -0-( tetraisopropyldisiloxane)uridine (VII). N3-Ben-
zoy l-5-iodouridine (0.40 g, 0.80 mmol) was dissolved in dry pyridine (4.0 mL) 
under argon. To the solution was slowly added 1,3-dichloro-1,1,3,3-
tetraisopropyldisiloxane (291 µL, 0.90 mmol), and the resulting suspension was 
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allowed to stir at room temperature for 12 h. The reaction mixture was 
concentrated in vacuo, dissolved in EtOAc (200 mL), washed with water (3x200 
mL), dried (Na 2SO4), and reconcentrated. Flash chromatography (5-10% 
EtOAc/petroleum ether) afforded 0.43 g (76% yield) of product in the form of a 
white foam. 1H NMR (CDC13) b 1.01-1.08 (m, 28H), 2.79 (m, lH), 3.98-4.04 (m, 
lH), 4.08-4.13 (m, 2H), 4.19-4.21 (m, lH), 4.37-4.40 (m, lH), 5.73 (s, lH), 7.48-7.53 
(m, 2H), 7.64-7.66 (m, lH), 7.89-7.92 (m, 2H), 8.07 (s, lH). 13C NMR (CDC13) b 
12.49, 12.64, 12.92, 13.40, 16.82-17.62, 59.96, 67.90, 68.83, 75.04, 82.27, 91.16, 129.16, 
130.52, 130.88, 135.28, 143.89, 148.59, 158.82, 167.58; FABMS m/ e (relative 
intensity) 717.1517 (M + H, 717.1525 calcd. for C2sH3sIN2OsSi2). 
N3-Benzoyl-5-(1-propyn yl)-3' ,5' -0-( tetraisopropy ldisil oxane )uridine (VIII). 
A mixture of N3-benzoyl-5-iodo-3' ,5' -O-(tetraisopropyldisiloxane)uridine (VII) 
(1.50 g, 2.10 mmol), Cul (0.08 g, 0.42 mmol), tetrakis(triphenylphosphine)-
palladium (0) (0.24 g, 0.21 mmol), and triethylamine (0.62 mL, 4.41 mmol) in dry 
DMF (30 mL) was stirred under argon. Commercial propyne was bubbled 
through the mixture for 10 h. The mixture was allowed to stir at room 
temperature for 8 h. To the reaction mixture were added methanol (17 mL), 
methylene chloride (17 mL), and NaHCO3 (2.5 g). After 30 minutes, the mixture 
was filtered through Celite, and concentrated in vacuo. The resulting residue was 
dissolved in EtOAc (200 mL), and washed with water (3x200 mL). The organic 
layers were combined, dried (Na2SO4), and concentrated under reduced pressure. 
Flash chromatography (10-20% EtOAc/petroleum ether) afforded 1.20 g (92% 
yield) of product as a yellow foam. 1H NMR (CDC13) b 1.00-1.04 (m, 28H), 2.01 (s, 
3H), 2.76 (s, lH), 3.98-4.10 (m, lH), 4.11-4.13 (m, 2H), 4.15-4.21 (m, lH), 4.35-4.40 
(m, lH), 5.76 (s, lH), 7.46-7.52 (m, 2H), 7.62-7.67 (m, lH), 7.89-7.90 (m, 2H), 7.92 
(s, lH); FABMS m/e (relative intensity) 629.2697 (M + H, 629.2714 calcd. for 
C31HisN2OsSi2). 
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N3-Benzoyl-5-(1-propynyl)-2' -0-allyl-3' ,5' -0-( tetraisopropyldisiloxane) uri-
dine (IX). N3-Benzoyl-5-(1-propynyl)-3',5'-O-(tetraisopropyldisiloxane)uridine 
(VIII) (7.43 g, 11.9 mmol) was dissolved in excess allyl bromide (178 mL). Silver 
(I) oxide (13.8 g, 59.4 mmol) was added, and the resulting mixture was refluxed 
at 80 °C under argon for 6 h. The reaction mixture was filtered through Celite, 
washed with EtOAc, and concentrated in vacuo. Flash chromatography (20% 
EtOAc/petroleum ether) afforded 3.60 g (45% yield) of product in the form of a 
white foam, and 1.10 g of a mixture of two products containing the desired one 
which was used for subsequent steps without further purification. 1H NMR 
(CDC13 ) 8 1.01-1.07 (m, 28H), 2.00 (s, 3H), 3.91-3.92 (d, lH, J = 3.4 Hz), 3.97-4.01 
(m, lH), 4.21-4.32 (m, SH), 5.12-5.16 (m, lH) 5.23-5.33 (m, lH), 5.72 (s, lH), 5.80-
5.90 (m, lH), 7.47-7.52 (m, 2H), 7.63-7.66 (m, lH), 7.90-7.94 (m, 2H), 8.07 (s, lH). 
13C NMR (CDC13) 8 12.45, 12.78, 12.89, 13.50, 16.87-17.50, 59.10, 67.78, 70.06, 71.29, 
81.00, 82.10, 89.67, 91.60, 100.48, 104.89, 117.48, 129.17, 130.60, 131.02, 134.07, 
135.29, 140.43, 148.03, 161.13, 168.09; FABMS m/e (relative intensity) 669.3066 (M 
+ H, 669.3027 calcd. for C34I-49N2OsSi2). 
5-(1-Propynyl)-2' -0-allyl-3',5' -0-(tetraisopropyldisiloxane)uridine (X). N3-
Benzoyl-5-(1-propynyl)-2; -O-allyl-3' ,5' -0-( tetraisopropyldisiloxane )uridine (IX) 
(164 mg, 0.247 mmol) was dissolved in dioxane (2.3 mL). Concentrated NH4OH 
(280 µL) was added, and the solution was stirred at room temperature for 5 h. 
Flash chromatography (30% EtOAc/petroleum ether) afforded 122 mg (88% 
yield) of product in the form of a white solid. 1H NMR (CDC13) 8 0.98-1.11 (m, 
28H), 2.00 (s, 3H), 3.88 (s, lH), 3.93-3.98 (d, lH, J = 15.3 Hz), 4.18-4.29 (m, 3H), 
4.36-4.39 (m, 2H), 5.18-5.21 (m, lH), 5.34-5.41 (rn, lH), 5.71 (s, lH), 5.92-6.00 (rn, 
lH), 7.96 (s, lH), 9.17 (s, lH). 13C NMR (CDC13) 8 12.47, 12.76, 12.88, 13.46, 16.83-
17.48, 59.11, 67.89, 70.41, 71.26, 80.90, 81.90, 89.46, 90.93, 100.33, 117.42, 134.26, 
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140.98, 148.90, 162.17; FABMS m/e (relative intensity) 565.2763 (M + H, 565.2765 
calcd. for C27l-45N2O7Si2). 
5-(1-Propynyl)-2'-0-allyluridine (IV). 5-(1-Propynyl)-2' -O-allyl-3' ,5' -O-
(tetraisopropyldisiloxane)uridine (X) (3.12 g, 5.52 mmol) was dissolved in 
dioxane (30 mL). 1 N HCl (30 mL) was added, and the resulting suspension was 
allowed to stir at room temperature for 9 h. The reaction mixture was 
neutralized with Dowex 1 (bicarbonate form) resin and filtered. The resin was 
washed with H 2O-MeOH (9:1 v /v), and the combined filtrates were concentrated 
in vacuo. Flash chromatography (50-80% EtOAc/petroleum ether) afforded 1.11 
g (62% yield) of product in the form of a white solid. 1H NMR (DMSO) 8 1.97 (s, 
3H), 3.57-3.66 (m, 2H), 3.85-3.93 (m, 2H), 4.08-4.14 (m, 3H), 5.09-5.28 (m, 4H), 
5.81-5.91 (m, 2H), 8.22 (s, lH), 11.62 (bs, lH). 13C NMR (DMSO) 8 60.19, 68.30, 
70.35, 72.18, 81.01, 85.20, 86.81, 89.39, 99.37, 104.68, 116.76, 135.16, 142.67, 149.79, 
162.09; FABMS m/e (relative intensity) 323.1258 (M + H, 323.1243 calcd. for 
C 1sI-L119N2O6)-
5-(1-Propynyl)-2'-0-allyl-5'-0-(4,4' -dimethoxytrityl)uridine (XI). A solution 
of 5-(1-propynyl)-2'-O-allyluridine (IV) (1.08 g, 3.35 mmol) and dimethoxytrityl 
chloride (1.53 g, 4.52 mrriol) in dry pyridine (15 mL) was allowed to stir under 
argon at room temperature for 2 h. Methanol (5 mL) was added, and the 
solution was stirred at room temperature for 30 minutes. The solution was 
concentrated in vacuo. The resulting residue was dissolved in methylene chloride 
(200 mL), washed with water (3x200 mL), dried (Na2SO4 ), and concentrated in 
vacuo. Flash chromatography (55% EtOAc/petroleum ether) afforded 1.25 g 
(62% yield) of product in the form of a slightly yellow solid requiring further 
purification. 1H NMR (CDC13) 8 1.60 (s, 3H), 3.40-3.42 (m, 2H), 3.80 (s, 6H), 4.10-
4.18 (m, 3H), 4.20-4.50 (m, 3H), 5.22-5.38 (m, 2H), 5.8-5.98 (m, lH), 6.8-6.85 (d, 
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4H), 7.20-7.44 (m, 9H), 8.02 (s, lH), 8.30 (s, lH); FABMS m/ e (relative intensity) 
624.2495 (M + H, 624.2472 calcd. for C36H37N2Os). 
5-(1-Propynyl)-2'-0-allyl-3'-(2-cyanoethyl-N,N-diisopropylphosphorami-
dite)-5'-0-(4,4'-dimethoxytrityl)uridine (XII). A solution of 5-(1-propynyl)-2'-O-
allyl-5'-O-(4,4'-dimethoxytrityl)uridine (XI) (0.79 g, 0.96 mmol) in dry methylene 
chloride (7 mL) was cooled to O °C, and to it were added dry triethylamine (0.40 
mL, 2.88 mmol) and 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite (0.32 
mL, 1.44 mmol). The solution was allowed to stir under argon at O °C for 10 
minutes, after which it was allowed to warm to room temperature. After 1 h, it 
was diluted with 50 mL of methylene chloride, washed with a saturated solution 
of NaHCO3 (2x50 mL), dried (Na2SO4), and concentrated in vacuo. Flash 
chromatography (1:3 EtOAc/petroleum ether) afforded 0.435 g (87% yield) of 
product in the form of a white solid. 
2',3',5'-Tribenzoate-5-methyluridine (XV). To a mixture of ~-D-ribofuranose-
1-acetate-2,3,5-tribenzoate (XIII) (11.59 g, 23 mmol) and thymine (XIV) (4.35 g, 34 
mmol) in dry acetonitrile (200 mL) was added N,O-bis(trimethylsilyl)acetamide 
(BSA) (17.1 mL, 69 mmol). The suspension was allowed to stir under argon. 
After 4 h, a clear solution was obtained, to which stannic chloride (9 .6 mL, 82 
mmol) was slowly added in three portions over a period of 36 h. The mixture 
was allowed to stir at room temperature for 2 days overall, after which it was 
diluted with chloroform (500 mL). Subsequently the organic mixture was 
washed with water (200 mL), and a saturated solution of NaHCO3 (2x200 mL), 
and the aqueous layers were extracted with chloroform. The organic layers were 
combined, dried (MgSO4), and concentrated in vacuo. The yellowish residue was 
used without further purification. 
5-Methyluridine (XVI). A suspension of crude XV ( <23 mmol) in 5:4:1 
THF /MeOH/H2O (920 mL) was cooled to O °C, and to it was added 2M Na OH 
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(92 mL, 184 mmol). The mixture was stirred for 20 minutes at O °C, after which 
ammonium chloride (11.8 g, 284 mmol) was added. Stirring was continued for 
25 minutes, after which a clear solution was obtained. The solution was 
extracted with ether, and the organic layer was concentrated in vacuo. Flash 
chromatography (5-25% MeOH/CH2Cl2) afforded 5.05 g (85% yield from XV) of 
product in the form of a white solid. 1H NMR (DMSO) 8 1.75 (s, 3H), 3.37-3.59 
(m, 2H), 3.79-3.82 (m, lH), 3.94-4.03 (m, 2H), 4.10-4.20 (bs, lH), 5.15-5.17 (bs, 2H), 
5.3 (bs, lH), 5.74-5.76 (d, lH), 7.73 (s, lH), 8.00-8.80 (bs, lH). 13C NMR (DMSO) 8 
60.19, 68.30, 70.35, 72.18, 81.01, 85.20, 86.81, 89.39, 99.37, 104.68, 116.76, 135.16, 
142.67, 149.79, 162.09. 
5-Methyl-3',5'-0-(tetraisopropyldisiloxane)uridine (XVII). A solution of 5-
methyluridine (XVI) (2.00 g, 7.75 mmol) in dry pyridine (20 mL) was cooled to 0 
°C under argon. To it was slowly added l,3-dichloro-1,1,3,3-tetraisopropyl-
disiloxane (2.73 mL, 8.52 mmol), and the resulting suspension was allowed to stir 
first at O °C for 20 minutes, and then at room temperature overnight. The 
reaction was quenched by addition of methanol (5 mL), and was subsequently 
concentrated in vacuo. The residue was dissolved in methylene chloride (300 
mL), washed with water (250 mL), dried (Na2SO4 ), and concentrated in vacuo. 
Flash chromatography (1:1 EtOAc/petroleum ether) afforded 3.11 g (81 % yield) 
of product in the form of a white foam. 1H NMR (CDC13) 8 0.94-1.23 (m, 28H), 
1.90 (s, 3H), 3.40-3.50 (bs, lH), 3.97-4.12 (m, lH), 4.17-4.22 (m, 4H), 4.35-4.40 (m, 
lH), 5.70 (s, lH), 7.43 (s, lH), 9.00-9.20 (bs, lH); FABMS m/e (relative intensity) 
501.2436 (M + H, 501.2452 calcd. for C22f-40N2O7Si2). 
4-(2,6-Dichlorophenyl)-5-methy 1-3' ,5' -0-( tetraisopropyldisiloxane)uridine 
(XVIII). To a suspension of 5-methyl-3',5'-O-(tetraisopropyldisiloxane)uridine 
(XVII) (5.00 g, 7.74 mmol) and N,N-dimethyl-4-aminopyridine (DMAP) (0.94 g, 
7.74 mmol) in dry methylene chloride (50 mL) were added dry triethylamine (1.1 
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mL, 7.74 mmol) and 2-mesitylenesulfonylchloride (2.34 g, 7.74 mmol) under 
argon. After 3 h, one more equivalent of triethylamine and 2-mesitylenesulfonyl-
chloride were added, and the suspension was allowed to stir at room 
temperature. After 10 h, a third equivalent of triethylamine and 2-mesitylene-
sulfonylchloride were added, and the reaction mixture was allowed to stir 
overnight. Then, 2,6-dichlorophenol (1.26 g, 7.74 mmol), triethylamine (1.1 mL, 
7.74 mmol), and diazabicyclo[2,2,2]octane (0.23 mL, 1.55 mmol) were added, and 
the reaction mixture was allowed to stir for 4 days. When the reaction seemed 
near completion by TLC, it was diluted with methylene chloride, washed with a 
saturated solution of NaHCO3 (3x), dried (MgSO4), and concentrated in vacuo. 
Flash chromatography (35% EtOAc/petroleum ether) afforded 4.1 g (82% yield) 
of product in the form of a yellow solid. 1H NMR (CDC13) 8 1.01-1.28 (m, 28H), 
2.18 (s, 3H), 4.05-4.17 (m, 2H), 4.22-4.28 (m, 2H), 4.37-4.40 (m, lH), 5.72 (s, lH), 
7.13-7.16 (t, lH), 7.33-7.35 (d, 2H), 7.86 (s, lH). 13C NMR (CDC13) 8 12.40, 12.49, 
12.65, 12.96, 13.41, 16.87-17.43, 60.40, 69.02, 74.92, 82.05, 92.26, 103.57, 127.05, 
128.68, 141.95, 145.10, 154.82, 168.92; FABMS m/e (relative intensity) 645.1960 (M 
+ H, 645.1986 calcd. for C23H43Cl2N2O7Si2). 
4-(2,6-DichlorophenyD-5-methyl-2'-0-allyl-3' ,5' -0-(tetraisopropyldisiloxa-
ne)uridine (XIX). To a solution of XVIII (3.00 g, 4.64 mmol) in dry THF (20 mL) 
was added allyl ethyl carbonate (1.21 mL, 9.28 mmol) under argon. This solution 
was added to a suspension of tris(dibenzyledene)dipalladium (0.42 g, 0.46 mmol) 
and 1,4-bis(diphenylphosphino)butane (0.79 g, 1.86 mmol) in THF (40 mL), and 
the greenish mixture was allowed to reflux under argon for 30 minutes. Then the 
suspension was filtered over Celite, the Celite was washed with ethyl acetate, 
and the combined organic layers were concentrated in vacuo. Flash 
chromatography (15% EtOAc/petroleum ether) afforded 2.67 g (84% yield) of 
product in the form of a yellow foam. 1H NMR (CDClJ 8 0.94-1.12 (m, 28H), 2.17 
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(s, 3H), 3.97-4.02 (m, 2H), 4.18-4.31 (m, 4H), 4.41-4.45 (m, lH), 5.13-5.18 (dd, lH), 
5.36-5.43 (dd, lH), 5.73-5.92 (m, lH), 7.10-7.16 (t, lH), 7.33-7.36 (d, 2H), 8.04 (s, 
lH). 13C NMR (CDC13) o 12.44, 12.51, 12.73, 12.93, 13.51, 16.90, 17.06, 17.27, 17.36, 
17.48, 60.00, 67.73, 71.15, 80.64, 81.93, 90.24, 103.27, 117.10, 127.00, 128.78, 129.10, 
134.68, 141.54, 145.21, 154.87, 168.89; FABMS m/e (relative intensity) 685.2314 (M 
+ H, 685.2299 calcd. for C311-Li?CbN2O7Si2). 
Allyl ethyl carbonate. Dry pyridine (27 mL, 0.33 mol) and absolute ethanol 
(29.2 mL, 0.49 mol) were mixed at O °C under argon. Then allyl chloroformate 
(35.3 mL, 0.33 mol) was added very slowly. Gas evolution was observed. A 
white precipitate was seen all of a sudden. The suspension was allowed to stir at 
room temperature for 2 h. Then ether (333 mL) was added with stirring, the 
mixture was filtrated, and the filtrate was washed with a saturated solution of 
NaCl, dried (Na2SO4 ), and concentrated in vacuo to afford a clear liquid which 
was stored under argon at O 0 C. 1H NMR (CDC13) o 1.22-1.30 (t, 3H), 4.13-4.21 (9, 
2H), 4.59-4.61 (m, 2H), 5.20-5.40 (m, 2H), 5.82-6.00 (m, lH). 
5-Methyl-2'-0-allyl-3',5'-0-(tetraisopropyldisiloxane)uridine (XX). To a 
solution of XIX (0.10 g, 0.146 mmol) and 2-pyridinealdoxime (0.089 g, 0.73 mmol) 
in dry acetonitrile (5 mL) was added 1,1,3,3-tetramethylguanidine (82 µL, 0.66 
mmol) under argon. The reaction mixture was allowed to stir at room 
temperature for 13 h. It was then diluted with EtOAc, washed with water (3x), 
dried (Na2SO4), and concentrated in vacuo. Flash chromatography (35:65 
EtOAc/petroleum ether) afforded 0.71 g (90% yield) of product in the form of a 
whitish solid. 1H NMR (CDC13) o 0.94-1.28 (m, 28H), 1.91 (s, 3H), 3.88-3.89 (d, 
lH), 3.96-4.00 (m, lH), 4.13-4.27 (m, 3H), 4.38-4.40 (m, 2H), 5.18-5.22 (dd, lH), 
5.34-5.41 (dd, lH), 5.72 (s, lH), 5.89-5.96 (m, lH), 7.60 (s, lH), 8.34 (s, lH); FABMS 
m/ e (relative intensity) 541.2776 (M + H, 541.2765 calcd. for C2sHisN2O7Si2). 
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5-Methyl-2'-0-allyluridine (11). To a solution of XX (1.92 g, 3.55 mmol) in 
dry THF (10 mL) was added lM tetrabutylammoniumfluoride/THF (7.1 mL, 7.10 
mmol). The mixture was allowed to stir at room temperature for 45 minutes. 
Then ammonium chloride (0.47 g, 8.87 mmol) was added, and the mixture was 
concentrated in vacuo. Flash chromatography (3-5% MeOH/CH2Clz) afforded 
quantitative yield of product in the form of a white solid. 1H NMR (DMSO) o 
1.28-1.31 (s, 3H), 3.56-3.64 (m, 2H), 3.84-3.92 (m, 2H), 4.03-4.13 (m, 3H), 5.08-5.25 
(m, 4H), 5.81-5.89 (m, 2H), 7.78 (s, lH), 11.31 (s, lH); FABMS m/e (relative 
intensity) 299.1232 (M + H, 299.1243 calcd. for C13H19N2O6)-
5-Methyl-2'-0-allyl-5' -0-(4,4'-dimethoxytrityl)uridine (XXI). A solution of 
5-methyl-2'-O-allyluridine (II) (0.18 g, 0.60 mmol) and dimethoxytrityl chloride 
(0.264 g, 0.78 mmol) in dry pyridine (9 mL) was allowed to stir under argon at 
room temperature for 2 h. Methanol (5 mL) was added, and the solution was 
concentrated in vacuo. The resulting residue was dissolved in methylene chloride 
(50 mL), washed with water (3x70 mL), dried (Na2SO4), and concentrated in 
vacuo. Flash chromatography (40% EtOAc/petroleum ether) afforded 0.23 g 
(71 % yield) of product in the form of a slightly yellow foam. 1H NMR (CDC13) o 
1.35 (s, 3H), 3.40-3.57 (m, 2H), 3.79 (s, 6H), 4.08-4.15 (m, 3H), 4.25-4.27 (m, 2H), 
4.36-4.47 (m. 3H), 5.24-5.36 (m, 2H), 5.82-6.00 (m, lH), 6.02 (s, lH), 6.82-6.86 (d, 
4H), 7.23-7.32 (m, 9H), 7.67 (s, lH), 8.20-8.40 (bs, lH); FABMS m/ e (relative 
intensity) 600.2456 (M + H, 600.2472 calcd. for C34H37N2Os). 
5-Methyl-2'-0-allyl-3'-(2-cyanoethyl-N,N-diisopropylphosphoramidite)-5' -
0-(4,4' -dimethoxytrityl)uridine (XXII). A solution of 5-methyl-2' -O-allyl-5' -O-
(4,4' -dimethoxytrityl)uridine (XXI) (0.218 g, 0.36 rnmol) in dry methylene 
chloride (5 mL) was cooled to O °C, and to it were added dry triethylamine (0.15 
mL, 1.08 mmol) and 2-cyanoethyl-N,N-diisopropykhlorophosphoramidite (0.12 
mL, 0.54 mmol). The solution was allowed to stir under argon at O °C for 10 
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minutes, after which it was allowed to warm to room temperature. After 1 h, it 
was diluted with 50 mL of methylene chloride, washed with a saturated solution 
of NaHCO3 (2x50 mL), dried (Na2SO4), and concentrated in vacuo. Flash 
chromatography (1:1 EtOAc/petroleum ether) afforded 0.236 g (82% yield) of 
product in the form of a white solid. 1H NMR (CDC13) 8 1.00-1.34 (m, 14H), 1.52-
1.55 (s, 3H), 2.35-2.39 (t, 2H), 2.61-2.65 (t, 2H), 3.28-3.33 (m, lH), 3.51-3.64 (m, 3H), 
3.76-3.84 (m, 6H), 4.11-4.23 (m, 3H), 4.50 (m, lH), 5.20-5.34 (m, 2H), 5.80-5.99 (m, 
lH), 6.03-6.11 (m, lH), 6.81-6.85 (m, 4H), 7.23-7.37 (m, 9H), 7.68-7.69 (m, lH), 
7.95-8.00 (s, lH); FABMS m/e (relative intensity) 801.3595 (M + H, 801.3628 calcd. 
for C43H54N4O9P). 
5-Methyl-2' -O-allyl-3',5' -O-(tetraisopropyldisiloxane) cytidine (XXIII). A 
solution of XIX (0.50 g, 0.73 mmol) in dry acetonitrile (10 mL) in a sealed tube 
was placed in an ice-salt bath, and allowed to cool to -3 °C. Gaseous ammonia 
was bubbled through the solution for 20 minutes. Then the sealed tube was 
placed in a warm oil bath ( ~85 °C), and the reaction solution was allowed to stir 
for 24 h. The solution was allowed to cool to room temperature and 
concentrated in vacuo. Flash chromatography (7% MeOH/CH2Cl2 ) afforded 0.365 
g (93% yield) of product in the form of a white solid. 1H NMR (DMSO) 8 0.87-1.06 
(m, 28H), 1.79-1.81 (s, 3H), 3.84-4.34 (m, 8H), 5.10-5.14 (m, lH), 5.28-5.35 (m, lH), 
5.58 (s, lH), 5.84-5.93 (m, lH), 6.82-6.83 (bs, lH), 7.34-7.35 (bs, lH), 7.41 (s, lH). 
13C NMR (DMSO) 8 12.21, 12.34, 12.53, 12.96, 13.73, 16.95, 17.01, 17.04, 17.10, 
17.27, 17.36, 17.51, 59.79, 68.46, 70.32, 80.84, 80.88, 89.11, 100.90, 116.23, 135.30, 
137.08, 154.84, 165.65; FABMS m/e (relative intensity) 540.2913 (M + H, 540.2925 
calcd. for C2s~6N3O6Si2). 
N4-Benzoyl-5-methyl-2' -O-all yl-3' ,5' -0-( tetraisopropy ldi siloxane)cytidine 
(XXIV). To a solution of XXIII (0.20 g, 0.37 mmol) in dry pyridine (5 mL) was 
added benzoyl chloride (0.21 mL, 1.85 mmol) under argon. The solution was 
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allowed to stir at room temperature for 3.5 h. Then ammonium hydroxide (0.72 
mL) was added, and the reaction was allowed to stir for an additional 15 
minutes. It was subsequently concentrated in vacuo, dissolved in EtOAc, washed 
with water (2x), dried (Na2 SO4 ) and concentrated in vacuo. Flash 
chromatography (5% MeOH/CH2Cl2) afforded 0.204 g (86% yield) of product in 
the form of a white solid. 1H NMR (DMSO) 8 0.91-1.98 (m, 28H), 1.98 (s, 3H), 3.31 
(s, 6H), 3.91-4.31 (m, 8H), 5.13-5.16 (dd, lH), 5.30-5.36 (dd, lH), 5.64 (s, lH), 5.86-
5.91 (m, lH), 7.46-7.51 (t, 2H), 7.56-7.59 (t, lH), 7.72-7.73 (s, lH), 8.13-8.19 (bm, 
2H); FABMS m/e (relative intensity) 644.3156 (M + H, 644.3187 calcd. for 
C32HsoN3O7Si2)-
N4-Benzoyl-5-methyl-2'-0-allylcytidine (XXV). To a solution of XXIV (0.26 
g, 0.41 mmol) in dry THF (4 ml) was added lM tetrabutylammoniumfluoride/ 
THF (0.82 mL, 0.82 mmol). The mixture was allowed to stir at room temperature 
for 15 minutes. Then ammonium chloride (0.027 g, 0.51 mmol) was added, and 
the mixture was concentrated in vacuo. Flash chromatography (5% MeOH/ 
CH2Cl2) afforded quantitative yield of product in the form of a white solid. 
1H 
NMR (DMSO) 8 2.00 (s, 3H), 3.60-3.80 (m, 2H), 3.90-4.00 (m, 2H), 4.10-4.20 (m, 
3H), 5.11-5.20 (m, 2H), 5.21-5.33 (m, 2H), 5.78 (s, lH), 5.80-5.96 (m, 2H), 7.45-7.55 
(t, 2H), 7.56-7.60 (t, lH), 7.78-7.80 (d, lH), 8.10-8.30 (m, 2H). 
N4-Benzoyl-5-methyl-2'-0-allyl-5'-0-(4,4'-dimethoxytrityl)cytidine (XXVI). 
A solution of XXV (0.183 g, 0.45 mmol) and dimethoxytrityl chloride (0.198 g, 
0.585 mmol) was allowed to stir in dry pyridine (8 mL) under argon at room 
temperature for 2 h. More dimethoxytrityl chloride (0.068 g, 0.20 mmol) was 
added, and the solution was allowed to stir for an additional 3.5 h. Methanol (8 
mL) was added, and the solution was concentrated in vacuo. The resulting 
residue was dissolved in methylene chloride (75 mL), washed with water (3x60 
mL), dried (Na2SO4), and concentrated in vacuo. Flash chromatography (10-40% 
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EtOAc/petroleum ether) afforded 0.19 g (60% yield) of product in the form of a 
slightly orange solid. 1H NMR (CDC13) 8 1.56 (s, 3H), 3.43-3.61 (m, 2H), 3.80 (s, 
6H), 4.10-4.13 (m, 2H), 4.29-4.31 (m, lH), 4.42-4.50 (m, 2H), 5.25-5.37 (m, 2H), 
5.80-6.00 (m, lH), 6.03 (d, lH), 6.84-6.87 (d, 4H), 7.25-7.52 (m, 9H), 7.87 (s, lH), 
8.27-8.30 (d, 2H); FABMS m/e (relative intensity) 704.2976 (M + H, 704.2972 
calcd. for C41f-42N3O3). 
N4-Benzoyl-5-methyl-2'-0-allyl-3'-(2-cyanoethyl-N,N-diisopropylphospho-
ramidite)-5' -0-(4,4' -dimethoxytrityl)cytidine (XXVII). A solution of XXVI 
(0.387 g, 0.55 mmol) in dry methylene chloride (7 mL) was cooled to O °C, and to 
it were added dry triethylamine (0.23 mL, 1.65 mmol) and 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite (0.18 mL, 0.825 mmol). The solution was 
allowed to stir under argon at O °C for 10 minutes, after which it was allowed to 
warm to room temperature. After 50 minutes, it was diluted with 50 mL of 
methylene chloride, washed with a saturated solution of NaHCO3 (2x50 mL), 
dried (Na2SO4), and concentrated in vacuo. Flash chromatography (25% EtOAc/ 
petroleum ether) afforded 0.435 g (87% yield) of product in the form of a white 
foam. 1H NMR (CDC13) 8 0.98-1.28 (m, 14H), 1.50-1.53 (s, 3H), 2.35-2.39 (t, 2H), 
2.61-2.65 (t, 2H), 3.32-3.35 (m, lH), 3.53-3.62 (m, 3H), 3.64-3.82 (s, 6H), 4.11-4.31 
(m, 3H), 4.49-4.52 (m, lH), 5.20-5.36 (m, 2H), 5.80-6.00 (m, lH), 6.14 (d, lH), 6.82-
6.87 (m, 4H), 7.24-7.51 (m, 9H), 7.84-7.91 (s, lH), 8.27-8.30 (d, 2H); FABMS m/e 
(relative intensity) 904.4084 (M + H, 904.4050 calcd. for CsoH59N5O9P). 
Oligonucleotide preparation. Oligonucleotides were synthesized by 
standard automated solid-support chemistry on an Applied Biosystems Model 
380B DNA synthesizer using O-(cyanoethyl)-N,N-diisopropylphosphorami-
dites.13b The phosphoramidite of the Amino-Modifier-dT [5'-(dimethoxytrityl)-5-
[[[N-(trifluoroacetyl)amino]ethyl]3-acrylimido]-2'-deoxuridine,3'-O-(2-cyano-
ethyl)-N,N-diisopropylphosphoramidite] purchased from Glen Research was 
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incorporated at the 5'-terminus of oligonucleotides 1, 2, 3, and 4 during 
oligonucleotide synthesis. Oligonucleotide concentrations were determined by 
UV absorbance at 280 nm using extinction coefficients (M·1 cm·1) of 6400 (T and T* 
derivative from Glen Research, au), 8300 (mC, ac), 9700 (PU), and 9500 (a/pU). 
Oligonucleotide deprotection and purification were carried out by Scott F. 
Singleton in our laboratory. 
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CHAPTER SEVEN: 
Progress Towards the Synthesis of N 7-2'-Deoxyisoinosine 
Introduction 
One of the goals in the area of triple helix formation is understanding the 
chemical principles underlying the sequence-specific recognition of double-
helical DNA. This understanding is crucial to our ability to uniquely 
recognize any single site in megabase size DNA. Until recently, two general 
motifs for the sequence-specific recognition of double-helical DNA by triple 
helix formation had been developed. These motifs differ in sequence compo-
sition of the third strand, the relative orientation and position of the third 
strand, and the hydrogen-bonding patterns. In one motif, pyrimidine oligo-
deoxyribonucleotides bind in the major groove of DNA parallel to the 
homopurine strand by formation of specific Hoogsteen hydrogen bonds 
between thymine and adenine (T•AT triplet) and protonated cytosine and 
guanine (C+GC triplet).1 In the other motif, purine-rich oligonucleotides 
bind anti parallel to the homopurine strand by formation of specific A• AT or 
T•AT and G•GC triplets (see Chapter One).2 
The inability to recognize mixed pyrimidine-purine sequences, as well as 
the observed sensitivity of triple helix formation to pH1c,3 and metal cation 
concentration and nature,4 have spurred efforts to design nonnatural bases 
capable of sequence-specific DNA recognition within wider sequence contexts 
and experimental conditions. To circumvent the pH dependence of the 
formation of triple helices containing C+GC triplets,1''3 a nonnatural base, 1-
(2-deoxy-~-D-ribofuranosy 1)-3-methy 1-5-amino-lH-pyrazolo [ 4,3-d]pyrimidin-
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7-one (Pl), was synthesized in our laboratory and shown to bind GC base pairs 
within a pyrimidine triple helix motif as selectively and strongly as C but 
over an extended pH range (see Chapter One).5 Additional nonnatural bases 
mimicking the hydrogen bonding functionality of protonated cytosine have 
been synthesized in other laboratories (see Chapter One).6 Other nonnatural 
nucleotides have been designed to recognize TA or CG base pairs within the 
pyrimidine or purine motif. Among these, 1-(2-deoxy-~-D-ribofuranosyl)-4-
(3-benzamido )phenylimidazole (D3) was shown to form specific hydrogen 
bonds with TA base pairs when incorporated into pyrimidine-rich 
oligonucleotides,7 and 2'-deoxynebularine was found to recognize CG and AT 
base pairs when incorporated into purine-rich oligonucleotides, although 
subsequent experiments showed that the specificity of 2'-deoxynebularine is 
dependent on solution conditions and sequence composition.8 Nonetheless, 
despite these encouraging findings, the formidable challenge of finding a 
general solution to the sequence-specific recognition of mixed pyrimidine-
purine sequences still confronts us. 
The recent development of a third nonnatural motif for the recognition of 
double-helical DNA may represent a significant step towards finding a 
solution to this problem. In this motif, the geometry of a base triplet found in 
the purine-purine-pyrimidine triple helix is maintained, while the third 
strand orientation is reversed by moving the third strand deoxyribose from 
the N9 to the N7 position. The development of this new motif originated 
from the discovery that an N7-glycosylated purine, 7-(2'-deoxy-~-D-erythro-
pentofuranosyl)guanine (7G) binds a GC base pair with high specificity when 
incorporated in a pyrimidine oligonucleotide (Figure 7.1).9 This finding is 
important as it suggested that a new parallel-stranded motif containing 
wholly N7-purines may lead to the generation of a new class of N7-purine 
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Figure 7.1. Schematic representation of G•GC and 7G• GC triplets. The third 
strand orientation is reversed by moving the third strand deoxyribose from 
the N9 to the N7 position. 
oligodeoxyribonucleotides capable of sequence-specific recognition of DNA by 
triple helix formation. Subsequent experiments were carried out to elucidate 
the sequence composition limitations of this new motif. In these experi-
ments, the equilibrium association constants for triple helix formation for 
two sets of sequences containing either alternating or largely contiguous 
7G•GC triplets were determined, and indicated that in those cases in which 
the 7G• GC triplets are alternating with T• AT triplets, there is a slight 
energetic penalty presumably due to the fact that 7G • GC and T• AT triplets are 
not isomorphous (Figure 7.2).103 In addition, pH dependence studies indicated 
that triple helix formation is not sensitive to changes in pH, as the third 
strand 7G does not require protonation for specific hydrogen bond 
formation. 103 
Following the design of N 7-2'-deoxyguanosine, studies were directed 
towards the design of N7-purine bases capable of AT recognition. As N9-2'-
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Alternating Triplets (pH 7.0 and 7.5): 
Third Strand Oligonucleotide: 5 '-TTTTT7 GT7 GT7 GT7 GT7 GT-3, 
Duplex: 5' -ATATAAAAAGAGAGAGAGATGGA-3, 
3'-TATATTTTTCTCTCTCTCTACCT-5' 
Contiguous Triplets (pH 7.0 and 7.5): 
Third Strand Oligonucleotide: 5 '-TTTT7 GTTTT7 G7 G7 G7 G7 G7 GT-3, 
Duplex: 5 ' -TTTTAAAAGAAAAGGGGGGACTGG- 3 ' 
3'-AAAATTTTCTTTTCCCCCCTGACC-5' 
Figure 7.2. Schematic representation of 7G-containing oligonucleotides and 
their target sites on double-helical DNA. The binding free energy for triple 
helix formation for two sets of sequences containing either alternating or 
largely contiguous 7G•GC triplets were determined by quantitative DNase 
footprint titrations. 
deoxyadenosine is known to bind AT base pairs when incorporated into 
purine-rich oligonucleotides,2 the binding properties of N 7-2'-deoxyadenosine 
(7 A) (Figure 7.3) were analyzed in the context of a pyrimidine-rich oligo-
nucleotides.10b Experiments show that the stability of base triplets decreases in 
the order 7A•AT>7A•CG>7A•GC>7A•TA when one 7A is incorporated at a 
single site in a pyrimidine-rich oligonucleotide (100 mM NaCl, 10 mM Bis-
Tris• HCI, 0.25 mM spermine, pH 7.0, 22 °C), indicating that 7 A is specific for 
AT base pair recognition. Experiments on the binding properties of 7 A in the 
context of N7-purine oligonucleotides were to be carried out at the time this 
thesis was written (Figure 7.4). However, it was noted that the fact that 7G • GC 
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Figure 7.3. Schematic representation of the N7-2'-deoxyadenosine• AT triplet. 
and 7 A• AT triplets are not isomorphous may cause some energetic penalty to 
the binding of double-helical DNA by oligonucleotides containing alternating 
7G•GC and 7A•AT triplets (Figure 7.5).10b Finally, additional studies have 
been carried out on the binding properties of N 7-2'-deoxynebularine as a 
potential AT and GC binder, and N7-2'-deoxyinosine as a potential CG and TA 
binder, and indicated that these bases are not specific for their desired targets. 
Research Design 
To overcome the limitations associated with the fact that 7 A• AT and 
7G•GC triplets are not isomorphous, we were interested in designing an 
isomorphous parallel N7 purine motif. N 7-2'-deoxyisoinosine (7iI) was 
proposed as a base potentially capable of forming specific 7il • AT triplets 
isomorphous with 7G•GC triplets when incorporated into oligonucleotides 
containing wholly N7-purines (Figures 7.6 and 7.7). Although the synthesis 
of N 9-2'-deoxyisoinosine had been reported, the synthesis of N 7-2'-deoxy-
isoinosine had yet to be reported. 11 We proposed to analyze the specificity of 
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Alternating Triplets: 
Duplex: 5' -ATATAAAAAGAGAGAGAGATGGA-3 , 
3'-TATATTTTTCTCTCTCTCTACCT-5' 
Contiguous Triplets: 
Third Strand Oligonucleotide: 5 ' - 7 A7 A7 A7 A7 G7 A7 A7 A7 A7 G7 G7 G7 G7 G7 G7 A-3 , 
Duplex: 5 ' -TTTTAAAAGAAAAGGGGGGACTGG- 3 ' 
3'-AAAATTTTCTTTTCCCCCCTGACC-5' 
Figure 7.4. Schematic representation of wholly N7-purine oligonucleotides 
containing 7G and 7 A, and their target sites on double-helical DNA. The 
binding free energy for triple helix formation for two sets of sequences 
containing either alternating or largely contiguous 7 A • AT triplets were 
proposed to be determined. 
7A• ATf1G • GC 
Figure 7.5. Diagram showing that a 7A • AT and a 7G• GC triplet are not 
isomorphous. 
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A 
N 7 -2'-Deo:xyisoinosine 
B 
C 
Figure7.6. Structure of N 7-2'-deoxyisoinosine (7il) (A), the 7il•AT triplet (B), 
and representation of isomorphous 7iI•AT /7G•GC triplets (C). 
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AT CG 
GC TA 
Figure 7.7. Putative interaction of the four base pairs with N 7-2'-deoxy-
isoinosine. 
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triple helix formation by pyrimidine oligodeoxyribonucleotides containing 7il 
by quantitative DNase I footprint titrations. 5' '12'13 More specifically, we 
proposed to determine the equilibrium association constant of a pyrimidine-
rich oligonucleotide containing N 7-2'-deoxyisoinosine binding to targets on 
duplex DNA containing all four natural base pairs juxtaposed to the novel 
base (7I•AT, 7l•GC, 7l•TA, 7l•CG) (Figure 7.8). 12' 13 Our ultimate goal is the 
study of the binding properties of 7il within oligonucleotides containing 
wholly N7-purines to double-helical DNA by triple helix formation (Figure 
7.8), with the hope of observing very stable triple helices with little pH 
dependence and few sequence composition limitations. 
Below is a description of the progress made towards the synthesis of the 5 ' -
0-DMT-protected phosphoramidite of 7il. Efforts towards the completion of 
the synthesis beyond compound VII (Figure 7.9), and of the synthesis of 
oligonucleotides containing 7il were being undertaken by postdoctoral fellow 
Helmut Brunar at the time this thesis was written. 
Synthesis of N7-2'-deoxyisoinosine 
The synthesis of N 7-2'-deoxyisoinosine is shown in Figure 7.9. Silylation 
of 2-amino-6-chloropurine with N,0-bis(trimethylsilyl)acetamide followed by 
coupling to ~-D-ribofuranose 1,2,3,5-tetraacetate in the presence of stannic 
chloride afforded the ~-anomer of the N 7-glycosylated nucleotide Ill in 64% 
yield. 14 The stereochemistry of the glycosidic bond as well as the regio-
chemistry of glycosidic bond formation was determined by comparison of the 
spectral data of the isolated product with that of previously characterized N 7 -
2'-deoxyguanosine.9 Initial attempts to convert the chloro-substituted adduct 
III into the corresponding 6-thio derivative, and catalytically hydrogenate this 
adduct in the presence of Raney Nickel to afford the desired compound IV 
A 
XY= TA GC CG 
Third Strand Oligonucleotide: 
Duplex DNA: 
B 
Alternating Triplets: 
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AT 
314 bp 
5'-AAGAGAXAGAGGAAA-3' 
3'-TTCTCTYTCTCCTTT-5' 
Duplex: 5 1 -ATATAAAAAGAGAGAGAGATGGA-3 1 
3'-TATATTTTTCTCTCTCTCTACCT-5' 
Contiguous Triplets: 
Duplex: 5 1 -TTTTAAAAGAAAAGGGGGGACTGG-3 1 
3'-AAAATTTTCTTTTCCCCCCTGACC-5' 
Figure 7.8. Schematic representation of a pyrimidine oligodeoxyribonucleo-
tide containing 7iI binding to double-helical DNA targets containing all four 
natural base pairs (A), and of wholly N7-7iI-containing-purine oligonucleo-
tides and their target sites on double-helical DNA (B). The binding free 
energy for triple helix formation for two sets of sequences containing either 
alternating or largely contiguous 71 • AT triplets is proposed to be determined. 
me denotes 5-methyl-2'-deoxycytidine. 
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Figure 7.9. Synthesis of the 5'-0-DMT-protected phosphoramidite of 7il. 
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failed. However, catalytic hydrogenation over 10% activated Palladium on 
carbon of the chloro derivative III in the presence of a stoichiometric amount 
of triethylamine afforded excellent yields of the crude 6H-substituted 
derivative which, upon treatment with gaseous NH31 was converted into the 
deprotected compound IV in nearly quantitative yield according to a 
procedure used by Seela et al. for the synthesis of N 9-2'-deoxyisoinosine. 11 
Protection of the 3'- and 5'-hydroxyl groups with 1,3-dichloro-1,1,3,3-tetraiso-
propyldisiloxane,15 followed by removal of the 2'-hydroxyl group of the sugar 
under Barton deoxygenation conditions afforded 2-amino-7-(2'-deoxy-3',5'-O-
( tetraisopropy ldisiloxane-1,3-diyl)-~-D-erythro-pentofuranosyl)purine (VI) in 
good overall yield. At this point, experiments were successfully carried out to 
convert the amino derivative VI into the corresponding oxo derivative by 
diazotization of VI with tert-butyl nitrite. 16 Next, deprotection of the sugar 
hydroxyls followed by protection of the 5'-0H with dimethoxytrityl chloride 
was attempted,17 but the instability of N 7-2'-deoxyisoinosine to the reaction 
conditions and silica gel chromatography indicated that an alternative route 
to the synthesis of the 5'-O-DMT-protected phosphoramidite of 7iI should be 
followed. In one route, the order of the tritylation and diazotization reactions 
was reversed. In this route, the 5'-O-DMT-protected amino derivative of VI 
was obtained in good yield from treatment of the sugar-deprotected 
derivative of VI with DMTCl, but attempts to convert this adduct into 7iI by 
diazotization with tert-butyl nitrite failed, due to the instability of the 5'-O-
DMT-protected 7il adduct and its tendency to depurinate. Further attempts to 
protect the O6-carbonyl of N 7-2'-deoxyisoinosine under Mitsunobu conditions 
also failed, due to the instability of the nucleoside. These results suggested a 
route in which the formation of 7iI is avoided altogether, and the O6-protected 
adduct of 7iI is synthesized directly from the conversion of the amine adduct 
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VI into the corresponding chloro-substituted derivative VII, and 
displacement of the chloro substituent of VII with a suitable protecting group 
such as allyl alcohol. This route is advantageous as it avoids the difficult 
purification of the remarkably polar N 7-2'-deoxyisoinosine. Compound VI 
was thus treated with SbC13 in the presence of tert-butyl nitrite to afford the 
chloro adduct VII in 88% yield.18 This adduct proved to be stable to 
chromatography. Reaction of this compound with allyl alcohol in the 
presence of NaH led to depurination of the nucleotide. However, subsequent 
preliminary experiments carried out by H. Brunar showed that reaction of VII 
with allyl alcohol in the presence of 1,4-diazabicyclo[2.2.2]octane and K2CO3 
did not lead to decomposition of the product, but afforded the desired adduct 
VIII, albeit in low yield. 19 Removal of the disiloxane group, followed by 
protection of the 5'-hydroxyl with DMTCI17 and conversion to the 
corresponding 2-cyanoethyl-N,N-diisopropyl phosphoramidite IX, as well as 
the subsequent syntheses of oligonucleotides containing N 7-2'-deoxyiso-
inosine were yet to be carried out by Brunar at the time this thesis was 
written. 
Experimental Section 
General. 1H spectra were recorded on a General Electric QE 300 NMR 
spectrometer and chemical shifts are reported in ppm using the solvent peak 
(DMSO, 2.49 ppm; CDC131 7.26 ppm) as internal standard. Flash chromato-
graphy was carried out under positive air pressure using EM Science Kieselgel 
60 (230-400 mesh size). 
Materials. Dry CH3CN was obtained from Aldrich, and dry dichloroethane 
and THF were obtained from Fluka. Pyridine was distilled from CaH2 and 
allyl alcohol was distilled from K2CO3. Stannic chloride, 1,3-dichloro-1,1,3,3-
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tetraisopropyldisiloxane, p-tolylchloroformate, and tributyltin hydride were 
purchased from Fluka. Tert-butyl nitrite was purchased from TCI America. 
2-Amino-6-chloro-7-(2',3',5'-tri-0-acetyl-~-D-ribofuranosyl)purine (III). To 
a suspension of 2-amino-6-chloropurine (5.00 g, 30 mmol) and ~-D-ribofura-
nose 1,2,3,5-tetraacetate (6.36 g, 20 mmol) in dry CH3CN under argon was 
added N,O-bis(trirnethylsilyl)acetamide (14.68 mL, 60 mmol). The suspension 
was allowed to stir for 1 h, after which it turned into a clear solution. Then, 
the solution was cooled to O °C, and to it SnC14 ( 11.76 mL, 200 mL) was slowly 
added over 15 minutes. The resulting yellow solution was allowed to stir at 
room temperature under argon overnight. It was then diluted with CHC13 
(400 mL), washed with water (2x200 mL) and a saturated solution of NaHCO3 
(2x200 mL), dried (Na2SO4), and concentrated in vacuo. The resulting solid 
was triturated with EtOAc (10 mL), and washed to afford 5.51 g (64% yield) of 
product in the form of a white solid. 1H NMR (CDC13) 8 2.12 (s, 3H), 2.14 (s, 
3H), 2.18 (s, 3H), 4.40-4.42 (m, 2 H), 4.47-4.49 (m, 1 H), 5.40-5.42 (t, 1 H), 5.57-5.61 
(t, 1 H), 6.49-6.51 (d, 1 H), 8.43 (s, lH). 
2-Amino-7-(~-D-ribofuranosyl)purine (IV). To a solution of 2-amino-6-
chloro-7-(2',3',5'-tri-O-acetyl-~-D-ribofuranosyl)purine (III) (3.00 g, 7.00 mmol) 
and Et3N (1.2 mL, 7.2 mmol) in DMF (35 mL) was added 10% activated 
Palladium on carbon (620 mg). The mixture was allowed to stir at room 
temperature for 24 hr under H 2 at 50 psi. The resulting suspension was 
filtered over Celite, and concentrated in vacuo. Flash chromatography (2% 
Et3N, 7% MeOH, 91 % CH2Cl2) afforded 2.42 g (88%) of the 6H-substituted 
product in the form of a yellow oil. Then, a solution this product (0.60 g, 2.19 
mmol) in dry methanol (50 mL) was cooled to O °C and saturated with 
gaseous NH3• The solution was allowed to return to room temperature and 
stir under argon for 24 h. The resulting cloudy solution was concentrated in 
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vacuo. Flash chromatography (20-30% MeOH/CH2Cl2) afforded 0.57 g (96% 
yield) of the final desired product in the form of a white solid. 1H NMR 
(DMSO) 8 3.61-3.64 (m, 2H), 3.94-3.95 (m, 1 H), 4.07-4.27 (m, 1 H), 4.25-4.27 (m, 1 
H), 5.17-5.19 (t, 1 H), 5.22-5.23 (d, 1 H), 5.46-5.48 (d, lH), 5.74-5.76 (d, lH), 6.25 (s, 
2H), 8.47 (s, lH), 8.82 (s, lH). 
2-Amino-7-(3',5'-0-(tetraisopropyldisiloxane-1,3-diyl)-f3-D-ribofuranosyl)-
purine (V). A solution of 2-amino-7-(f3-D-ribofuranosyl)purine (IV) (3.94 g, 
14.7 mmol) in dry pyridine (60 mL) was cooled to O 0C, and to it 1,3-dichloro-
1,1,3,3-tetraisopropyldisiloxane (5.2 mL, 16.2 mmol) was added. The solution 
was allowed to stir at O °C for 20 minutes. It was then allowed to return to 
room temperature and stir for 6 h. The reaction solution was then 
concentrated in vacuo, and the resulting orange solid oil was dissolved in 
CH2Cl2 (100 mL), washed with water (50 mL), and a saturated solution of 
NaHCO3 (50 mL), and the combined aqueous layers were extracted with 
CH2Cl2• The combined organic layers were dried (Na2SO4), and concentrated 
in vacuo. Flash chromatography (3.5% MeOH/CH2Cl2) afforded 5.89 g (79% 
yield) of product in the form of a reddish solid. 1H NMR (CDC13) 8 0.98-1.10 
(m, 28H), 4.12-4.15 (m, 2H), 4.20-4.23 (m, lH), 4.51-4.52 (m, lH), 5.01 (s, 2H), 
5.84-5.85 (d, lH), 8.23 (s, lH), 8.64 (s, lH). 
2-Amino-7-(2' -deoxy-3 ',5'-0-( tetraisopropyldisiloxane-1,3-diyl)-f3-D-
erythro-pentofuranosy l)purine (VI). To a solution of 2-amino-7-(3',5'-O-
( tetraisopropy ldisiloxane-1,3-diy 1 )-f3-D-ribofuranosyl)purine (V) ( 4.0 g, 7 .85 
mmol) and N,N-dimethyl-4-aminopyridine (2.11 g, 17.3 mmol) in dry CH3CN 
was added p-tolylchloroformate (1.45 mL, 9.42 mmol) under argon. The 
yellow suspension was allowed to stir at room temperature for 14 h. The 
resulting solution was diluted in CH2Cl2, and washed with cold lN HCl, and 
then with a saturated solution of NaHCO3• The aqueous layers were extracted 
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with CH2Cl2, and the combined organic layers were dried (MgSO4), and 
concentrated in vacuo. Flash chromatography (3.5% MeOH/CH2Cl2) yielded 
3.39 g (66%) of a yellow-orange foam which was not further purified. The 
obtained product was dissolved in dry toluene (75 mL), and to it a,a'-azobis-
isobutyronitrile (0.20 g, 1.22 mmol) and nBu3SnH (1.96 mL, 7.38 mmol) were 
quickly added. The resulting orange solution was allowed to stir under argon 
at 75 cc for 3 h, during which time it was degassed frequently. The resulting 
yellow solution was concentrated in vacuo. Flash chromatography (3-4% 
MeOH/CH2Cl2) afforded 1.45 g (60% yield) of a slightly yellow solid which was 
not further purified. 1H NMR (CDC13) 8 0.94-1.10 (m, 28H), 2.57-2.60 (m, 2H), 
3.91-3.94 (m, 2H), 4.06-4.10 (m, lH), 4.60-4.70 (m, lH), 4.99 (s, 2H), 6.11-6.14 (m, 
lH), 8.17 (s, lH), 8.57 (s, lH). 
2-Chloro-7-(2'-deoxy-3',5'-0-(tetraisopropyldisiloxane-1,3-diyl)-~-D-
erythro-pentofuranosyl)purine (VII). A suspension of 2-chloro-7-(2'-deoxy-
3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)-~-D-erythro-pentofuranosyl)purine 
(VI) (0.030 g, 0.06 mmol) in dry dichloroethane (1 mL) was cooled to ~-10 cc 
(ice-salt water bath), and to it tert-butyl nitrite (0.035 mL, 0.30 mmol) and SbCl3 
(0.025 g, 0.11 mmol) were added. The reaction mixture was allowed to stir 
under argon at ~-10 cc for 4 h. Then the mixture was poured onto an ice-
water bath and stirred. The mixture was transferred to a separatory funnel, 
and extracted with CHC13• The organic layer was washed with water, a 5% 
solution of NaHCO3, dried (Na2SO4), and concentrated in vacuo. Flash 
chromatography (3% MeOH/CH2Cl2) afforded 0.027 g (88% yield) of product in 
the form of a white solid. 1H NMR (CDC13) 8 1.01-1.14 (m, 28H), 2.59-2.63 (m, 
2H), 3.99-4.16 (m, 3H), 4.71-4.76 (m, lH), 6.29-6.32 (m, lH), 8.56 (s, lH), 8.98 (s, 
lH). 
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